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Amylin Structure, Aggregation, and Pancreatic β Cell Toxicity 
Sharadrao Maruti Patil, PhD 
University of Connecticut, 2015 
 In most type 2 diabetes patients, amyloid plaques have been found juxtaposed with 
membranes of pancreatic β-cells. These plaques are composed of amyloid fibrils of the 37 residue 
endocrine hormone amylin and cause distinct changes in cell membrane morphology associated with 
the destruction of β-cells. Research is still ongoing to identify the toxic species involved and the 
mechanisms by which mature fibrils or oligomers cause cytotoxicity. The projects undertaken were 
designed to study the molecular structural features of amylin, mechanism of amyloid aggregation 
and, to develop cytotoxicity inhibitors. We determined the structure of human amylin bound to SDS 
micelles using NMR. In this membrane mimetic environment amylin adopts an α- helix structure for 
residues 5-28, with a kink between residues 18 and 22. The last nine C-terminal residues are 
unfolded. Paramagnetic spin probe data suggest the segment between residues 5 and 17 is within the 
hydrophobic lipid environment while residues 20-29 remain at the lipid-solvent interface. 
Experimental techniques such as total internal reflection fluorescence microscopy, fluorescence 
assays and cytotoxicity assays were undertaken to study fibrillization and the effect of designed 
cytotoxicity inhibitors. Microscopy experiments demonstrate three types of aggregate growth 
processes: globular seed formation, unidirectional fibril elongation and fibril thickening. The three 
aggregation processes are suggestive of secondary nucleation mechanisms. Lastly, three amylin 
peptide analogs were designed to inhibit fibrillization via electrostatic charge repulsion. The three 
analogs fibrillize poorly on their own and inhibit fibril elongation of WT-amylin at physiological 
salt concentrations. The most effective inhibitor Arg-1, inhibits amylin fibrillization and cytotoxicity 
with a potency comparable to other types of fibrillization inhibitors described in the literature. 
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CHAPTER I:  Introduction 
Amyloids 
 Amyloid Diseases are characterized by fibrillar deposits of amyloidogenic proteins. 
Amyloid deposits are associated with some 30 diseases including Alzheimer's [1], Parkinson's [2], 
dialysis-related amyloidosis [3], type 2 diabetes [4], Huntington’s Disease, systemic amyloidosis, 
and light-chain amyloidosis. Some amyloids have physiologically normal functions such as 
hormone storage [5] and bacterial biofilm formation [6]. The name amyloid comes from early 
mistaken identification of the substance as starch (Amylum) based on iodine staining techniques. 
Amyloids are formed by a variety of unrelated peptides & proteins but have similar morphologies 
by electron microscopy (Fig. 1.1A). The characteristic amyloid structures include long un-
branched fibers of diameter 5-10 nm with a twist at about 100 nm along the growth axis. The 
characteristic property of amyloid is the green birefringence under polarizing microscope after 
binding to Congo Red dye. Amyloid deposits are found in a number of protein misfolding diseases 
characterized by fibrillar protein deposits, in which protein monomers form intermolecular β-
sheets running along the length of the fibrils. Amyloid fibril growth shows typical nucleation 
kinetics. Amyloid fibrils are insoluble and are resistant to proteases and extreme treatments. 
 Amyloid aggregation is entropically disfavored until a critical nucleus is formed. In order 
to generate a long-range fibril like order in such structures, a critical number of molecules must be 
present such that the favorable enthaplic terms associated with their regular stacking can most 
effectively offset the accompanying loss of configurational entropy [7]. The effective peptide 
concentration, pH, and ionic strength also contribute towards such aggregation kinetics. Once a 
critical nucleus is formed aggregation is energetically favorable due to stable, and ordered fibrillar 
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structure formation. Initially a smaller number of nuclei are formed, this phase is called as “lag 
phase” and there is a delay before macro-aggregates (fibrils) are detected. Ones the nucleus is 
formed, fibril growth proceeds rapidly by further association of either monomers or oligomers with 
these nuclei. Protein monomer dissociation is more unfavorable at this stage and the monomer 
association with a growing surface and polymerization is close to irreversible. Fibrillization 
continues until the monomer concentration is sufficiently low. This stage is characterized as a 
plateau phase, where an apparent steady state is reached. The rate of fibril formation is governed 
by number of factors such as seeding which provides nucleation sites (surfaces for further 
aggregation) and eliminates the lag time. A typical amyloid fibrillization curve is shown below in 
Fig. 1.1B.  
 
 
Figure 1.1 Amyloid fibrils and fibrillization kinetics. (A) Negatively stained electron microscopy image of amyloid 
fibrils. (B) Kinetic curve depicting a typical amyloid fibrillization (20 μM amylin in 20 mM phosphate buffer at pH 
7.4, 2% Dimethyl sulfoxide (DMSO) and at 25 °C temperature).  
A B 
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Amyloid and Type 2 diabetes mellitus  
 Type 2 diabetes affects over 315 million people worldwide and is thought to cost upward 
of $250 billion dollars a year in the United States alone. One of the hallmarks of type 2 diabetes, 
found in 90% of patients, is the formation of extracellular amyloid aggregates composed of amylin.  
The endocrine hormone amylin also called as Islet Amyloid polypeptide (IAPP), appears to have 
key roles in diabetes pathology [8, 9]. The amyloids cause changes in the morphology of the 
pancreatic β-cells [8] and aggregates of amylin are toxic when added to cultures of β-cells, 
suggesting that the amyloid deposits found in situ may be responsible for β-cell death [10, 11].  In 
several transgenic mouse and rat models expression of human amylin has been found to correlate 
with β-cell apoptosis and diabetes-like symptoms [12], although considerable controversy remains 
on whether the fibrils themselves or smaller aggregates of amylin constitute the toxic species [13-
16]. The amyloid deposits accumulate in the interstitial fluid between islet cells and are usually 
juxtaposed with the β-cell membranes[8]. Genetic evidence that indicates amylin is directly 
involved in pathology includes a familial S20G mutation that leads to early onset of the disease 
[17] and produces an amylin variant that aggregates more readily [18, 19].  
Amylin is a 37 residue (~4 KDa) peptide hormone synthesized by the β-cells of the 
pancreas. It is involved in the metabolism of sugar and is secreted along with insulin. Amylin 
controls metabolic functions in concert with insulin by controlling glucose levels and gastric 
emptying. Amylin inhibits glucagon secretion and induces a feeling of satiety after a meal [8, 9]. 
After being expressed as pro-amylin in response to increased glucose concentrations, amylin 
undergoes post-translational modification inducing removal of 9 residues from the N-terminus and 
19 residues from the C-terminus. Subsequently the C-terminus is enzymatically amidated and a 
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Cys 2-Cys 7 disulfide bond is formed. These post-translational modifications are necessary for the 
physiological activity of amylin. The amyloidogenic propensity of amylin also increases as it 
undergoes post-translational modifications [20]. The amino acid sequence of amylin after post-
translational modifications is shown below.  
NH3-KCNTATCATQ RLANFLVHSS NNFGAILSST NVGSNTY-NH2 
In patients afflicted with type 2 diabetes, amylin is found in fibrillar deposits in the 
pancreas. These deposits are thought to be responsible for islet cell toxicity during type 2 diabetes 
progression. Under normal conditions amylin is synthesized and processed in the secretary 
granules and released along with insulin. Circulating amylin levels increase in a number of 
pathological conditions, including obesity, syndrome X, pancreatic cancer, and renal failure [20]. 
Normal human fasting amylin levels range from 1-10 pM, whereas post prandial levels increases 
to 5-20 pM. In obese insulin-resistant individuals amylin levels are reported up to 50-70 pM [21]. 
Amylin levels together with insulin are raised initially in type 2 diabetes but fall as the disease 
progresses to a stage where the pancreatic islets of Langerhans β-cells that synthesize amylin no 
longer function [8]. The concentration of amylin in the storage vesicles of β-pancreatic cells is 
much higher, where it is stored in concentrations of 0.1-4 mM together with insulin. At these high 
concentrations, aggregation may be prevented due to binding of amylin to insulin, or storage in 
the form of unprocessed 67 residue pro-peptide. The low pH of the storage granules (pH 5.5) as 
compared to the extracellular matrix (pH 7.4) may also slow down the aggregation of amylin, as 
studies from our lab and others have shown that amylin fibrillization is enhanced going from acidic 
to neutral pH [22, 23]. The schematic representation of the potential relationship of islet 
dysfunction, islet amyloid, and β-cell destruction in type 2 diabetes mellitus is shown in Fig. 1.2.  
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Autopsy studies of human pancreases obtained from type 2 diabetes patients show the 
presence of amyloid plaques in the interstitial spaces between β-cells in the islets of Langerhans 
and mature amylin is the major constituent of these plaques. The mechanism of amylin misfolding 
that leads to amyloid formation is still unclear and investigation of the structural properties of 
amylin during the early stages of fibrillization should clarify the pathway to fibrillar structure [24, 
25].  Detailed structural models are available for Aβ [26] and αS [27] bound to SDS micelle 
mimetics of membranes. For amylin there were models of peptide fragments 1–19 [28], 20–29 
[29], and 17–29 [30] bound to micelles but no structural model for the complete hormone was 
 
 
 
Figure 1.2 Schematic representation of the potential relationship of islet dysfunction, islet amyloid, and pancreatic β-
cell destruction in the pathophysiology of type 2 diabetes mellitus (adapted from [31]). 
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available. This turns out to be particularly important as the interplay between structure and 
dynamics in amylin only comes to light when considering the whole molecule. In chapter II of my 
thesis I discuss the solution structure of human amylin bound to SDS micelles. The structural data 
is complemented with information on dynamics and data on the immersion of amylin into micelles. 
Molecular structure data for amylin prompted our attention towards investigating amyloid 
fibrillization mechanics and the prevention of cytotoxicity. The projects focused on studying the 
fibrillization using fluorescence microscopy and spectroscopy along with the study of amyloid 
toxicity to mouse pancreatic cells. The application of fluorescence microscopy technique called 
total internal reflection fluorescence microscopy (TIRFM) to the study of individual amyloid 
fibrils was pioneered by the Goto lab who used the technique to study growth process of amyloid 
fibrils formed by the Alzheimer’s disease peptide Aβ(1-40), glucagon, and β2-microglobilin a 
protein involved in kidney dialysis-related amyloidosis [32-36].  The pioneering studies of amyloid 
by TIRFM provided important information on the kinetics of individual fibril growth starting from 
seeds, and on the unidirectional polarity of fibril elongation which is consistent with an amyloid 
structure in which β-strands pair predominantly in parallel along the length of the fibril [34, 35]. 
Chapter III of the thesis describes the use of TIRFM to image the aggregation of amylin.  Previous 
TIRFM studies of Aβ (1-40), glucagon, and β-microglobulin looked at fibril elongation starting 
from seeded solutions, that is mature fibrils were fragmented by sonication to provide nucleation 
sites for fibril growth [32, 34, 35].  Because amylin fibrillization is very fast, and because we 
wanted to examine the seeding processes, the reactions in our work were not seeded.  Our data 
emphasize that amylin fibrillization proceeds through multiple mechanisms involving a mixture 
of fibril types, and emphasizes the importance of heterogeneous or secondary nucleation [32, 37-
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39] in amylin aggregation.  
Consideration of amyloid structures suggests that like-charges, replicated along the fibril 
axis by the intermolecular β-sheet pairing of monomers, should energetically disfavor self-
association through electrostatic repulsion [40, 41]. Conversely, compensation of charges 
displayed on fibril surfaces may be important in the interactions of amyloids with polyanions such 
as heparan sulfate proteoglycans and membrane lipid bilayers [40, 42, 43]. Replacements of single 
charged residues can have large effects on fibrillization kinetics as shown with amyloid-beta[41], 
α-synuclein [44, 45], and amylin[46]. Amylin represents a particularly favorable system for 
investigating the roles of electrostatic charges in fibrillization, since the core of the intermolecular 
β-sheet fibril structure has only His18 as pH-titratable group. Introduction of single charged amino 
acids in the portion of the amylin sequence that forms the fibril core has been shown to markedly 
inhibit fibrillization [46].  
We therefore thought to exploit the property of electrostatic repulsion by designing peptide 
variants that incorporate a string of residues with like charges into the amylin sequence. The 
designed peptide Arginine-variant 1 (Arg-1), substitutes four arginines for WT-amylin residues 
Asn14-Val17.  The second analog, Arginine-variant 2 (Arg-2), substitutes four arginine residues 
for residues Phe23-Ile26 in the center of the amyloidogenic segment. A third peptide, the 
Membrane Trojan analog (Mem-T) was conceived as an inhibitor of the interactions of WT-amylin 
with cell membranes, rather than as a fibril elongation inhibitor. Chapter IV of the thesis examines 
the ability of the designed amylin analogs Arg-1, Arg-2 and Mem-T to form fibrils using a kinetic 
assay that employs the amyloid-specific fluorescent dye thioflavin T (ThT), and by imaging the 
reaction products with transmission electron microscopy (TEM). We investigated the ability of 
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peptide analogs to inhibit fibril formation when added in trans to WT-amylin, and characterized 
the concentration dependence of inhibition. We also investigated the ability of the above 
mentioned peptide inhibitors to inhibit fibrillization and in turn suppress cytotoxicity towards a 
mouse model of β-pancreatic cells when challenged with WT-amylin. 
 The projects undertaken successfully address the gaps between previous research on 
amylin in relation to type 2 diabetes. The NMR structure of amylin in presence of SDS micelle 
provides an insight into the peptide membrane interactions of the full length amylin peptide. The 
detailed molecular level study of possible amylin-membrane interaction could be significant in 
order to derive the possible membrane oligomer structures and fibril nucleation processes. The 
earlier studies of amyloids using TIRFM has provided an important information on kinetics of 
individual fibril growth starting from a seed. The TIRFM studies from our lab investigated the 
kinetics of individual fibril growth started without the initial seeding processes. Therefore, our 
microscopy study provides a real-time images of the fibril nucleation and the initial seed formation 
along with the effect of charge on the kinetics of fibril formation. In the concluding project, we 
designed amyloid cytotoxicity inhibitors and the results represent a new electrostatic-based 
approach to inhibit amyloid fibrillization and toxicity. The results point towards the possibility of 
rational design of more potent amyloid inhibitors. 
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CHAPTER II: NMR Structure of Micelle-bound Human Amylin 
Excerpted from: S.M. Patil, S. Xu, S.R. Sheftic, and A.T. Alexandrescu, Dynamic alpha-helix structure of 
micelle-bound human amylin, J. Biol. Chem. 284 (2009), 11982-11991. 
 
Abstract  
 To better understand the structural basis for the interactions between amylin and 
membranes, we determined the NMR structure of human amylin bound to membrane mimetic SDS 
micelles. The first four residues in the structure are constrained to form a hairpin loop by the single 
disulfide bond in amylin. The last nine residues near the C terminus are unfolded. The core of the 
structure is an α-helix that runs from about residues 5-28. A distortion or kink near residues 18-22 
introduces pliancy in the angle between the N- and C-terminal segments of the α-helix. Mobility, 
as determined by 15N relaxation experiments, increases from the N to the C terminus and is strongly 
correlated with the accessibility of the polypeptide to spin probes in the solution phase. The spin 
probe data suggest that the segment between residues 5 and 17 is positioned within the 
hydrophobic lipid environment, whereas the amyloidogenic segment between residues 20 and 29 
is at the interface between the lipid and solvent. This orientation may direct the aggregation of 
amylin on membranes, whereas coupling between the two segments may mediate the transition to 
a toxic structure. 
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Introduction 
A recurrent theme for amyloidogenic proteins is that toxicity appears to be exerted through 
membrane-bound oligomers that form pores and disrupt ion balance across membranes [7, 9, 47-
49].  Experimental evidence for such oligomers has been found for the amyloid-β (Aβ) peptides 
[50], which cause Alzheimer disease, and for α-Synuclein (αS), the protein involved in Parkinson 
disease [51]. The similar toxic effects exerted by these amyloidogenic molecules may have a 
common structural and physical basis. Detailed structural models were available for Aβ [26] and 
αS [27] bound to SDS micelle mimetics of membranes. For amylin there were models of peptide 
fragments 1–19 [28], 20–29 [29], and 17–29 [30] bound to micelles but as of yet no model of the 
complete hormone. This was particularly important because the interplay between structure and 
dynamics in amylin only comes to light when considering the whole molecule. The solution 
structure of human amylin bound to SDS micelles is described in this chapter.  The structure is 
complemented with information on dynamics and he data on immersion of amylin into micelles. 
Materials and Methods 
Materials - Recombinant human amylin (0.5 mg, lot number 718071NAM) and 15N-amylin (1 g, 
lot number 70507) were from rPeptide (Bogart, GA). The peptides were expressed in Escherichia 
coli and differ from human amylin by not having an amidated C-terminus. SDS (electrophoresis 
grade) was from Bio-Rad. D2O, d25-SDS, d4-acetic acid, d6-methanol, MnCl2, and 16-doxyl-stearic 
acid were from Aldrich.  
NMR Sample Preparation - 1 mg of 15N-amylin was used for all heteronuclear NMR studies. 
Sample 1 was prepared by taking up 0.5 mg of lyophilized 15N-amylin powder in a 0.25 ml 90% 
H2O, 10% D2O solution of 100 mM d25-SDS, 60 mM acetic acid, pH 4.6, to give a final amylin 
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concentration of 0.5 mM. Sample 1 was used for NMR assignments, structure determination and 
relaxation studies. Sample 2 was prepared by dissolving 0.5 mg of amylin into 0.66 ml of the 
solution described above to give a final concentration of 0.2 mM. Sample 2 was divided into 
aliquots and used for the paramagnetic quenching studies with Mn2+ and 16-doxyl-stearate. Sample 
3 was prepared by dissolving 0.5 mg of amylin at natural isotope abundance in 99.96% D2O 
containing 100 mM SDS, and 60 mM d4-acetate, pH 4.2. An internal 2,2-dimethyl-2-silapentane-
5-sulfonate standard was used for chemical shift referencing. 
NMR Spectroscopy - All NMR experiments were done on a 600-MHz Varian Inova spectrometer 
equipped with a cryogenic probe. Pulse programs were implemented from the Varian ProteinPack. 
A temperature of 37 °C was used for all experiments. NMR assignments were based on three-
dimensional HNHA, HNHB, TOCSY-HSQC (70-ms mixing time), and NOESY-HSQC (100- and 
200-ms mixing times) experiments. Spin systems were first grouped by amino acid type using 
through-bond scalar connectivities. Sequence-specific assignments were then made using dαN and 
dNN sequential walks [52] using NOESY-HSQC data. Stereospecific assignments for glycine 
methylene hydrogens were obtained from an HNHB spectrum as described in the literature [53]. 
Stereospecific assignments for side chain β-methylene hydrogens were made based on qualitative 
comparisons of the relative sizes of 3JNHα couplings in HNHB spectra [54] and intraresidue HN-
Hβ and Hα-Hβ NOEs in short mixing time NOESY experiments [55]. Assignments for micelle-
bound amylin have been deposited with the BMRB under accession number 16105. 
Structure Determination - A summary of the restraints used to calculate the NMR structures of 
micelle-bound amylin and of the statistics relating to the qualities of the structures is given in Table 
2.1. Distance restraints were grouped into four ranges (strong 1.8–2.7, medium 1.8–3.5, weak 1.8–
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5.0, and very weak 1.8–5.5 Å) based on the intensities of cross-peaks in the NOESY spectra. 
Backbone ϕ angle dihedral restraints of -60 ± 30° were included for 22 residues with 3JHNHα 
couplings [56] smaller than 6 Hz. Side chain χ1 restraints were included for eight residues based 
on HNHB coupling data and NOE data from short mixing time NOESY experiments [55]. 
Standard α-helix hydrogen bond restraints were included for 17 residues with 3JHNHα couplings 
and Hα secondary shifts in the α-helix range. Of the 17 residues, 8 could be identified in one-
dimensional 1H NMR spectra as experiencing hydrogen exchange protection for up to 30 min when 
amylin was dissolved in d25-SDS micelles suspended in D2O (Thr-9, Gln-10, Leu-12, Ala-13, Leu-
16, Leu-27, Ile-26, and Ser-20). For the remaining 9 residues, spectral crowding precluded 
unambiguous information on exchange protection in one-dimensional spectra. We calculated 
control structures with hydrogen bond restraints included for only the 8 amides unambiguously 
protected. These structures showed slightly decreased precision (the backbone r.m.s.d. increased 
from 1.4 to 1.7 Å for residues 6–27 and from 0.4 to 0.5 Å for residues 6–17). Despite the lower 
precision, there were no systematic changes in structure, and the NMR ensemble calculated with 
the full complement of hydrogen bonds fell within the breadth of the conformational ensemble 
calculated with less hydrogen bonds. We feel that the inclusion of all 17 hydrogen bond restraints 
is justified by the NOE and 3JHNHα coupling data that support hydrogen-bonded α-helical structures 
for the residues in question, and by the consistency of the hydrogen bonds with preliminary 
structures calculated without these restraints. The final NMR structure calculations started from 
500 conformations with randomized ϕ, ψ angles. Structures were calculated with the program X-
PLOR (version 3.851) [57] according to a published protocol [58]. The 30 lowest energy structures 
with no distance violations greater than 0.3 Å or dihedral violations greater than 3° were kept for 
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analyses. The coordinates were deposited with the Protein Data Bank accession code 2KB8. 
15N Relaxation Studies of Amylin Dynamics - 15N relaxation data were obtained using 1H-15N 
correlation experiments from the Varian Protein Pack based on published methods [59]. 
Longitudinal relaxation data were obtained from eight spectra collected with T1 relaxation periods 
of 20, 50, 130, 210, 310, 500, 700, and 1000 ms. To measure time constants for transverse 
relaxation, eight T2 relaxation periods of 10, 30, 50, 70, 90, 110, 150, and 190 ms were used. Pre-
acquisition delays of 2 s were used between transients. T1 and T2 values were determined from 
nonlinear least squares fits of the intensity decay as a function of relaxation period to Equation 2.1, 
 I = I0 · exp (-τ/T1, 2)                     (Eq. 2.1) 
Where, I is the intensity for relaxation period τ; I0 is the initial amplitude; and T1, 2 is the time 
constant for either T1 or T2 relaxation. Uncertainties in the T1 and T2 values were taken as the 
standard errors of the fits. 1H-15N NOE values were calculated as the ratio of intensities in an 
experiment recorded with proton saturation for 4 s to a control experiment where the saturation 
period was replaced with an equivalent 4-s delay as shown in Equation 2.2, 
NOE = I(s)/I(c)                 (Eq. 2.2)  
Uncertainties in the NOE values were calculated as shown in Equation 2.3, 
         σ NOE = I(s)/I(c) √(
𝛥𝐼(𝑠)
𝐼(𝑠)
)
2
+ (
𝛥𝐼(𝑐)
𝐼(𝑐)
)
2
                                 (Eq. 2.3) 
where, ΔI(s) and ΔI(c) indicate the root mean square base-line noise in the spectra with and 
without saturation [60]. 
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Table 2.1 Statistics for the 30 best micelle-bound amylin structuresa. 
NMR Restraints (total) 
Distance (total) 
Intraresidue 
Sequential (|i-j| = 1) 
Short Range (1 < |i-j| < 5) 
Long Range (5 ≤ |i-j|)  
Hydrogen bonds (17*2)  
Dihedral (total) 
( angle) 
(c1 angle) 
341 
311 
  34 
129 
113 
    1 
  34 
  30 
  22 
    8 
Residual restraint violations b 
Distance (Å) 
Dihedral (o) 
0.044 ± 0.005 
0.73 ± 0.16 
RMS deviations from ideal geometry 
Bonds (Å) 
Angles (o) 
Improper torsions (o) 
0.0034 ± 0.0003 
0.71 ± 0.02 
0.55 ± 0.03 
Non-bonded energies (kJ/mol)   
Van der Waals energy b 
Lennard-Jones energy c 
 28 ± 6 
1 ± 12 
Ramachandran regions      favored     allowed 
residues 1-37                      69.7 %      20.6 % 
residues 6-27                      95.5 %       4.5 % 
 gen. allowed 
       7.2 % 
       0.0% 
disallowed 
     2.4 % 
     0.0% 
Coordinate precision rmsd (Å)   
NMR ensemble to average 
residues 1-37 
residues 6-27 
residues 6-17 
residues 18-27 
C, C, N 
3.66 ± 0.76 
1.36 ± 0.45 
0.40 ± 0.14 
0.77 ± 0.23 
all heavy 
4.29 ± 0.80 
1.80 ± 0.42 
1.00 ± 0.19 
1.33 ± 0.32 
 
a Values are reported as the means over the final 30 structures ± 1 s.d.  These final lowest-energy structures had no      
 NOE violations greater than 0.3 Å or dihedral violations greater than 3°. 
b The energy was calculated using the X-PLOR [57] Frepel function with van der Waals interactions and atomic radii   
 set to 0.8 times their CHARMM values [61]. 
c Calculated using the CHARMM empirical energy function  [61]. 
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 S2 order parameters describing the amplitudes of internal motions [62] were calculated with 
the program TENSOR 2.0 [63] assuming isotropic rotational diffusion [27] for the amylin-micelle 
complex. To obtain a value for the global correlation time for rotational diffusion, we restricted our 
analysis to residues 5–17, which had 1H-15N NOE values greater than 0.55, 3JHNHα couplings smaller 
than 6 Hz, and Hβ chemical shifts consistent with stable α-helix structure. Using this subset of residues, 
we obtained a correlation time of 6.7 ns for global tumbling, which was used to calculate S2 values for 
individual residues. 
Paramagnetic Studies of Amylin Positioning in SDS Micelles - Separate experiments on 0.2 mM 
amylin in 100 mM SDS were performed with 16-doxyl-stearate and MnCl2. 16-Doxyl-stearate was 
prepared as a 100 mM stock solution in d6-methanol. The stock solution was used to bring the 
concentration of sample 2, to 1.85 mM in 16-doxyl-stearate. The aggregation number of SDS micelles 
is about 60 [64], so that a 100 mM SDS solution corresponds to a micelle concentration of 1.85 mM, 
or 1 spin probe per micelle. In a second experiment the concentration of 16-doxyl-stearate was raised 
to 9.2 mM corresponding to five spin probes per micelle. Experiments with paramagnetic Mn2+ were 
done at concentrations of 0.2 and 1 mM MnCl2, corresponding to ratios of 1:1 and 5:1 of the 
paramagnetic ion to amylin. 1H-15N HSQC spectra were used to measure paramagnetic quenching. For 
each experiment a separate control experiment was recorded to obtain cross-peak intensities in the 
absence of paramagnetic agents. 
CD Spectroscopy - Circular dichroism experiments were carried out on an Applied Photophysics II*-
180 instrument with samples maintained at a temperature of 37 °C. Far-UV wavelength scans from 
280 to 180 nm were collected on 250 μL volume samples held in a 1-mm path length cuvette. The 
samples contained 35 μM amylin in 60 mM acetic acid, pH 4.6, and varying concentrations of SDS. 
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Results  
Amylin Adopts an α-Helical Structure in the Presence of SDS Micelles - Although human 
amylin forms fibrils rapidly in water [23], it is soluble and stable for at least 2 months in 100 mM 
SDS at an acidic pH of 4.6. The 1H-15N HSQC spectrum of amylin under these conditions is shown 
in Fig. 2.1.  
Fig. 2.2A shows CD spectra of amylin with increasing concentrations of SDS at pH 4.6. In 
the absence of SDS, the CD spectrum of amylin looks roughly like that for an unfolded protein. 
Weak minima at 208 and 222 nm together with the lack of a pronounced minimum at 195 nm, 
however, are more indicative of a mixture of random coil and nascent α-helix conformations. The 
nascent α-helix structure in the absence of SDS probably corresponds to that characterized in detail 
by NMR for unfolded rat amylin [65]. In the presence of 5 mM SDS, there is already significant 
α-helix structure in the peptide. Under the conditions of our study (37 °C, pH 4.6), the critical 
micelle concentration of SDS in acetate buffer is about 2 mM. As the SDS concentration is raised 
from 5 to 10 mM, the amount of α-helix structure starts to plateau (Fig. 2.2A), and there are only 
small further changes in the CD spectrum between 10 and 100 mM SDS (Fig. 2.2A). We chose 
100 mM SDS for our studies because this value corresponds to a micelle concentration of ~2 mM 
(the number of SDS molecules per micelle is expected to be ~60). Compared with the 0.5 mM 
amylin concentration, 100 mM SDS ensures an excess of micelles to peptide so that each micelle 
should have only one molecule of amylin bound. Pulse-field gradient NMR experiments [66] give 
a diffusion constant for amylin in complex with SDS that within experimental error was the same 
as that obtained for the complex formed between SDS and Aβ-(1–40), a 40-residue peptide of 
similar size to the 37-residue amylin (Damylin/DAβ 0.99 ±0.06). This observation suggests that 
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Figure 2.1 1H-15N HSQC spectrum of micelle-bound amylin annotated with backbone NMR assignments. Side-chain 
correlations are indicated with the superscript ‘SC’.  Conditions: 0.5 mM 15N-amylin, 100 mM SDS, 60 mM acetate, 
pH 4.6, 37 oC. 
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like Aβ [67], amylin binds to micelles as a monomer at the large 100 mM SDS concentration used 
for this study. In addition to work at pH 4.6, we also obtained CD data at pH 10.8 in the presence 
of SDS. His-18, the only side chain in amylin that titrates in the physiological range, should lose 
its positive charge between pH 4.6 and 10.8. The CD spectrum between 200 to 280 nm showed 
very little difference between the two pH values. In the 180–200 nm range, the spectrum at pH 
10.8 lacked the large positive band associated with α-helix structure and was noisier, possibly due 
to light scattering caused by increased aggregation at pH 10.8. 
 Fig. 2.2B shows the sequence profile of 3JHNHα couplings calculated from an HNHA 
experiment [56]. Couplings below 6 Hz indicative of ϕ dihedral angles in the α-helix range occur 
for all residues between 5 and 28, except 18 and 22. On average the group of couplings between 
residues 5 and 17 is smaller than that for residues 23–28. Fig. 2C shows the difference between 
random coil values [68] and the Hα chemical shifts of amylin. The secondary shifts for the region 
between residues 5 and 28 are positive, typical of α-helix structure. The secondary shifts show a 
periodicity of 3–4 residues, also consistent with α-helix structure [69, 70]. Periodicity is also 
observed for the HN chemical shifts (Fig. 2.2D), and this type of periodicity has been attributed to 
α-helix curvature [71, 72]. The secondary Hα shifts, which are the most sensitive to secondary 
structure, appear to be on a gradient decreasing from residues 8 to 28 (Fig. 2.2C).  The data suggest 
a higher stability for α-helix structure in the N-terminal half of amylin. Fig. 2.2E summarizes the 
short range NOEs observed for amylin. The NOEs are indicative of α-helix structure. There is a 
break in the pattern near residues 18-22, consistent with a discontinuity in the α-helix structure. 
Although there is overlap of HN chemical shifts within this segment (Fig. 2.1) that precludes the 
detection of HN-HN NOEs, other types of NOEs predicted for an α-helix structure such as  
  
   19 
 
 
 
Figure 2.2 Data illustrating the α-helix structure of micelle-bound amylin. (A) CD spectra of amylin at 0, 5, 10, and 
100 mM concentrations of SDS. (B) 3JHNHα couplings obtained from a 3D HNHA experiment.  (C) Secondary Hα 
chemical shifts calculated as the difference between micelle-bound amylin and ‘random coil’ values [68]. (D) 
Periodicity of HN chemical shifts illustrated as the difference from ‘random coil’ values [68]. (E) Summary of short-
range NOEs. 
-20 
-10 
20 
30 
10 
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dαN(i,i+3), dαN(i, i + 4), and dαβ(i, i + 3) are weak or missing. Moreover between residues 5 and 
28, His-18 and Asn-22 are the only two sites with 3JHNHα values above 6 Hz, consistent with a 
departure from α-helix structure in this segment. Although not apparent in the semi-quantitative plot 
(Fig. 2.2E), α-helix NOEs are weaker for the 22-28-residue segment compared with the 5-17-residue 
segment. 
NMR Solution Structure of Micelle-bound Amylin - The NMR structure of amylin is shown in 
Fig. 2.3. Information on experimental restraints used to calculate the NMR structure ensemble and 
parameters related to the quality of the structures are given in Table 2.1. At the N-terminus, residues1- 
4 are constrained to a hairpin topology by a disulfide bond between Cys-2 and Cys-7. The Cys-7 part 
of the disulfide is in the α-helix and is ordered, giving a nonaveraged side chain χ1 of -60°. The Cys-
2 residue is disordered. The last 8 residues between Thr-30 and Tyr-37 are also disordered. The core 
of the structure consists of an α-helix running from residues 5 to 28. Most of the members of the NMR 
ensemble have a kink or bend in the α-helix between residues 18 and 22. When the NMR ensemble 
is superposed on the mean backbone coordinates of the entire α-helix (residues 6-27), the resulting 
root mean square deviation (r.m.s.d.) of 1.4 Å is rather large (Fig. 2.3A and Table 2.1). Consequently, 
we did a systematic search for residue ranges that would improve the r.m.s.d., and we found that the 
precision of the structure improves if the segments 6-17 (Fig. 2.3B) and 18-27 (Fig. 2.3C) are 
considered separately. Leaving out segment 18-22 did not improve the fit significantly compared with 
that obtained for residues 6-27. This indicates that the poor r.m.s.d. when the whole helix is considered 
is because of an uncoupling of the relative orientations of the 6-17- and 18-27-residue segments rather 
than disorder in the middle of the helix. We used the MolMol program [73] to calculate a value of 30 
±18° for the inter-helical angle between segments 6-17 and 18-27. 
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Figure 2.3 NMR structure of micelle-bound amylin and sequence conservation relative to the human protein.  (A) 
Ensemble of the 30 best NMR structures overlaid on the mean Cα, N, and C’ backbone atom coordinates of residues 
6 to 27.  (B) Structures fitted to the backbone mean of residues 6 to 17.  (C) Structures fitted to the backbone mean of 
residues 18 to 27.  (D) Sequences of the 10 closest homologs of human amylin obtained from a BLAST [74] search 
against the Swiss-Prot [75] database.  Residues that differ with respect to the human sequence are shown in inverse 
type. 
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 The organization of the micelle-bound amylin structure into subdomains is reminiscent of 
that seen with αS and the Alzheimer Aβ-(1- 40) peptide. In the presence of SDS micelles αS folds 
into an α-helix hairpin structure [27, 76]. The Aβ-(1– 40) peptide when bound to SDS micelles 
adopts an α-helical structure with a kink between residues 26 and 28 [26]. The two helical segments 
15-24 and 28-36, flanking the kink superpose well individually but have different orientations 
relative to each other with an inter-helical angle of 48 ±15° [26].  
Generally the kinks in micelle bound structure correspond with locations of turns adopted 
by these proteins in amyloid fibril structure[77]. Of the two α-helix segments, residues 6-17 gave 
a more precise structure than residues 18-27 (Fig. 2.3, B and C, and Table 2.1). This is consistent 
with the magnitudes of the 3JHNHα couplings (Fig. 2.2B) and Hα secondary shifts (Fig. 2.2C), which 
suggest the α-helix structure is more stable in the 6–17-residue segment. As described below, 
micelle-bound amylin shows a gradient of backbone dynamics, with the 6-17-residue segment 
corresponding to the least flexible part of the polypeptide chain. The structural precision and 
dynamics of micelle-bound amylin correlate with the amino acid sequence conservation in amylin 
homologues. Fig. 2.3D shows the sequences of the 10 closest homologues of human amylin 
identified in a BLAST search [74] against the Swiss-Prot data base [75]. The N-terminal half of 
amylin, which has the highest avidity for membranes [78], shows the highest sequence 
conservation. The C-terminal part of amylin, which in human amylin is the most amyloidogenic 
[78, 79], has the lowest sequence conservation. 
Dynamic Properties of Micelle-bound Amylin - Fig. 2.4 shows 15N relaxation data for micelle-
bound amylin. The experimental relaxation parameters T1 (Fig. 2.4A), T2 (Fig. 2.4B), and the 
1H-
15N NOE (Fig. 2.4C) suggest a gradient of increasing flexibility from the N- to the C-terminus.  
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Figure 2.4 Dynamics of micelle-bound amylin (A) 15N T1 values.  (B) 15N T2 values. (C) 1H-15N NOEs. (D) S2 order 
parameters calculated [63] from 15N relaxation data using an isotropic model of rotational diffusion for the amylin-
micelle complex.  Errors in S2 values were calculated with the TENSOR program [63] using 100 Monte Carlo 
simulations to probe the uncertainty in internal mobility due to errors in the experimental relaxation data. 
Calculations to obtain a correlation time for global rotational diffusion were done with the program 
TENSOR 2.0 [63] using data for the least flexible segment between residues 5 and 17. The 
calculations assuming isotropic tumbling since, amylin is bound to a roughly spherical micelle 
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[27], gave a global correlation time of 6.7 ns. For comparison, free SDS micelles have a correlation 
time of ~5.5 ns at 35 °C [80], and the correlation time of a complex formed between SDS micelles 
and a 22-residue peptide similar in size to the 37-residue amylin was 6.6 ns [81]. Although the 
agreement observed is good, we note that the correlation time of SDS micelles depends on a 
 
Figure 2.5 Spin probe studies of amylin positioning in SDS micelles. (A) Effects of MnCl2 on 1H-15N HSQC cross-
peak intensities. (B) Effects of 16-doxyl-stearate on cross-peak intensities. (C) Control 1H-15N HSQC of micelle-
bound amylin showing intensities in the absence of paramagnetic spin probes. (D) Spectrum in the presence of 1.0 
mM MnCl2. The correlations that persist are labeled.  Side-chain correlations are indicated with the superscript ‘SC’. 
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number of variables, including detergent concentration, ionic strength, and the molecules 
complexed to the micelle [82]. Nevertheless, the 6.7 ns rotational correlation time is most 
consistent with amylin binding to the SDS micelles as a monomer. The TENSOR2.0 program [63] 
was used to calculate S2 order parameters, which describe the amplitudes of internal motions on 
the fast ps to ns time scale. The data are shown in Fig. 2.4D and suggest a subdivision of amylin 
dynamics into three subdomains. The segment running from residues 4 to 18 has the lowest 
mobility with all S2 values greater than 0.8. Residues 19-30 have S2 values between 0.7 and 0.5. 
Finally, the last 7 residues have S2 values smaller than 0.4. Only two residues Asn-3 and Thr-4 
required R2ex exchange broadening terms (2 Hz) to account for the experimental relaxation data.  
Positioning of Amylin in the SDS Micelle - Fig. 2.5 shows the results of paramagnetic quenching 
experiments used to define the interactions of amylin with SDS micelles. Paramagnetic Mn2+ 
provides a probe of surface accessibility to bulk solution. At a 1:1 ratio of Mn2+ to amylin, the C-
terminal half of the protein is already substantially broadened (Fig. 2.5A). The 30-37-residue 
segment, which is unstructured, experiences the most severe quenching. The 21-29-residue 
segment, although α-helical, experiences more broadening than the 5-17-residue segment. At a 5:1 
ratio of Mn2+ to amylin, most of the backbone HN signals from residues after Val-17 are barely 
visible. The 2-16-residue segment survives even at this higher concentration of Mn2+, indicating it 
is immersed in the micelle (Fig. 2.5, C and D). Interestingly, the 2-16-residue segment also shows 
at least partial protection of side chain amide protons. Each of the side chains of Asn-14, Arg-11, 
Gln-10, and Asn-3 has at least one HN proton inaccessible (Fig. 2.5D). In addition to Mn2+ we 
also looked at paramagnetic quenching with 16-doxyl-stearate (Fig. 2.5B). This lipid has a spin 
label near the ω-end of the detergent chain, so the paramagnetic probe should be incorporated near 
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the hydrophobic center of the micelle. In contrast to Mn2+, the 16-doxyl probe caused little specific 
quenching, except perhaps for residues 2, 5, and the glycine at position 33. These data suggest that 
although amylin is immersed below the surface of the micelle, it does not traverse to its center. 
Discussion 
In this study we report NMR assignments, the solution structure, and dynamics of amylin 
when bound to SDS micelles. Although SDS micelles are not physiological, their relatively small 
size makes them amenable to high resolution structure studies by NMR. Indeed, the most detailed 
structural models available for the amyloidogenic proteins Aβ [26] and α-synuclein [27] in 
membrane-like environments came from work with SDS micelles. We envision that the micelle-
bound structure of amylin will pave the way for studies with more realistic membrane mimetics 
like bilayers or vesicles.  
Aspects of the amylin NMR structure related to its dynamic and micelle-binding properties 
are highlighted in Fig. 2.6. Fig. 2.6A shows a ribbon representation of the NMR structure color 
coded according to the S2 order parameters derived from 15N relaxation data (Fig. 2.4). Micelle-
bound amylin folds into an α-helix running from about residue 5 to 28. The structure is not 
uniformly stable but shows a ramp of increasing flexibility toward the C terminus (color coded 
from blue for rigid, to red for flexible). Residues 5-17 form the most rigid part of the α-helix, and 
disorder increases from residues 18 to 28. Residues 1-4 are constrained to form a hairpin turn by 
the Cys-7-Cys-2 disulfide bond, and residues ~30-37 are unfolded. We note that in contrast to the 
recombinant peptide studied here, amylin in vivo undergoes post-translational processing that 
results in an amidated C-terminus. Amidation is required for amylin activity [8], presumably due 
to the interactions of the hormone with its receptors. Because the last 8 residues in the  micelle  
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Figure 2.6   Properties of the micelle-bound amylin structure. (A) Ribbon diagram of the NMR structure color-coded 
according to S2 order parameters (data from Fig. 2.4D).  The color ramp ranges from blue (large S2, rigid) to red (small 
S2, flexible). The side-chains of Cys2 and Cys7 are shown in yellow to illustrate the disulfide bond. (B) Stereo-pair 
(cross-eyed) showing the precision of side-chain conformations for residues 6-16 is similar for the hydrophobic 
(brown) and hydrophilic (violet) faces of the helix. (C) Schematic diagram illustrating the structure of micelle bound 
amylin. The ensemble of 30 NMR structures were superposed on the mean backbone coordinates of residues 6-17, 
and the ribbon diagrams were color-coded according to spin probe accessibility with 1.0 mM MnCl2 (data from Fig. 
2.5A). The color ramp ranges from blue for backbone amides protected from the spin probe to red for amides that 
experience large NMR peak intensity losses in the presence of 1 mM MnCl2. The gray ellipsoid illustrates an SDS 
micelle. The micelle and peptide are not drawn to scale, and we do not have quantitative information on the distance 
the peptide penetrates into the micelle. The schematic is simply to illustrate that based on spin probe data the N-
terminal half of the peptide is immersed into the micelle, and that immersion correlates with the dynamic properties 
of the peptide (Fig. 2.6B). 
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bound amylin structure are disordered, we think it is unlikely that amidation has a role in the interaction 
of the peptide with membranes. In our structure the α-helix of amylin has a kink or discontinuity near 
residues 18–22. The micelle-bound states of other amyloidogenic proteins, kinks or distortions from 
α-helix conformations also correlate with the locations of turns in the fibrillar β-sheet structures [77]. 
Thus in micelle-bound Aβ the first 15 residues are disordered and a kink in the α-helix occurs in the 
26–28-residue region [26]. The first 15 residues are also disordered in Aβ fibrils, and a reverse turn 
occurs between residues 26 and 30 [83]. The micelle-bound state of α-synuclein consists of a broken 
helix with an interruption of α-helical conformations near residues 42-44 [27]. This location roughly 
corresponds to a turn between strands β1 and β2 in the fibril structure, and more generally regions of 
α-synuclein with small S2 order parameters [27] in the micelle bound structure  appear to correlate with 
gaps between β-strands in a recent model of α-synuclein fibrils [84]. For amylin, residues 12-17, 22-
27, and 30-37 are thought to make up the strands of β-sheet in amyloid fibrils of the peptide [24]. The 
strands correspond to the dynamic subdomains of micelle-bound amylin identified in the current work, 
and the discontinuity in the α-helix structure near residues 18-22 corresponds to a turn in the putative 
fibril structure. These observations suggest that intrinsic sequence turn propensities may have roles in 
determining β-sheet topology in the fibrils.  
NMR structure of a 1-19-residue fragment of human amylin in dodecylphosphocholine 
micelles also identified α-helix structure between residues 7 and 17 [28]. The difference from our 
structure at the C terminus is probably due to end fraying effects in the fragment. A second 20-29-
residue fragment in SDS micelles adopted a structure consisting of a series of reverse turns [29]. A 
third 17-29-residue fragment showed NMR and CD evidence for weakly stable α-helix structure [30]. 
A model for intact amylin in large unilamellar vesicles is available from EPR studies [78]. This work 
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identified α-helix structure running from residues 9 to 22. The helix starts later than position 5 in our 
structure. This may result from the substitution of the cysteines at positions 2 and 7 with alanines for 
the EPR studies. Although the helix ends at position 22 in the EPR study rather than 28 in this work, 
the data are consistent with our dynamic structure of amylin. The EPR experiments measure mobility 
and accessibility of the spin labels introduced into amylin [78]. Although residues 23-28 are in an α-
helix conformation according to the NMR data (Fig. 2.2, B-D), both mobility (Fig. 2.4D) and solvent 
accessibility (Fig. 2.5A) are increased in this region compared with the 5–17-residue segment.  
As noted for micelle-bound α-synuclein [27], protein backbone dynamics are highly correlated 
with the degree of immersion of individual sites into the micelle. Indeed, conformational restriction of 
segments of the polypeptide chain bound to micelles is a common theme in peripherally bound proteins 
[85]. Although amylin binds roughly parallel to the micelle surface, the degree of immersion varies 
from site to site based on accessibility to paramagnetic Mn2+. The S2 order parameters of amylin (Fig. 
2.4D) are linearly correlated with the quenching data obtained at 0.2 mM Mn2+, with an R2 of 0.73. 
This indicates that 73% of the variance in S2 values can be explained by the variance in solvent 
exposure of amylin. The strong correlation probably arises because the lower dielectric constant of the 
micelle environment should favor hydrogen bonding of polar groups in the polypeptide backbone [9]. 
Greater immersion in the micelle would thus increase the stability of hydrogen-bonded α-helix 
structure and decrease backbone mobility. Interestingly, our paramagnetic quenching data with Mn2+ 
show that some of the NH-containing side chains in amylin are at least partially protected from solvent 
by the micelle. A stereo pair illustrating the side chain conformations of residues 6-17 is shown in Fig. 
2.6B. The brown side chains in Fig. 2.6B are hydrophobic and should point toward the interior of the 
micelle, whereas the violet hydrophilic side chains should be oriented toward the solvent [78]. Fig. 
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2.6B shows that the precision of the side chains in the NMR ensemble is similar for the two faces of 
the amphipathic α-helix, which seems consistent with the paramagnetic quenching data that suggest 
hydrophilic residues in the 5–17-residue region are partially immersed in the micelle. Consistently, 
amylin monolayer insertion depth measurements using EPR indicate that the center of the stable α-
helix of amylin is immersed 6-9 Å below the lipid head groups, with the immersion depth decreasing 
from the N to the C terminus of the helix. Monolayer experiments are also consistent with an insertion 
of the N-terminal part of amylin into lipid membranes [86].  
A highly schematic model illustrating our results on the binding of amylin to SDS micelles is 
shown in Fig. 2.6C. The gray ellipsoid in Fig. 2.6C represents an SDS micelle. The ribbon diagrams 
in Fig. 2.6C illustrating the NMR ensemble are color coded according to spin probe accessibility, with 
blue representing inaccessible and red representing accessible. The segment between residues 5 and 
17 is immersed just below the surface of the micelle, stabilizing α-helical structure and dampening the 
dynamics of this region. The Cys-7-Cys-2 disulfide directs residues 1-4 to form a hairpin turn that 
presumably brings Lys-1 near the surface of the micelle to avoid burying a positively charged group 
in a hydrophobic environment. The N-terminal part of amylin thus acts as a “hook” anchoring the 
hormone to the micelle.  
Although amylin can bind to phospholipids as a monomer [86], we are unaware of such an 
interaction in the normal function of amylin. At the same time amylin needs to bind to transmembrane 
receptors [87] and to cross the blood-brain barrier [88] so the hydrophobic character of the N-terminal 
part of the hormone could facilitate those functions.  
At the end of the 5-17-residue segment, residues 18-28 show a gradient of diminishing 
protection from paramagnetic quenching and increased backbone dynamics. Presumably these 
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residues are located at the interface between the micelle and solvent. Although residues 18–28 are in 
α-helical conformations, the axis of the helix shows considerable variance relative to the 5–17-residue 
segment with an average inter-helix angle of 30 ᵒC. The ability of the N-terminus to insert into 
membranes could facilitate the assembly of amylin into toxic aggregates. Anchoring in the membrane 
would work to increase the effective concentration of amylin and would reduce the entropic cost of 
self-association by orienting molecules within the plane of the membrane lipid bilayers [9]. The 
dynamic character of the 22–29-residue segment would allow induced fit association, and its placement 
at the interface between lipids and solvent may nucleate aggregation. Under the conditions of the 
present studies, amylin is very stable, but we have an excess of SDS micelles to peptide. When the 
peptide predominates, with different types of lipids or under slightly different solution conditions, 
membranes could catalyze amylin aggregation [89-91].  
The gradient in dynamics, the correlation of the helices when coordinates are fitted over the 
entire 5-28-residue region, and the presence of a few short range NOEs that span the 18-22- residue 
region suggest that although there is flexibility in the relative orientation of the α-helical segments 5-
17 and 18-28, their structures remain coupled. This is important because although our work provides 
a model for amylin peripherally associated to membranes, a toxic pore composed of oligomeric amylin 
would have to traverse the membrane lipid bilayers. Presumably, aggregation of the amyloidogenic 
20-29-residue segment results in the transmission of a conformational switch to the 5-17-residue 
segment that allows it to traverse the membrane bilayer. Structural coupling between the 
amyloidogenic and membrane-immersed segments could thus facilitate the transition to a toxic state 
when membrane-bound amylin oligomerizes.  
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Figure 2.7 Human amylin structure at pH 4.6 superimposed on top of human amylin structure at pH 7.3 highlighting 
the difference between intrahelical angles (PDB code 2KB8 and 2L86). 
 
 Subsequent NMR structural studies of amylin in SDS micelles at physiological pH show 
structural similarities with our structure done at acidic pH. An α-helix was found running from residues 
7-17, and residues 21-28. In addition to the similarities to our structure, the 310 helix was found 
between residues Gly33-Asn35. The biggest difference was in the angle between the two α-helical 
segments separated by the kink near His 18.  In the neutral pH structure this angle constrained to 
85° compared to 30° in our structure (fig. 2.7). The C-terminal region of the peptide in neutral and 
acidic pH remains unstructured [92]. The higher intra helical angle identified for the structure of 
micelle bound amylin at neutral pH, resembles to the structure of amylin and the related mutant 
pramlintide determined later in fluorinated organic solvents [93], suggesting the kink in the helix 
between residues 17-22 is not enforced by membrane binding. Structural similarity have also been  
 
 
N-terminal 
pH 4.6 
pH 7.3 
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Figure 2.8 The 3-dimensional structures of human amylin in presence of SDS micelle (A), rat amylin in the presence 
of DPC micelles (B). The hydrophobic residues that have been implicated in coiled-coil interactions (blue) stabilize 
the amylin oligomer (adapted from Westermark et.al. [4, 94]). 
 
found between the rat amylin structure determined in the presence of DPC micelle and our human 
amylin structure bound to SDS micelle (fig. 2.8) [4, 94]. The interaction of the peptide with the 
lipid membrane is of significant interest as it increases the rate of peptide aggregation which can 
in turn result in membrane disruption [90, 91]. The NMR structure of a truncated version of a 
truncated version of human amylin (human amylin 1-19) showed that protonation of His 18 causes 
a change in its membrane binding topology from a buried to a surface associated state [28] a 
phenomenon that was also with β-cell membranes as demonstrated by a H18R human amylin 1-
19 mutant [95]. The higher intra helical angle between residues 18-22 and the charge on His-18 at 
physiological pH correlate with higher fibrillization propensity and cytotoxicity of human amylin. 
Therefore, the effects of charge on amylin fibrillization are discussed in next chapter of this thesis. 
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CHAPTER III: Heterogeneous Amylin Fibril Growth Mechanisms Imaged by  
Total Internal Reflection Fluorescence Microscopy 
Excerpted from : S.M. Patil, A. Mehta, S. Jha, and A.T. Alexandrescu, Heterogeneous amylin fibril growth 
mechanisms imaged by total internal reflection fluorescence microscopy, Biochemistry 50 (2011) 2808-2819. 
 
Abstract 
 Total internal reflection fluorescence microscopy has been used to visualize the 
fibrillization of amylin. Data were obtained at acidic pH where fibrillization is hindered by the 
charging of histidine-18 and at slightly basic pH where the loss of charge on the histidine promotes 
aggregation. The experiments show three types of aggregate growth processes. In the earliest steps 
globular seeds are formed with some expanding radially during the course of the reaction. The 
dimensions of the globular seeds as well as their staining with the amyloid-specific dye thioflavin 
T indicate that they are plaques of short fibrils. The next species observed are fibrils that invariably 
grow from large globular seeds or smaller punctate granules. Fibril elongation appears to be 
unidirectional, although in some cases multiple fibrils radiate from a single seed or granule. After 
fibrils are formed, some show an increase in fluorescence intensity that we attribute to the growth 
of new fibrils alongside those previously formed. All three aggregation processes are suggestive 
of secondary (heterogeneous) nucleation mechanisms in which nucleation occurs on preformed 
fibrils. Consistently, electron micrographs show changes in fibril morphology well after fibrils are 
first formed, and the growth processes observed by fluorescence microscopy occur after the 
corresponding solution reactions have reached an initial apparent plateau. Taken together, the 
results highlight the importance of secondary nucleation in the fibrillization of amylin, as this could 
provide a pathway to continued fibril growth once an initial population of fibrils is established. 
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Introduction 
We used TIRFM in conjunction with the amyloid specific dye ThT to follow the growth 
processes of individual amylin aggregates. At the interface between a medium with a large 
refractive index (glass slide) and a medium with a small refractive index (aqueous solution), laser 
excitation can be used to induce a thin 100-200 nm electromagnetic field called an “evanescent 
wave” in the medium with the smaller refractive index [33, 96, 97].  This narrow illumination field 
can be used for TIRFM imaging of objects lying along the plane of the coverslip [33]. Compared 
to conventional fluorescence microscopy, background fluorescence from fluorophores in bulk 
solution decreases exponentially with distance from the slide-solution interface in TIRFM [97]. 
While TIRFM has the same resolution as light microscopy, the exquisite sensitivity of the 
technique makes it possible to detect single molecules. 
The amyloid-specific dye ThT was used to image the fibrils. Binding of ThT to amyloid 
fibrils causes marked changes in the fluorescence spectrum of the dye. These include red shifts in 
the excitation maximum from 385 to 450 nm and in the emission maximum from 445 to 482 nm 
and a large increase in quantum yield when the dye is bound to the amyloid cross-β structure [98].  
These properties make ThT ideal for imaging amyloid fibrils by TIRFM, since fluorescence from 
the free dye in solution is minimal and the dye is specific to amyloid fibrils [33]. Conversely, 
aggregates that lack the specific cross-β sheet structure of amyloid fibrils will be invisible to 
TIRFM imaging using ThT. Alternatively, fluorescent dyes can be covalently attached to 
amyloidogenic proteins to image their fibrillization [99-101]. Amyloid fibril imaging by TIRFM 
has provided important information on the kinetics of individual fibril growth and on the 
unidirectional polarity of fibril elongation [34, 35, 99-101]  predicted by fibril structure composed 
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primarily of parallel β-sheets. 
 Previous TIRFM studies looked at fibril elongation starting from seeded solutions; that is, 
mature fibrils were fragmented by sonication to provide nucleation sites for fibril growth [32, 34, 
35]. Amylin fibrillization is fast and we also wanted to investigate seed formation, therefore the 
reactions in the present work were not seeded. Because we were interested in the effects of charge 
on amylin fibrillization, we obtained TIRFM data under acidic conditions close to those the 
hormone experiences when it is stored in β-cell secretory granules, and near the neutral pH 
conditions amylin is exposed to when it is released into the extracellular matrix [23].  Data on the 
growth of individual aggregates on the surface of a slide monitored by TIRFM were compared to 
snapshots sampling the population of aggregates that develop in solution using the higher 
resolution afforded by EM. Kinetics of individual fibrillar aggregates measured by TIRFM were 
compared with fibrillization kinetics in solution measured by fluorescence spectroscopy. Our 
results indicate that amylin fibrillization proceeds through multiple mechanisms involving a 
mixture of fibril species and emphasize the importance of secondary nucleation [32, 37-39] in 
amylin fibrillization. 
Material and Methods: 
Sample Preparation. Human amylin containing an amidated C-terminus and a Cys2-Cys7 
disulfide bond was purchased from Anaspec (Cat. No. 60254-05; San Jose, CA). The peptide, 
which was >95% pure, was supplied as a dry powder in 0.1 mg amounts sealed in glass vials. 
Because the peptide is poorly soluble in water, samples were dissolved in 10% acetonitrile (ACN) 
according to the manufacturer’s suggestion. A 20 mM sodium phosphate buffer was used for 
studies at pH 8 while a 60 mM sodium citrate buffer was used for experiments at pH 4. Additional 
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experiments were done in which the peptide was initially dissolved in 100% Dimethyl sulfoxide 
(DMSO) before adjusting the samples to a final concentration of 4% (v/v) DMSO in aqueous 
buffers. Amylin solutions were used immediately or stored at 80 °C. Unless otherwise specified, 
the final amylin concentrations in all samples was 100 μM. This peptide concentration was chosen 
because it gave the best results for TIRFM experiments in terms of the number of fibrils formed 
and the speed of the fibrillization reactions. The samples additionally contained the metal chelator 
EDTA at a 0.5 mM concentration and the bacteriostatic compound sodium azide at a 0.05 mM 
concentration. Before use in fibrillization reactions, the solutions were sonicated continuously for 
5 min in an ice bath at a power of 75% using a Fisher Scientific Sonic Dismembrator Model 500. 
TIRFM Experiments. Fibrils were imaged using the fluorescent dye ThT (Ultrapure, Anaspec; 
San Jose, CA) which was included in the samples at a concentration of 5 μM. Samples of ∼30 μL 
were inserted in the space between the glass slides (Fisher Cat. No. 12-544-1) and a clean coverslip 
(Fisher Cat. No. 12542-C; Pittsburgh, PA), was affixed on two edges with double-sided tape. The 
assembly was sealed with Dow Corning high-vacuum grease and placed on the microscope with 
the coverslip facing the objective. Glass coverslips were cleaned by soaking for 1 h in 2:1 (v/v) 
HNO3: HCl, washing with water, and rinsing three times with deionized water. Coverslips were 
stored in 70% ethanol and dried before use. Glass slides were prepared in the same way except 
they were cleaned with a 1% (w/v) Alconox solution. 
 Fibril growth was imaged using a TIRFM system integrated into an Andor Revolution XD 
Spinning Disk Confocal instrument with a Nikon TiE inverted microscope. ThT excitation was 
achieved at 405 nm, using the available laser line on our instrument closest to the excitation 
maximum of 450 nm for amyloid-bound ThT [98]. Excitation profiles for amyloid-bound ThT 
  
   38 
 
 
recorded on a standard fluorescence spectrophotometer were used to establish that excitation at 
405 nm leads to an ∼50% loss in fluorescence intensity compared to excitation at 450 nm. 
Although this results in a loss of sensitivity, ThT excitation at 405 nm can still be used to visualize 
fibrils. To selectively monitor fluorescence from amyloid-bound ThT which has an emission 
maximum of 482 nm,[98] we used a 483 ( 16 nm bandpass filter from Semrock (Rochester, NY). 
Images were recorded with an Andor 897 iXon EMCCD camera using an oil immersion TIRF lens 
(1.49 NA, 100x, Nikon). Samples were maintained at a temperature of 24 ±1 °C during the 
experiments. We did additional experiments on a Leica TCS SP2 laser confocal scanning 
microscope to verify that the seed like aggregates imaged by TIRFM were detected due to ThT 
fluorescence. For these experiments we excited the sample at a fixed wavelength of 458 nm and 
scanned through the emission spectrum which had a maximum at 483 nm, consistent with the 
fluorescence maximum of amyloid-bound ThT [98].  Image analysis, including calculations of 
fibril lengths and seed diameters, was performed with ImageJ software from the NIH [102].  
Briefly, the “set scale” utility of ImageJ was used for calibration according to the resolution of our 
camera which was 133 nm/pixel. The line utility was then used to measure the length or diameters 
of objects. Curved fibrils were approximated by line segments, and their lengths were calculated 
from the sum of the segments. To characterize kinetics, fibrils were observed every 2 h of the 48 
h experiment at pH 4 and every 1 h of the 23 h experiment at pH 8. When measuring kinetics, we 
excluded any species that appeared between consecutive TIRFM images collected 5 or 15 min 
apart and then maintained a constant size, since these are likely to represent aggregates that have 
precipitated from solution onto the coverslip [34, 35]. 
EM Experiments. Samples containing 100 μM amylin at pH 8 or pH 4 were incubated at 25 °C, 
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and aliquots of the reaction were removed for imaging after 0.5, 5, 10, 20, and 170 h (1 week). 
Aliquots were immediately transferred to 400-mesh carbon coated Maxtaform Cu/Rh grids (Ted 
Pella Inc., Redding, CA) and stained with a 1% (w/v) solution of uranyl acetate. EM images were 
recorded using an AMT XR-40 (2048 x 2048 pixel) camera that was side-mounted on a FEI Tecnai 
BioTWIN G2 Sprit transmission electron microscope. At least five images were obtained for each 
sample and time point, and the most representative images were analyzed. 
Fibrillization Kinetics in Solution. The time course of fibrillization in solution was monitored in 
duplicate using 200 μL samples of amylin, contained in white polystyrene clear bottom 96-well 
plates (Corning Inc., Corning, NY). Plates were covered with a clear polyester sealing tape (Fisher 
Scientific, Agawam, MA) to prevent evaporation. Samples had 100 μM amylin concentrations for 
consistency with the TIRF experiments and 10 μM ThT (Sigma; St. Louis, MO). To look at the 
effects of predissolving amylin in different organic solvents, we compared amylin dissolved in 
pure ACN and brought up in buffer to a final concentration of 10% (v/v) ACN to amylin dissolved 
in pure DMSO and brought up to a concentration of 4% (v/v) DMSO. All experiments were done 
without agitation, at a temperature of 25 °C. ThT fluorescence was recorded at 1 min intervals for 
30 h using excitation at 440 nm and emission at 490 nm on a Fluoroskan Ascent 2.5 fluorescence 
plate reader. 
Results 
TIRF Microscopy of Amylin Fibrillization at pH 4 and 8- Fibrillization of amylin is enhanced 
at pH 8 compared to pH 4 due to the loss of the positive charge on His18, which lessens 
electrostatic repulsion between the amylin monomers packed in fibrils. These effects are 
physiologically relevant since amylin is stored at pH 5.5 in the secretory granules of pancreatic β-
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cells but is exposed to pH 7.4 when it is released into the extracellular matrix [23]. To look at the 
effect of pH on fibrillization, we obtained TIRFM data at pH 4 and 8, where His18 in amylin fibrils 
is fully charged and fully uncharged, respectively.  
 Fig. 3.1 shows 42 x 42 μm sections of the 68 x 68 μm TIRFM images collected. The earliest 
images obtained after 45 min (Fig. 3.1A, C) are compared with images at the end of the reactions: 
48 h at pH 4 (Fig 3.1B) and 23 h at pH 8 (Fig. 3.1D). The first images at both pH values show 
mostly round “seeds” (Fig. 3.1A, C), even though no attempt was made to seed the reaction by 
fragmenting preformed fibrils [33-35]. Because amylin fibrillization is fast, some seeds and a few 
fibrils already formed during the 45 min lag time of the experiment between dissolution of the 
peptide and TIRFM imaging. In addition to seeds, we observed smaller punctate “granules”. The 
term ‘seed’ is used to describe aggregates with a round, nonfibrillar morphology for consistency 
with previous studies [33-35] and because the growth of the fibrils we see by TIRFM invariably 
starts from these aggregates. As shown below, the dimensions of the seeds together with their 
binding of the amyloid-specific dye ThT (which is a prerequisite for TIRFM observation) indicate 
they correspond to plaques of short fibrils rather than the oligomeric nuclei that initiate fibril 
growth through primary nucleation mechanisms. The number of seeds initially observed at pH 8 
(Fig. 3.1C) was larger than at pH 4 (Fig. 3.1A). As the reaction progressed, more fibrils formed at 
pH 8 (Fig. 3.1D) than at pH 4 (Fig. 3.1B) and the fibrils at pH 8 were more clustered (Fig. 3.1D). 
The smallest objects we could identify were about 0.2 μm (200 nm) as the resolution of our camera 
is 133 nm/pixel. Although we counted objects with sizes between 0.2 and 0.5 μm as small seeds, 
we caution that we cannot easily distinguish between a round seed and an elongated fibril 
morphology for objects smaller than about 0.5 μm. 
  
   41 
 
 
 
Figure 3.1. TIRFM images of human amylin at pH 4 (A, B) or pH 8 (C, D) showing the initial (A, C) and final stages 
of the reactions (B, D). Images were color inverted so that white corresponds to nonfluorescent material and black to 
fibril-induced ThT fluorescence. The dashed box in (B) corresponds to the area shown in Fig. 3.4. In panel D, a is an 
example of a large seed, b is an example of a small seed (granule) with at least two faint fibrils emanating from it, and 
c is an example of a fibril. 
 Fig. 3.2 compares the distributions of seed and fibril lengths at the end of the reactions, 
when no further changes were seen in the TIRFM images. Qualitatively, we have seen between a 
2- and 5-fold increase in the numbers of seeds and fibrils at pH 8 compared to pH 4 in multiple 
TIRFM experiments. A quantitative assessment is not possible because we are not observing a 
macroscopic average. The number of individual aggregates varies between experiments or even 
when different sections of a slide are compared. The distributions of seeds and fibril lengths,  
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Figure 3.2. Distributions of seeds and fibrils at the last time points of the TIRF experiments (A) at pH 4, after 48 h of 
incubation and (B) at pH 8, after 23 h of incubation. By these times fibril growth processes had subsided for each of 
the samples. 
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however, show similar patterns in multiple experiments. At both pH values there were about twice 
as many fibrils as seeds at the end of the reaction, while seeds were the dominant species at the 
start of the reaction. The average fibril lengths when the reactions reached completion were ∼2 
μm at both pH values although a small number of fibrils as long as 57 μm were observed (Fig. 
3.2). Seed diameters were on average about 50% larger at pH 8 (0.56 μm, 60 samples) compared 
to pH 4 (0.34 μm, 29 samples) while fibril lengths were the same. The distributions of seed sizes 
fell of more rapidly than fibrils (Fig. 3.2), suggesting that large seeds are unstable or disfavored. 
Seeds Observed by TIRFM Correspond to Plaques of Short Fibrils. Fig. 3.3 shows a small 
seedlike object with a 0.15 μm diameter imaged by EM that is comparable to the 0.35 μm diameter 
of seed b in the TIRFM image of Fig. 3.1D. The subsequent EM images in Fig. 3.3 shown 
progressively higher magnifications of the areas indicated by the rectangles. As the resolution of 
the EM images increases, the globular seed can be seen to be composed of a cluster of small 
wormlike fibrils. Atomic Force Microscopy (AFM) studies reported that in the initial stages of 
amylin fibrillization globular oligomers are formed with an average length of 23 nm. The 
oligomers grew in height from 2 to 6 nm before elongating into fibrils [103].  The sizes of the 
oligomers observed by AFM are some 10-100 times smaller than the smallest 0.2 μm sized 
aggregates discernible by TIRFM. In EM images of amylin fibrillization reactions we see some 
fibrils as short as 10-20 nm, but these have an elongated rather than a globular morphology. For 
objects shorter than about 10 nm it would be difficult to distinguish between a fibrillar and globular 
morphology. Globular aggregates that could correspond to the types of oligomeric intermediates 
seen by AFM were not seen by EM under the conditions of our study. The oligomeric species 
observed by AFM elongated into fibrils in about 30-60 min [103]. This time scale is on the order 
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of our 20-45 min dead time for preparation of samples for our EM and TIRFM experiments. 
Moreover, the AFM studies were done with 10 μM amylin concentrations, [103] which should 
result in slower fibrillization kinetics than at the 100 μM amylin concentrations used for this work. 
Some of the seeds observed by TIRFM grow over periods of 10-20 h, a rate much slower than the 
lifetime of the globular oligomers observed by AFM [103]. Moreover, nearly all of the seeds 
observed by TIRFM persisted at the ends of the 24 h (pH 8) or 48 h (pH 4) experiments, whereas 
for a primary nucleation mechanism, the population of oligomeric species should decrease at the 
 
Figure 3.3. Electron micrographs of a granule-like seed (arrow) with a diameter of ∼0.15 μm that at increasing 
magnification can be seen to be comprised of a cluster of fibrils. The EM data were recorded for a 100 μM amylin 
sample that was aggregated for 5 h at pH 8. 
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Figure 3.4. Snapshots of amylin fibril growth at pH 4 imaged by TIRFM. The time each image was obtained after 
transfer of dissolved amylin to a glass slide is given in the lower left-hand side of the panels. The data are from a total 
of 568 time points, recorded every 5 min for 2895 min (2 days). The time from preparing the sample to the first image 
collection was 45 min. Letters illustrate different species observed as described in the text. Lines are drawn to the 
location where each aggregate is seen at the earliest time point. Arrows indicate the ends of fibrils at the indicated 
time points. 
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expense of fibrils during the course of the reaction [103]. Finally, the detection of species by 
TIRFM through ThT fluorescence requires that amylin is assembled in a cross-β conformation. 
The specific changes in ThT fluorescence when the dye binds fibrils generally do not occur when 
the dye binds oligomers [104].  We therefore conclude that the seeds observed by TIRFM are 
plaques of short fibrils. The seeds observed by TIRFM can clearly act as nucleation sites for fibril 
growth, since all of the fibrils we observed start from small seeds or granules. The growth 
processes, however, are more consistent with a secondary or heterogeneous nucleation mechanism 
than with the primary or homogeneous nucleation events that lead to the formation of the initial 
fibrils following the lag phase of fibrillization. 
TIRF Microscopy Reveals Three Distinct Mechanisms of Aggregation. Fig. 3.4 shows 
snapshots of an amylin aggregation reaction at pH 4. The data are illustrated for pH 4 because 
fibrillization kinetics are slower and there are fewer fibrils under these conditions, making it easier 
to show key steps in the reaction. Aggregation mechanisms were similar at pH 8, except where 
noted. The principal differences were that at pH 8 more fibrils formed and these were more 
clustered. The time course of aggregation in Fig. 3.4 suggests three distinct aggregation 
mechanisms: seed growth, fibril elongation, and fibril thickening. The three types of aggregation 
mechanisms are discussed in detail below. 
Radial Seed Growth. The first species observed in experiments at both pH 4 and 8 are seeds 
illustrated by aggregates a and b in Fig. 3.4. After fibrils started to grow, few if any new seeds 
were observed. Some seeds such as a grew in intensity and expand radially with time, while the 
majority like b remained unchanged as the reaction progressed. The globular morphology of the 
seeds is different from the elongated morphology of amyloid fibrils, [105] and to our knowledge 
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radial expansion of fibrillar aggregates has not been previously described. 
 A number of seeds such as a sprouted fibrils as they grew, developed a coarse frayed 
periphery, and eventually lost their globular appearance. Other seeds showed a similar change to 
a coarser morphology but had no fibrils extending from them. The majority of seeds such as b 
stayed constant over the course of the reaction. The observation that some seeds became frayed as 
fibrils start to form, together with the distribution data in Fig. 3.2 showing that smaller seeds 
predominate, suggests that large seeds are unstable and that the fibril morphology is preferred as 
the aggregation reaction progresses. 
Fibril Elongation. Fibrils either extended from large seeds such as fibril d or grew in apparent 
isolation (c, e, and g). On closer inspection, all fibrils can be traced back to small seeds or granules 
that have a larger fluorescence intensity than the fibrils that grow from them. In Fig. 3.4, the 
granule starting points of the fibrils are indicated by lines pointing to their origin, whereas the ends 
of the growing fibrils are identified with arrows. 
 In previous TIRF studies with Aβ and β2 microglobulin, fibril growth was observed to be 
unidirectional [34, 35]. By contrast, previous AFM studies of amylin observed bidirectional growth 
of amylin fibrils, with elongation occurring from both ends [106]. We see apparent growth in 
multiple directions of the fibrils shown in Fig. 3.4. For example fibril e slowly forms the top of 
the question-mark-shaped fibril between 870 and 1440 min. The bottom part of the question mark 
of fibril e then grows very rapidly after 1870 min. The top of fibril f grows toward seed a between 
870 and 1870 min, but a fainter new arm of f extends in the opposite direction between 1320 and 
2105 min. By contrast, fibril g grows in one direction, and fibril c is formed from the merging of 
the two branches c and c’ after 1155 min. After c and c’ have come together both the bottom-most 
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arm and the arm on the left (c’) continue to grow in opposite directions, albeit at different rates. 
For all the fibrils that show apparent multidirectional growth (e.g., c, e, f) the elongation of the 
different branches is asynchronous with respect to the starting time and occurs at different rates. 
Moreover, all of the fibrils start to grow from a granule or small seed that appears as a nodule of 
higher fluorescence intensity than the fibrils that extends away from the origin (shown by the 
fluorescence intensities in Fig. 3.5). For fibril c, e, and f the initial granules can be seen as early 
as 870 min. We think the data in Fig. 3.4 are more consistent with multiple fibrils growing 
unidirectionally from a single seed. First, the extension of different arms occurs at different times 
during the reaction (for example, fibril f). Second, the elongation of different arms occurs with 
different rates. Third, growth in multiple directions in rosette-like bundles is observed from larger 
seeds such as a. 
 
Figure 3.5 Fibril elongation from a seed. Figure showing an individual seed growth over time. 
Fibril Thickening- The third process evident in the TIRFM data is an increase in the fluorescence 
intensity of some of the fibrils during the course of the reaction. We attribute this observation to 
growth of new fibrils along the templates provided by preformed fibrils, in a mechanism analogous 
to the “heterogeneous nucleation mechanism” first described for sickle cell hemoglobin fibrils 
[37]. Heterogeneous nucleation, also called “secondary nucleation”, has been previously shown to 
play a role in amylin fibrillization based on kinetic studies [38, 39]. 
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 The intensity increases in preformed fibrils are best illustrated by fibril d, which is first 
observed in faint outline by 870 min (Fig. 3.4). The fibril appears between two images collected 
in a 5 min interval and as such is likely to represent a fibril that has precipitated from solution [34, 
35].  Consequently, we have no information on the growth of fibril d before ∼870 min. Once 
deposited on the slide, fibril d continues to grow slowly to close a lariat-like loop until 1870 min. 
In addition to these elongation processes, the fluorescence of fibril d becomes markedly more 
intense between 870 and 2895 min. The same type of increase in intensity is also seen for a number 
of the other fibrils including fibril c between 1195 and 2895 min. For reference, seed b maintains 
roughly the same intensity from the time it is first observed at 235 min to the end of the reaction 
at 2895 min, and fibril g shows little change in intensity between 1440 and 2895 min. 
 Fibrils are often observed in aligned bundles in high-resolution AFM and EM images. 
Since these structures are often wound around each other in a supercoil, it is unlikely they are 
formed by fibrils sticking together. One mechanism that could account for the growth of fibrils in 
bundles is the heterogeneous nucleation mechanism first proposed for sickle-cell hemoglobin 
fibrils [37].  Fibrils are first formed by homogeneous (or primary) nucleation during the lag time 
of the reaction and then elongate during the growth phase [37, 107]. After an initial population of 
fibrils are formed, additional heterogeneous (or secondary) nucleation sites can became available 
along the length of preformed fibrils. These can promote the growth of new fibrils using the 
original fibrils as templates [37]. An alternative to this mechanism is that the strands in a bundle 
could grow simultaneously. Evidence for this mechanism was obtained from AFM imaging of 
amylin fibril growth on a mica surface [103].  On the basis of the TIRFM data, both types of 
mechanisms appear to have a role in amylin fibrillization. Fibril f, for example, is one of the most 
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intensely fluorescent in Fig. 3.4. The high fluorescence intensity of fibril f is maintained as it grows 
upward toward seed a, from 870 to 1870 min. An exception is in the frame at 1155 min, where a 
small thin, possibly frayed extension is seen for fibril f that grows in advance of the thicker fibril. 
To a good approximation, however, the growth of fibril f is consistent with a mechanism where if 
its stronger fluorescence intensity is due to a bundle rather than a single fibril, the strands in the 
bundle grow at the same time. In contrast to fibril f, the fibrils c and d start out as faint strands 
that increase in intensity with time, which is more readily explained by a template-assisted growth 
mechanism rather than simultaneous growth of strands in a bundle of fibrils. The increase in 
intensity of fibrils c and d is not distributed evenly throughout the fibril but appears to occur in 
patches or nodules that suggest the presence of multiple heterogeneous nucleation sites along the 
length of a fibril. 
 At the resolution of TIRFM we cannot accurately determine the width of fibrils [34]. 
Oscillation of fluorescence intensity could occur from fibrils diffusing in and out of the TIRFM 
illumination field. The changes we observe happen on time scales of hours (Fig. 3.4), however, 
and we see increases in fluorescence intensity rather than the variations that would be expected if 
the fibrils were moving in and out of the evanescent field. Differential binding of ThT to the fibrils 
is another explanation that seems unlikely to account for the increase in fluorescence intensity 
since the initial staining of the fibrils occurs in less than 5 min. One possibility we cannot exclude 
is that preformed fibrils could be undergoing a conformational change that leads to increased ThT 
fluorescence. That the fluorescence increases occur progressively along the length of the fibrils 
and with rates similar to fibril growth seems more consistent with the formation of new fibrils than 
with changes in the properties of preformed fibrils.  
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Figure 3.6. Time course of amylin fibrillization followed by EM. The panels on the left side show fibrils grown at pH 
4 and the right side fibrils grown at pH 8. Images were sampled after solution incubation periods of 5 h (top), 10 h 
(middle), and 1 week (bottom). In contrast to the TIRFM (Fig. 3.4), we cannot track the same aggregates over time 
by EM. To give a representative description, the images shown are the most typical of 510 images from different 
regions of the EM grid prepared for each time point and pH. All images are at a magnification of 68,000x. 
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Comparison of Fibril Growth by TIRFM and EM. In contrast to TIRFM where we can watch 
individual aggregates grow on the surface of a slide, EM can be used to image fibrils at high 
resolution after growth in bulk solution and transfer to a copper grid for uranyl acetate staining 
and imaging. We obtained EM images of amylin fibrils after aggregation times of 0.5, 5, 10, 20, 
and 170 h (1 week). For each time point we recorded five images from different areas of the grid 
and show the most representative for time points at 5, 10, and 170 h in Fig. 3.6. Although EM is 
not suited for quantifying the amount of aggregates, we saw a qualitative increase in the number 
of fibrillar species with time, and more fibrils were formed at pH 8 than pH 4.  
 At the earliest time points in the reaction, between 0.5 and 5 h, the fibrils at pH 4 form 
sheets of very thin fibrils together with a smaller number of short robust fibrils (Fig. 3.6). The 
fibrils formed during comparable times at pH 8 have a more frayed appearance (Fig. 3.6). By 10 
h, the sample at pH 4 shows a larger number of long fibrils together with the thin sheets of fibrils 
observed at earlier time points. In the pH 8 samples the fibrils formed by 10 h are longer and are 
more often arranged in curved coiled ribbon structures compared to the sticklike fibrils seen at pH 
4. The last set of images in Fig. 3.6 show the samples after 1 week (170 h), well after changes in 
TIRFM images had subsided (24-48 h). In the last time points, the fibrils at pH 8 reach lengths of 
12 μm while at pH 4 some fibrils as short as 0.05-0.1 μm are still observed together with long 
fibrils (Fig. 3.6). Note that these shorter fibrils at pH 4 would be too small to be resolved by TIRFM. 
The fibrils in the final time point at pH 8 are arranged in dense meshworks and have an average 
width of 14.4 ± 5.6 nm compared to 6.8 ± 1.9 at pH 4, consistent with previous reports that amylin 
fibrils at pH 8 are thicker than at pH 4 [23]. 
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Figure 3.7. Kinetics of individual seed growth, fibril elongation, and fibril thickening from TIRFM data at pH 4 (A, 
B, C) and pH 8 (D, E, F). The data for each fibril were fitted to a six-parameter equation38 in order to extract lag times, 
growth rates, and maximal length parameters, which are given in Table 3.1. 
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Kinetics of Individual Aggregate Growth. Fig. 3.7 shows growth curves for seeds, fibrils, and the 
process we attribute to fibril thickening at pH 4 and 8. Kinetic parameters obtained from least-squares 
fits of the data are summarized in Table 3.1. Under both conditions seed growth is observed first 
followed by fibril elongation and fibril thickening. Because many of the seeds we looked at were 
already present at the start of the reaction, we consider the lag time for seed formation undefined in 
the TIRFM experiment. On the basis of solution experiments, the lag times for fibrillization under 
the conditions of the TIRFM experiments (samples in 10% acetonitrile) are about 30 min (Fig. 3.8 , 
Table 3.1), which is shorter than the ∼45 min dead time of the TIRFM experiments. The apparent 
average lag time for species with a distinct fibrillar morphology by TIRFM is much longer: about 4 
h at pH 8 (Fig. 3.7B) and 14 h at pH 4 (Fig. 3.7D). We note that in the earliest stages of the TIRFM 
experiments most of the ThT fluorescence is due to seeds, which are likely to be composed of plaques 
or clusters of fibrils too small to be resolved by TIRFM. Fibril thickening had the longest lag times 
between 26 and 37 h at pH 4 and between 3 and 4 h at pH 8 (Fig. 3.7 C and F ). Radial seed growth 
had the slowest rate, fibril elongation rates were intermediate, and fibril thickening rates were the 
fastest (Table 3.1). Comparing the reactions at the two pH values, all processes had longer lag times 
and slower growth rates at pH 4 compared to pH 8 (Table 3.1). 
 At the completion of the reactions we could measure the maximum dimensions of the 
individual aggregates used to characterize fibrillization kinetics by TIRFM. The averages of these 
values are given in Table 3.1. We saw no correlation between growth rates and the final sizes of 
individual seeds or fibrils. The final dimensions for the thickening process are shorter than for 
elongation because the increases in fluorescence intensity often occurs in patches along the length 
of a fibril, and we only characterized the growth kinetics of uninterrupted segments.  
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Fibrillization Kinetics in Solution. Fig. 3.8 shows kinetic data for amylin fibrillization in 
solution. The reactions were carried out at the same 100 μM amylin concentration and 25 °C 
temperature as the TIRFM experiments. For one set of experiments monomeric amylin was 
initially dissolved in ACN and brought up in buffer to a final concentration 10% ACN (v/v). This 
set of conditions is the same as for the TIRFM and EM experiments shown in Fig. 3.1-3.7. We 
also looked at amylin that was initially dissolved in DMSO [23] and brought up in buffer to a final 
concentration of 4% DMSO (v/v). The first 10 h of the reactions shows a sigmoidal profile typical 
of a nucleated fibrillization reaction consisting of a lag time, a growth phase, and a plateau [107, 
108]. This portion of the data were fitted to a six parameter model [108] to obtain the kinetic 
parameters for the solution reactions given in Table 3.1. The lag times obtained in solution are 
much shorter than the lag times for fibril growth obtained for the fibrils imaged by TIRFM. The 
rates of fibril growth are slower for individual fibrils but within a factor of 2 of the solution rates 
(Table 3.1). Part of the reason for this difference is that in the TIRFM experiment we are measuring 
the kinetics of the longest fibrils in the reaction (18 μm), whereas the majority of the fibrils formed 
in the early stages of the reaction are too short to be discerned as such at the resolution of the TIRF 
microscope (<0.5 μm). When considering differences in elongation rates between the experiments, 
it is also important to note that in solution we are measuring only ThT fluorescence, which does 
not distinguish between the species with different morphologies or different growth processes 
observed by TIRFM. 
 At time points following the initial leveling off of fluorescence after 10 h, the solution 
reactions show behavior that deviates from standard fibrillization time curves. In 4% DMSO 
solvent, there is a decrease in fluorescence following the initial plateau. It has been argued that  
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Figure 3.8 Kinetics of fibrillization in solution followed by ThT fluorescence at pH 4 (A) or pH 8 (B). For each pH, 
samples were initially dissolved in ACN and brought up in buffer to a final concentration of 10% (v/v) ACN or in 
DMSO and brought up to a final concentration of 4% (v/v) DMSO. The data for each set of conditions are averages 
of duplicate measurements. Representative errors are shown for 5% of the data points in the ACN experiments, and 
errors in kinetic parameters from the duplicate data sets are given in Table 3.1. The data for the first 10 h only were 
fitted to a six-parameter equation [108] to obtain values for lag times and rate constants which are given in Table 3.1. 
For the pH 4 data in the presence of 10% CAN, we separately fitted the data between 8 and 30 h to a second sigmoidal 
transition (dashed curve). For the other experiments the data beyond 10 h do not define a sigmoidal transition and 
were not fit. 
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Figure 3.9 Effects of solvents used to dissolve amylin on fibrillization reactions. (A) Varying DMSO concentrations.  
Starting from a stock solution of amylin in pure DMSO, samples were diluted with 20 mM phosphate buffer (pH 8) 
to the DMSO concentrations indicated. The amylin concentration for all experiments was 5 µM, ThT was 10 µM, and 
all experiments were done at a temperature of 25 oC. Lag times and rates increased with increasing DMSO 
concentration. Lag times: 108, 119, 135, 209, 215 min. Rates: 4.7 x 10-3, 3.8 x 10-3, 4.6 x 10-3, 7.2 x 10-3, 9.8 x 10-3 
min-1 between 1 and 10% DMSO. (B) Varying ACN concentrations. The amylin concentration was 100 µM in 60 mM 
citrate buffer (pH 4) at 25 oC. Note that all reactions with ACN show biphasic transitions. With increasing ACN 
concentration the rate of the first transition decreases about two fold while the second transition rate appears constant. 
Rate 1: 9.0 x 10-3, 5.1 x 10-3, 4.5 x 10-3; rate 2: 2.0 x 10-3, 2.6 x 10-3, 1.5 x 10-3.  Apparent lag times for the second 
transition increase from 1 to 10% ACN (180, 230, 260 min), while for the first transition they could not be accurately 
defined. Errors are from duplicate measurements and are shown for 5% of the data in both A and B. 
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once fibrils have formed the solution is no longer homogeneous so that fluorescence measurements  
become erratic and are of questionable value [109]. At amylin concentrations below 20 μM the 
plateaus in 4% DMSO are nearly flat, suggesting that the decreasing plateau at 100 μM amylin 
may be due to an increase in the turbidity of the samples accompanying the formation of insoluble 
fibrils. For the 10% ACN solvent, we see a reproducible increase in fluorescence following the 
initial fluorescence plateau. This increase in fluorescence following an initial steady state is 
observed for fibrillization reactions where the amylin concentration is as low as 5 μM and suggests 
that fibrils continue to form after the first 10 h of the reaction. At pH 4 this is manifested as a 
second sigmoidal curve that starts after the first apparent plateau is reached (Fig. 3.8A). Note that 
the increase in florescence intensity during the second sigmoidal phase is about 40% of the increase 
in the first sigmoidal phase that occurs within the first 10 h of the reaction. At pH 8 we also see a 
continuing increase in fluorescence after the initial sigmoidal phase, with a shallower apparently 
linear time dependence that does not subside by 30 h (Fig. 3.8B). In this case as well, the increase 
in fluorescence between 10 and 30 h is about 70% of the increase in fluorescence during the first 
10 h of the reaction. The increases in ThT fluorescence during the second stage of the reaction 
suggests that fibrils are formed through secondary nucleation, catalyzed by the initial population 
of fibrils that grew during the first 10 h. 
 If we compare the time course of the individual aggregates measured by TIRFM to the 
solution data, the largest seeds that we could measure accurately at pH 4 formed between 0 and 20 
h (Fig. 3.7A), a time that extends beyond the first 10 h sigmoidal phase of the solution reaction in 
10% ACN (Fig. 3.8A). Fibrils grew between 9 and 40 h (Fig. 3.7B)-a time that also extends past 
the first and into the second sigmoidal phase of the reaction in solution (Fig. 3.9A). Consequently,  
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Table 3.1. Growth Rates of ThT-Sensitive Amylin Aggregatesa. 
 pH 4 
seed diameter N.D.e 0.27 ± 0.04 0.81 ± 0.18 4 
fibril elongation 14.14 ± 1.54 0.56 ± 0.09 2.60 ± 0.51 10 
fibril thickening 31.3 ± 2.4 1.75 ± 0.76 1.08 ± 0.31 4 
solution (10% ACN, pt 1)b,c 0.59 ± 0.35 1.20 ± 0.02 N.A.f N.A.f 
solution (10% ACN, pt 2)b,d 11.93 ± 2.09 0.74 ± 0.25 N.A.f N.A.f 
solution (4% DMSO)b  
pH 8 
2.56 ± 0.34 1.70 ± 0.30 N.A.f N.A.f 
pH 8     
seed diameter N.D.e 0.70 ± 0.09 1.06 ± 0.26 10 
fibril elongation 4.31 ± 1.11 0.73 ± 0.18 2.10 ± 0.13 9 
fibril thickening 4.18 ± 0.25 2.35 ± 0.83 0.48 ± 0.02 3 
solution (10% ACN)b 0.42 ± 0.01 1.15 ± 0.01 N.A.f N.A.f 
solution (4% DMSO)b 0.04 ± 0.04 1.32 ± 0.01 N.A.f N.A.f 
a Rates for the different growth processes were obtained by nonlinear least-squares fits of the kinetic curves in Fig. 3.7 
and 3.8 as described [108]. Rate constants are reported as means ±1 standard error. Note that the uncertainties for the 
TIRF data describe the variation between individual aggregates (Fig. 3.7) while for the solution data (Fig. 3.8) they 
were obtained from duplicate measurements of solution population-weighted averages.  
b The units for the fibril growth rates from solution experiments are fluorescence intensity (arbitrary units)/h. For 
solution experiments, except 10% ACN at pH 4 , kinetic parameters were calculated by considering only the first 10 
h of the reactions which show a sigmoidal time dependence characteristic of fibrillization.  
c Kinetic parameters derived from the first part of the reaction between 0 and 10 h.  
d Kinetic parameters derived from the second part of the reaction between 8 and 30 h.  
e Not determined since many of the seeds are already visible in the first images recorded at both pH 4 and pH 8. The 
dead time for the TIRF experiments was ∼45 min.  
f Not applicable. 
 
the lag times and elongation rates of the fibrils observed by TIRFM are in much better agreement 
with the kinetic parameters obtained from the second phase of the solution reaction (Table 3.1). 
The increases in fluorescence intensities of the fibrils imaged by TIRFM occur between 20 and 40 
Conditions  Lag time 
(h) 
 Growth rate 
(μm/h) 
 Max length 
(μm) 
 Species 
average
d 
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h (Fig. 3.4 and 3.5C), well past the first 10 h sigmoidal phase of the solution reaction (Fig. 3.8A).  
  Finally, the changes in fibril morphology and association by EM (Fig. 3.6) occur on slower 
time scales than the first 10 h transition seen for the solution reaction at pH 4 with 10% ACN (Fig. 
3.8A).At pH 8 where fibrillization is faster, the growth of individual seeds (Fig. 3.7C) and fibrils 
(Fig. 3.7D) is more comparable to the solution rates (Fig. 3.8B), but asynchronicity is still observed, 
with some individual fibrils imaged by TIRFM growing after the first fluorescence plateaus is 
reached in bulk solution. In the presence of 4% DMSO, the rate of fibrillization is increased and the 
reactions reach a larger ThT fluorescence plateau, suggesting that more fibrils are formed than with 
10 % ACN (Fig. 3.8). We found that increasing the DMSO concentration between 1% and 10% (v/v) 
promotes fibrillization primarily by increasing the elongation rate of the reaction (Fig. 3.9). Thus, 
DMSO appears to act as a catalyst for fibrillization. By contrast, at large concentrations (≥95%) 
DMSO disaggregates fibrils to monomers. Given the differences in solution reaction profiles 
between samples dissolved in 10% ACN and 4% DMSO, we collected additional TIRFM data to 
examine the time dependence of fibrillization of a 100 μM amylin sample at pH 8 in 4 % DMSO 
(Fig. 3.9). Compared to samples in 10 % ACN, the sample in 4% DMSO fibrillized much faster and 
the appearance of fibrils was more abrupt, resembling a phase transition. Most fibrils formed in 2 h 
in the TIRFM experiment-a time more in line with the reaction in solution (Fig. 3.8B). We saw 
examples of all three growth mechanisms observed with 10% ACN: seed growth, fibril elongation, 
process with 4% DMSO. These observations suggest primary nucleation is favored over secondary 
nucleation in 4% DMSO compared to 10 % ACN. The organic phases such as dichloromethane, 
chloroform, or lipids have been shown to accelerate the fibrillization of a 20-29 fragment of amylin 
and shift the balance from secondary to primary nucleation mechanisms [39]. 
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Discussion 
 TIRFM shows three types of amylin fibrillization processes: seed growth, elongation, and 
fibril thickening. Seeds are the earliest species seen and are likely to consist of plaques of short 
fibrils based on their size, growth rates, and ThT binding. Fibrils invariably elongate from small 
seeds or granules, except for some rare cases where we see fibrils apparently branch from other 
fibrils in a mechanism similar to that observed in TIRFM studies of glucagon fibrillization [32]. 
Fibril elongation appears to be unidirectional, if we consider that multiple fibrils can grow in 
opposite directions with different rates, starting from a common seed. A third type of process is 
manifested as a progressive increase in the fluorescence intensity of preformed fibrils. We attribute 
the fluorescence intensity increases to template-assisted growth of fibrils alongside preformed 
fibrils. The fluorescence intensity increases often occur in patches, suggesting that multiple 
secondary nucleation sites can occur along the length of a fibril. We also see instances of fibrils 
that grow with a uniformly high fluorescence intensity from start to finish (upper branch of fibril f 
in Fig. 3.4), which could be consistent with the simultaneous growth of strands in a bundle of fibrils 
as has previously seen in AFM experiments [103]. 
 Although the three types of aggregation processes (seed growth, fibril elongation, and fibril 
thickening) manifest themselves differently by TIRFM, they may occur by the same mechanism, 
namely heterogeneous or secondary nucleation. This seems consistent with the time course of the 
growth processes imaged by TIRFM and EM, which for samples in 10% ACN occur after the 
completion of the main phase of the reaction in bulk solution. In the classical nucleation 
mechanism, aggregation is initially disfavored by entropy since association involves loss of 
rotational and translational degrees of freedom for the monomers. The time required to form the 
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“critical nuclei” that propagate polymerization is manifested as a lag time, during which 
aggregation is not detected [37]. Once critical nuclei are formed in a process called 
“homogeneous” or “primary” nucleation, the reaction enters a growth phase as the loss of entropy 
for the monomers is compensated by the gain in enthalpy due to the formation of new noncovalent 
interactions when the monomers become incorporated into the growing fibril [37]. The reaction 
proceeds, reaching an eventual plateau. In a double nucleation mechanism, fibrils can form through 
homogeneous or primary nucleation steps but can also be initiated by heterogeneous or secondary 
nucleation on the surfaces of preformed fibrils [37, 110].  Additional mechanisms that could play 
a role in secondary nucleation include branching of fibrils or fragmentation of fibrils in a way that 
introduces new sites for incorporation of monomers [39].  
 Our proposal of heterogeneous nucleation of amylin fibrillization in the current study has 
been confirmed recently by Goto lab using TIRFM and fluorescently tagged amylin. Their findings 
using ThT and Alexa 532-amylin confirms that amylin fibrillization takes place at both ends of a 
short fibril or seed. The study also confirms the increase in fluorescence of the preformed fibrils 
that we have reported in our study, corresponds to the lateral binding of Alexa532-amylin [111] to 
the preformed fibrils. Studies by the Miranker lab, looking at the dependence of polymerization 
kinetics on monomer and seed concentrations, established that secondary nucleation is the 
predominant mechanism of amylin fibrillization in aqueous solution [38, 39]. Additional 
amyloidogenic proteins for which secondary nucleation appears to play important roles in 
fibrillization include Aβ, [112] prion protein, [113] β2-microglobulin, [114] insulin, [115] and 
glucagon [32]. One strategy to inhibit fibrillogenesis is to develop compounds that interfere with 
the formation of the primary nuclei needed for fibril formation. However, if primary and secondary 
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nucleation have a different structural basis, interfering with primary nucleation may not be 
effective in controlling secondary nucleation once a population of fibrils has been established. The 
possible mechanisms for inhibition of fibrillization and hence cytotoxicity are discussed in next 
chapter of this thesis. 
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CHAPTER IV:  Charge-Based Inhibitors of Amylin Fibrillization and Toxicity    
Abstract:  
 To test the hypothesis that repulsion of like-charges is one of the main forces opposing 
amyloid fibril assembly, we designed peptides that substitute strings of positively or negatively 
charged residues in the sequence of the amyloidogenic hormone amylin, which contributes to type 
2 diabetes pathology. Peptide Arg-1 substitutes four positively charged arginine residues for the 
segment of amylin that forms the end of strand 1 and Arg-2 the beginning of strand 2, in structural 
models of amylin fibrils. A third variant Mem-T that substitutes negatively charged aspartate 
residues for the segment with the largest avidity for membranes was designed to interfere with the 
ability of amylin to disrupt membranes.  All three of the charge-loaded peptides fibrillize poorly on 
their own and inhibit fibril elongation of WT-amylin at physiological salt concentrations. The 
inhibition of fibril elongation rates is dependent on salt concentration indicating the analogs affect 
WT-amylin through electrostatic interactions. Arg-1 protects against WT-amylin cytotoxicity 
towards the MIN6 mouse model of pancreatic -cells, Arg-2 protects against cytotoxicity at higher 
concentrations, while Mem-T has no effect. Although Mem-T inhibits fibril elongation rates like the 
other two analogs, it decreases the lag times for WT-amylin fibrillization possibly due to 
complementary electrostatic interactions between the negative charges in the analog and the positive 
charges in the WT peptide. The most effective inhibitor Arg-1, inhibits WT-amylin fibril elongation 
rates with an IC50 of ~1 µM and cytotoxicity with an IC50 of ~50 µM, comparable to other types of 
amylin fibrillization inhibitors reported in the literature. These studies suggest that electrostatic 
interactions can be exploited to develop new types of inhibitors of amyloid fibrillization and toxicity.  
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Introduction 
Amyloidoses are protein misfolding diseases characterized by fibrillar protein deposits, in 
which protein monomers form intermolecular -sheets running along the length of the fibrils. In 
type 2 diabetes, the positively charged 37-residue hormone amylin, the subject of the present study, 
misfolds into cationic fibrils that have been implicated in the destruction of the pancreatic β-cells 
that make insulin and amylin, thus contributing to pathology. 
 Consideration of amyloid structures suggests that like-charges, replicated along the fibril 
axis by the intermolecular -sheet pairing of monomers, should energetically disfavor self-
association through electrostatic repulsion [40, 41]. Conversely, compensation of charges 
displayed on fibril surfaces may be important in the interactions of amyloids with polyanions such 
as heparan sulfate proteoglycans and membrane lipid bilayers [40, 42, 43]. Replacements of single 
charged residues can have large effects on fibrillization kinetics as shown with amyloid-beta [41], 
-synuclein [44, 45], and amylin [46]. Amylin represents a particularly favorable system for 
investigating the roles of electrostatic charges in fibrillization, since the core of the intermolecular 
-sheet fibril structure has only one pH-titratable group, His18.  
 We have extensively characterized the pH dependence of amylin fibril formation, due to 
the acid-base equilibrium of His18 [116]. The histidine has a pKa lowered to 5.0 in the fibrils 
compared to the random coil value of 6.5 [116]. The lowered pKa is due to electrostatic repulsion 
between positively charged His18 residues on neighboring molecules in the fibril and the 
hydrophobic environment of the residue in the amyloid structure. The lowered pKa indicates that 
protonation of His18 is energetically unfavorable for fibril formation. As such, His18 acts as an 
electrostatic switch, inhibiting fibrillization in its charged state at acidic pH and favoring  
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Figure 4.1 Design of fibrillization inhibitors. (A) Sequences of WT-amylin and three peptide analogs that incorporate 
strings of positive or negative charges in the amylin sequence. (B) Model of the stacked β-hairpin structure of amylin 
fibrils based on ssNMR [25]. Positively charged arginine residues are shown as spheres that are positioned at the end 
of strand β1 in Arg-1 (blue), or in the hairpin turn followed by the start of strand β2 in Arg-2 (green). (C) Solution 
NMR model of micelle-bound amylin, in which the N-terminal residues 5-17 are embedded in the hydrophobic 
environment of the micelle [117]. The Mem-T peptide incorporates five aspartate residues in this region (red) in order 
to interfere with membrane binding through electrostatic repulsion between negatively-charged residues on the peptide 
and lipid head-groups.  
fibrillization in its uncharged state at neutral pH. The charged state of His18 also affects the 
morphology of amylin fibrils as determined by EM (please see Fig. 3.6) [23, 116, 118]. At 
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physiological pH where His18 is uncharged, WT-amylin forms a greater number of fibrils, the 
fibrils are longer, have a more twisted morphology, and are more likely to be laterally associated 
into bundles than the fibrils formed at acidic pH when His18 is charged. The morphological 
features of WT-amylin at acidic pH are replicated in the  H18R-amylin mutant, which substitutes 
the histidine with a positively-charged arginine [116]. The presence of a charged arginine at 
position 18 in H18R-amylin lowers cytotoxicity to MIN6 -cells compared to WT-amylin, which 
has an uncharged histidine at a physiological pH of 7.4 (Fig. 4.2) [95, 116]. Similar results were 
obtained with a S20K variant of amylin. The S20K mutation fibrillizes much more slowly than 
WT-amylin, partly due to the introduction of a positive charge in a segment of the peptide that 
participates in the hairpin turn of the fibril structure [46]. Moreover, the S20K mutant peptide 
inhibits fibrillization of WT-amylin when added in trans [46]. 
 These observations suggest that the introduction of single charged amino acids in the 
portion of the amylin sequence that forms the fibril core can markedly inhibit fibrillization. We 
therefore thought to exploit these properties by designing peptide variants that incorporate a string 
of residues with like charges into the amylin sequence, as shown in Fig. 4.1. The first peptide 
Arginine-variant 1 (Arg-1), substitutes four arginines for WT-amylin residues Asn14-Val17 (Fig. 
4.1A).  These residues are part of strand β1 (blue spheres in Fig. 4.1B) in the model of the amylin 
fibril structure determined by ssNMR [25]. The protofilament building block of the amylin fibril 
structure has two C2-symmetry related stacks of intermolecular β-sheets (shown in orange and 
purple in Fig. 4.1B) [25]. 
 The positively charged residues introduced in the Arg-1 variant would be on the surface of 
the protofilament. In our design, we envisioned that Arg-1 would act as a fibril extension inhibitor. 
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Figure 4.2 Cytotoxicity experiments using cultures of a MIN6 mouse insuloma model of β-pancreatic cells. Data are 
expressed as means ± S.E.M from triplicate measurements. Peptides were prepared as stock solutions in DMSO and 
were freshly added to the cells to give a final peptide concentration of 80 µM as measured with a micro-BCA assay, 
and a final DMSO concentration of 1% (v/v). The vector control contained 1% DMSO only, which was present in all 
experiments except the cells alone control wells. (adapted from [116])  
 
The highly amyloidogenic segment between residues Ser20-Ser29 [4, 79] is retained in the 
sequence, and would allow the peptide to attach to growing fibrils of WT-amylin, whereas the four 
arginines in Arg-1 would disfavor addition of monomers through electrostatic repulsion with the 
positively charged residues Arg11 and His18 in the WT-sequence.  It is important to note that since 
the C-terminus of amylin is naturally amidated, there are no negatively charged residues in the 
sequence of WT-amylin (Fig. 4.1A). In a second analog, Arginine-variant 2 (Arg-2), four arginine 
residues are substituted for residues Phe23-Ile26 in the center of the amyloidogenic segment. In 
  
   69 
 
 
the fibril structure [25] this corresponds to the end of the -hairpin and the start of strand 2 (green 
spheres in Fig. 4.1B). The design objectives for Arg-2 were the same as for the Arg-1 peptide but 
the string of four arginine residues are positioned in the interior of the protofilament structure as 
opposed to the surface (Fig. 4.1B). A third peptide, the "Membrane Trojan" analog (Mem-T) was 
conceived as an inhibitor of the interactions of WT-amylin with cell membranes, rather than as a 
fibril elongation inhibitor. The motivation for the design of the Mem-T analog was studies that 
suggest the species responsible for amylin toxicity may not be amyloid fibrils but soluble 
oligomers that form membrane-spanning pores, thus compromising intracellular ion homeostasis 
and cellular integrity [4, 119]. The Mem-T analog (Fig. 4.1C) was conceived based on our NMR 
structure of WT-amylin bound to membrane mimetic SDS micelles [117]. In the NMR structure, 
the Ala5-Val17 segment is positioned in the hydrophobic environment of the micelle based on 
paramagnetic probe studies[117]. The Ala5-Val17 has the highest avidity for lipid membranes 
based on a number of studies [4, 86]. We thus envisioned that the Mem-T analog would be able to 
form mixed oligomers on the surfaces of membranes with WT-amylin, through the His18-Tyr37 
segment, on the surfaces of membranes but that membrane penetration of the mixed oligomers 
would be blocked through electrostatic repulsion between the negatively charged aspartates in the 
Mem-T peptide and the negatively charged phosphate groups of the membrane lipid bilayer (Fig. 
4.1C).   
 In the present work we examined the ability of the three amylin analogs Arg-1, Arg-2 and 
Mem-T to form fibrils using a kinetic assay that employs the amyloid-specific fluorescent dye 
thioflavin T (ThT), and by imaging the reaction products with transmission electron microscopy 
(TEM). We investigated the ability of peptide analogs to inhibit fibril formation when added in 
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trans to WT-amylin, and characterized the concentration dependence of inhibition. Because we 
expected the three designed peptides to exert their effects through electrostatic interactions, we 
looked at the effects of NaCl concentration on inhibition. Finally, we examined the ability of the 
peptide inhibitors to suppress cytotoxicity in a MIN6 mouse model of -pancreatic cells when 
challenged with WT-amylin. 
Materials and Methods 
Materials-Human WT-amylin was from Biopeptide (San Diego, CA). The Arg-1, Arg-2 and 
Mem-T peptides were custom-synthesized by NeoBioLab (Woburn, MA). All peptides were 
synthesized with an amidated C-terminus, which occurs as a natural post-translational 
modification in human WT-amylin. The peptides were purified to >95%, supplied as dry powders, 
and were taken up in 100% DMSO to form 1.1 mM peptide stock solutions that were stored in 
aliquots at -80 °C before use. Freshly thawed aliquots of the stock solutions were lyophilized and 
re-dissolved to the desired peptide concentration in 1 % (v/v) DMSO for cytotoxicity experiments 
and 2 % (v/v) DMSO for all other experiments. Ultrapure grade Thioflavin T was from AnaSpec 
(Fremont, CA). The Alamar Blue dye to measure cell viability in cytotoxicity assays and DMEM 
cell culture medium were from Invitrogen (Carlsbad, CA). All other chemicals, used for buffer 
preparations were from Fisher (Pittsburgh, PA).  
ThT Assays of Fibrillization Kinetics - The time course of fibrillization in solution was 
monitored using 100-200 μL samples of WT-amylin and analog peptides contained in white 
polystyrene clear bottom 96-well plates (Corning Inc., Corning, NY). Plates were covered with a 
clear polyester sealing tape (Fisher Scientific, Agawam, MA) to prevent evaporation. Stock 
solutions of WT amylin and inhibitor peptides were prepared in 100% DMSO, which dissolves 
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and disaggregates amylin, and stored at -80°C when not in use. Starting from the 100% DMSO 
stock solutions, samples for fibrillization reactions were prepared to contain final concentrations 
of 20 μM amylin (except where noted otherwise) and 10 μM ultrapure ThT in 20 mM sodium 
phosphate buffer, pH 7.4, with 2% (v/v) DMSO. Amylin was the final component added, in order 
to reduce the dead time for the reactions. The plates ware incubated at 25 °C without agitation. 
Fluorescence intensity was recorded at 2-min intervals with excitation at 440 nm and emission at 
490 nm on a Fluoroskan Ascent 2.5 fluorescence plate reader. Fibrillization reactions for the 
peptides alone were performed in triplicate, and for analog-peptide inhibition of WT-amylin in 
duplicate, to estimate experimental uncertainties in kinetic parameters.  
Transmission Electron Microscopy - Samples containing 80 μM concentrations of WT-amylin 
and the three analogs were incubated without agitation at a temperature of 37°C in 20 mM 
phosphate buffer (pH 7.4). For the inhibition reactions, samples contained WT-amylin at an 80 
μM concentration, together with 160 μM of Arg-1, Arg-2 or Mem-T analogs.  Aliquots from the 
reactions were removed after 2 days for EM imaging. The aliquots were blotted onto carbon-coated 
400-mesh Maxtaform copper grids (Ted Pella Inc. Redding, CA) for 1-3 min, followed by negative 
staining with 1 % uranyl acetate. EM images were recorded on an FEI Tecnai G2 Spirit BioTwin 
transmission electron microscope equipped with an AMT XR-40 camera. 
Cytotoxicity Assays - Amylin samples were prepared by dissolving lyophilized peptides in 100% 
DMSO to 8 and 12 mM concentrations for WT-amylin and the analogs, respectively. Peptide 
concentrations were measured using the Micro BCA Protein Assay kit ( Thermo Scientific, 
Rockford, IL). Stock solutions were diluted with FBS (fetal bovine serum)-free DMEM 
(Dulbecco's Modified Eagle Medium) to final concentrations of 40, 80 and 160 μM. The solutions 
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were sonicated continuously for 5 min at 75% amplitude before use. FBS was added in the final 
step, to a concentration of 15% (v/v). The final DMSO concentration for all cytotoxicity 
experiments was 1% (v/v). 
 Cytotoxicity was measured using the mouse insuloma 6 (MIN6) cell line model of β-
pancreatic cells, which was a gift from Dr. Anil Rustgi (University of Pennsylvania). Cells were 
seeded at a density of 20,000 per 100 μL in black clear-bottom 96-well plates. The cells were 
grown in DMEM with 15% FBS, 25 mM glucose, 2 mM L-glutamine, 500 mM sodium pyruvate, 
55 μM β-mercaptoethanol, 1000 units/ml penicillin, and 100 μg/ml streptomycin, for 20 h at 37 
°C in a humidified incubator with 5% CO2.  The culture medium was then removed and replaced 
with fresh medium containing WT-amylin and/or inhibitor peptides. The cells were incubated for 
another 24 h followed by the addition of 10% (v/v) of the redox indicator dye AlamarBlue at the 
concentration supplied by the manufacturer (Invitrogen). Fluorescence, due to the reduction of 
AlamarBlue by viable cells was measured after 6 h using, excitation and emission wavelengths of 
544 and 590 nm, respectively. Cell viability was calculated from the ratio of AlamarBlue 
fluorescence in treated to untreated cells. Uncertainties were calculated from the standard errors 
of measurements done in triplicate.  
Results 
Incorporation of Charged Residues Inhibits Fibrillization. The three amylin analogs Arg-1, 
Arg-2, and Mem-T considered in this work, substitute strings of like-charged amino acids for 
segments of the amylin sequence. We first compared fibrillization of the analogs and WT-amylin 
(Fig. 4.3). At a physiological salt concentration of 150 mM NaCl and peptide concentration of 20 
µM, we could only detect fibrillization for WT-amylin and Arg-1. The change of ThT fluorescence 
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between the start and steady-state plateau of the reactions is 30-fold larger for WT-Amylin 
compared to the Arg-1 peptide (Fig. 4.3A). The lag-time for the Arg-1 analog (210 min) is 
increased about 2-fold compared to WT-amylin (120 min) while the elongation rate for Arg-1 
(0.0068 min-1) is reduced about 30% compared to WT-amylin (0.010 min-1). At the 20 µM peptide 
concentrations used for these experiments we did not detect any fibrillization with the Arg-2 or 
Mem-T peptides (Fig. 4. 3A). With a 20-fold higher peptide concentration of 400 µM, we observed 
weak fibrillization of Mem-T (Fig. 4.3B orange to red) but Arg-2 still failed to fibrillize (Fig. 4.3B 
light to dark green). The fibrillization of Mem-T at the larger 400 µM peptide concentration was 
highly salt dependent. In the absence of salt only a very weak signal for fibrils was detected (orange 
in Fig. 4.3B). Fibrillization was stimulated at physiological salt concentrations and above (red in 
Fig. 4.3B), as expected for a mechanism in which charge-repulsion for the Mem-T analog is abated 
when the charges become screened by salt. At a physiological salt concentration of 150 mM NaCl, 
the fibrillization of 400 µM Mem-T (lag time of 10,000 min, elongation rate of 6.1 ± 1.4 x 10-6  
min-1) was still much weaker than that of WT-amylin at a 20 µM peptide concentration (lag time 
120 min, elongation rate of 0.0100 ± 0.0001  min-1). The Arg-2 peptide did not form fibrils under 
any of the conditions tested (Fig. 4.3). 
 EM images of the aggregates present after 2 days were consistent with the kinetics data 
(Fig. 4.4).  WT-amylin formed large amounts of fibrils (Fig. 4.4A).  By contrast Arg-1 formed 
much fewer fibrils; the section of the grid shown in Fig. 4.4B has a relatively high number to aid 
visualization. The image in Fig. 4.3B clearly shows that the Arg-1 formed a larger proportion of 
short fibrils than WT-amylin. For Arg-2 (Fig. 4.4C) and Mem-T (Fig. 4.4D) we only detected 
amorphous aggregates with non-fibrillar morphologies. Taken together, these observations 
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Figure 4.3 Fibrillization kinetics of WT and charged amylin variants. (A) Reaction profiles for 20 µM peptide 
concentrations in the presence of 150 mM NaCl. (B) Reaction profiles for 400 µM concentrations of Arg-2 and Mem-
T at the indicated salt concentrations. 
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Figure 4.4 TEM images of aggregates formed by WT and charged amylin variants. (A) WT-amylin, (B) Arg-1, (C) 
Arg-2, (D) Mem-T after incubation for 2 days in 20 mM phosphate buffer, pH 7.4, at a temperature of 37 oC. All 
peptide concentrations were 80 µM. 
indicate that the introduction of charged residues in amylin analogs strongly interferes with their 
ability to form fibrils. The increased lag times and reduced elongation rates in the kinetic assays 
indicate that the charged residues inhibit fibrillization (Fig. 4.3). EM imaging shows, compared to 
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WT-amylin, Arg-1 forms fewer fibrils with shorter lengths, while Arg-2 and Mem-T form few if 
any fibrils (Fig. 4.4). 
Charge-Loaded Peptide Analogs Inhibit Fibrillization of WT-amylin. We next examined 
whether the charge-loaded analog peptides affected the fibrillization of WT-amylin when added 
in trans (Fig. 4.5). In spite of their poor ability to fibrillize on their own, each of the three analogs 
affects the kinetics of WT-amylin fibrillization indicating that the analogs interact with the WT 
peptide. The most readily apparent effect is that fibrillization rates are reduced with increasing 
concentration of the analogs, manifested by a reduction in the slopes of the growth part of the 
reactions compared to WT-amylin alone. With Arg-1 there is also a reduction in the steady-state 
fluorescence plateaus with increasing concentration of the inhibitor (Fig. 4.5A). Fibrillization lag 
times are increased with increasing concentrations of the Arg-2 peptide (Fig. 4.5B) but decrease 
at high concentrations of the Mem-T analog (Fig. 4.5C). 
 Fig. 4.6 shows the effects of analog peptide concentrations ranging between 0.001 and 120 
µM on the kinetic parameters for the fibrillization of 20 µM WT-amylin. All three peptides reduce 
fibril elongation rates. The Arg-1 and Arg-2 inhibitors cause an 8-10 fold reduction in elongation 
rates, as conceived in the design of the peptides as fibril-elongation inhibitors. Mem-T shows a 
smaller 4-fold reduction in elongation rates (Fig. 4.6A). Although Mem-T was conceived as an 
inhibitor of the interactions of WT-amylin with membranes, the substitution of a string of 
negatively charged aspartate residues in the N-terminal half of the amino acid sequence inhibits 
fibril elongation, probably by the same mechanism as the introduction of positively charged 
arginine residues in the Arg-1 and Arg-2 analogs. That inhibition of fibril elongation is weaker  
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Figure 4.5 Effects of peptide inhibitors at the indicated concentrations on the fibrillization of 20 µM WT-amylin: (A) 
Arg-1, (B) Arg-2, (C) Mem-T. All reactions were done in the presence of 150 mM NaCl. 
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Figure 4.6 Effects of peptides added in trans on parameters describing the fibrillization kinetics of 20 µM WT- amylin: 
(A) elongation rates, (B) lag times, (C) fluorescence plateaus. Inhibition data from Arg-1, Arg-2, and Mem-T are 
shown in blue, green, and red, respectively. All experiments were done in duplicate in the presence of 150 mM NaCl. 
The data points are average values for the kinetic parameters, and the uncertainty bars are standard errors of the mean 
calculated from the duplicate reactions. Curves represent four-parameter non-linear least squares fits of the inhibition 
data to the IC50 equation [120] (when these could be fitted). 
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with Mem-T than with the arginine analogs, is likely a consequence of WT-amylin being an 
entirely cationic peptide with no negatively charged residues at neutral pH. Thus electrostatic 
repulsion would be expected to be stronger between the intrinsic positively charged sites in WT- 
amylin and the introduced positive charges in the two arginine inhibitors than with the negative 
charges in the Mem-T analog.  An IC50 analysis of the inhibition data was performed to obtain 
quantitative information on the fibrillization of WT-amylin as a function of the concentrations of 
the charge-loaded analog peptides (Fig. 4.6). The Arg-1 concentration-dependence for the 
inhibition of WT-amylin fibril elongation rates gives an IC50 value of 0.6 ± 0.5 µM. For Arg-2 and 
Mem-T, the IC50 values are ~10 µM (Fig. 4.6A). In addition to effecting elongation rates, Arg-2  
 
Figure 4.7 Representative kinetic traces for the fibrillization of WT-amylin at the larger peptide concentration used 
for the cytotoxicity assays (80 µM amylin), and the indicated concentrations of the Arg-1 inhibitor. 
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increases the lag times for WT-amylin fibrillization with an IC50 of ~0.1 µM. This indicates that 
Arg-2, in addition to inhibiting fibril elongation, inhibits the nucleation step of the reaction (Fig. 
4.6B). By contrast, Mem-T causes a reduction in lag times at high concentrations of the analog    
(>10 µM) suggesting that it promotes the nucleation of WT-amylin. The half-maximal 
concentration for this effect was about 70 µM. The reduction in lag times with Mem-T is 
reminiscent of what we previously observed with negatively charged heparin polysaccharides 
which enhance fibrillization of WT-amylin [43], and may occur because the negative charges in 
Mem-T complement the positive charges in the cationic amylin peptide, thereby facilitating fibril 
nucleation. With increasing Arg-1 concentration, there were no effect on the lag times within 
experimental uncertainty when the experiments were done with a 20 µM concentration of WT-
amylin (Fig. 4.6B). When the reactions were done at a larger WT-amylin concentration of 80 µM, 
the concentration used for cytotoxicity experiments (see below), we saw increases in lag times 
with increasing Arg-1 concentration as well as decreases in elongation rates and steady-state 
fluorescence plateaus (Fig. 4.7 and 4.8). The effects of Arg-1 may be masked at the lower 20 µM 
WT-amylin concentration as fibrillization lag times increase with decreasing peptide 
concentration. Within experimental uncertainty, steady-state fluorescence plateaus were only 
observed to decrease with the Arg-1 analog, with an IC50 of 2.8 ± 1.7 µM (Fig. 4.6C). 
 TEM imaging of WT-amylin fibrils formed in the presence of the charge-loaded analogs 
showed that the morphology of the fibrils is preserved compared to WT-amylin (Fig. 4.9). In the 
presence of the least effective inhibitor Mem-T, the fibrils of WT-amylin were indistinguishable 
from those formed with WT-amylin alone (Fig. 4.10A, 4.10D). In the presence of the effective 
analogs Arg-1 (Fig. 4.10B) and Arg-2 (Fig. 4.10C), we observed somewhat fewer fibrils and a  
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Figure 4.8 Dependence of kinetic parameters for the fibrillization of 80 µM WT-amylin (see Fig. 4.7) on the 
concentration of Arg-1 inhibitor. Experiments were done in duplicate in the presence of 150 mM NaCl. Data points 
are average values for the kinetic parameters, uncertainty bars are standard errors calculated from the duplicate 
reactions, and curves are four-parameter fits of the inhibition data to the IC50 equation. The IC50 values were 9.1 ± 5.2 
µM for the elongation rates (A), 11.0 ± 12.4 µM for the lag times (B), and 50 ± 80 µM for the steady-state fluorescence 
plateaus. 
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Figure 4.9.  TEM images of fibrils formed from 80 µM WT-amylin in the presence or absence of inhibitor peptides. 
(A) WT-amylin alone, (B) with 160 µM Arg-1, (C) with 160 µM Arg-2, (D) with 160 µM Mem-T. Aliquots were 
removed for EM imaging 24 h after the fibrillization reactions were started. Reactions were carried out in 20 mM 
sodium phosphate (pH 7.4), 1% DMSO (v/v) at 37 °C. 
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Figure 4.10 Salt-dependence on the effectiveness of charge-based inhibitor peptides. Elongation rates with Arg-1 (A), 
Arg-2 (B), Mem-T (C) and lag times with Mem-T (D). 
 
greater amount of short fibrils compared to when WT-amylin was fibrillized alone. The increase 
in the amount of short fibrils is consistent with the greater potency of the Arg-1 and Arg-2 peptides 
as inhibitors of WT-amylin fibril elongation rates. Thus, while Arg-1 and Arg-2 peptides do not stop 
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fibrillization, they appear to inhibit fibril elongation as manifested by the smaller amounts of fibrils 
and the greater proportion of short fibrils in the presence of the inhibitors. 
Salt Modulates the Inhibition of WT-amylin Fibrillization by Charge-loaded Analogs. Since 
we expected the charge-loaded amylin analogs to inhibit fibrillization through electrostatic 
repulsion we looked at the effects of salt, which should screen charges. Fig. 4.10A shows the 
effects of NaCl concentration on the most potent inhibitor Arg-1. Although we have too few data 
points to accurately determine IC50 values, the experiments clearly show that larger Arg-1 
concentrations are required to decrease elongation rates with increasing salt concentration. This is 
the expected result for an inhibition mechanism that involves electrostatic repulsion, as the charges 
become increasingly screened with increasing salt concentration. A very similar effect is seen with 
Arg-2 (Fig. 4.10B) but with the least effective inhibitor Mem-T, salt effects on elongation rates 
are reduced close to the uncertainties of the measurements (Fig. 4.10C). The shortening of 
fibrillization lag times with the Mem-T peptide, however, shows a strong salt concentration 
dependence indicating that the enhanced nucleation of WT-amylin fibrils in the presence of Mem-
T occurs through electrostatic interactions (Fig. 4.10D). 
 It is interesting to consider that the data in Fig. 4.10A and 4.10B indicate that the reduction 
in elongation rates with Arg-1 and Arg-2 is more effective at physiological salt concentration or 
higher than in the absence of salt. This is because the fibrillization of WT-amylin, in the absence 
of any inhibitors, is enhanced with increasing ionic strength [121]. A 7-fold reduction in elongation 
rates is seen as the concentration of Arg-1 is increased between 0 and 200 µM at 150 mM NaCl. 
In the absence of salt, there is only a 4-fold reduction over the same inhibitor concentration range 
(Fig. 4.10A).  
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Figure 4.11 Effects of charge-based inhibitors on amylin cytotoxicity. (A)  Cytotoxicity of WT-amylin and analogs 
towards a MIN6 mouse insulinoma cell models of β-pancreatic cells.  Gray, cells-only, defined as 100% cell viability 
and 1% DMSO vector used for all experiments except the first; brown, positive melittin control; orange, WT-amylin 
at different concentrations; blue, green, red -cells challenged with 80 µM Arg-1, Arg-2, Mem-T respectively; light 
blue, green, red - cells challenged with 80 µM WT-amylin and the indicated molar ratios of the respective inhibitors. 
(B) Viability of MIN6 cells challenged with 80µM WT-amylin as a function of Arg-1 concentration. The cell viability 
data were fit to an IC50 value of 47 ± 17 µM Arg-1. All data points are averages from measurements performed in 
triplicate and the uncertainties are the associated SEMs. 
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Arg-1 and Arg-2 are Inhibitors of WT-amylin Cytotoxicity Towards β Cells. We next looked at 
the effects of the charge-based amylin analogs on the cytotoxicity of WT-amylin towards a MIN6 
model of pancreatic β-cells (Fig. 4.11). In control experiments, all three analog peptides show no 
toxicity towards the MIN6 cells (dark blue, green, red in Fig. 4.11A), giving viabilities comparable to 
untreated cells (gray in Fig. 4.11A). We next did a concentration series challenging the MIN6 cells 
with 40, 80, and 160 µM WT-amylin (orange in Fig. 4.11A). As the concentration of WT-amylin is 
increased, cell viability drops to about 45% in the presence of 160 µM WT-amylin, comparable to the 
value obtained with the potent toxin bee-venom melittin, which was used as a positive control (brown 
in Fig. 4.11A). We chose an 80 µM concentration of WT-amylin for the inhibitor studies, as a 
compromise between detecting a sufficient signal in the assay (~25% cytotoxicity) and minimizing the 
WT-amylin peptide concentration, since this would require lower concentrations of the inhibitors to 
counteract the effects of WT-amylin. The Arg-1 analog protects against WT-amylin at a stoichiometric 
ratio of the two peptides: 80 µM Arg-1 for MIN6 cells challenged with 80 µM WT-amylin (light blue 
bars in Fig. 4.11). The Arg-2 analog is less effective than Arg-1, and only protects against cytotoxicity 
at a 2:1 inhibitor: WT-amylin molar ratio (160 µM Arg2: 80 µM WT amylin, light green in Fig. 4.11A). 
The Mem-T analog failed to protect against WT-amylin cytotoxicity (pink in Fig. 4.11A).  
 For the most potent analog, Arg-1, we looked in detail at the inhibitor concentration 
dependence of cytotoxicity for MIN6 Cells challenged with 80 µM WT-amylin (Fig. 4.11B). The 
inhibitor concentration data were fit with an IC50 value of 47 ± 17 µM. This value is comparable to 
other WT-amylin cytotoxicity inhibitors reported in the literature, such as oligopyridylamide [122] and 
diarylated thiophene [123] -helix mimetics (IC50 values of ~7 µM and ~50 µM estimated from the 
data in Fig. 4.3D of [122] and Fig. 4.4B of [123], respectively). 
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Discussion 
 The motivation for the studies described in this work was to see if electrostatic charge 
repulsion could be exploited to design new types of inhibitors of amylin fibrillization and 
cytotoxicity. Our work [116, 118] and that of others [23, 124, 125] has shown that charging of 
His18 in amylin at low pH can markedly inhibit fibrillization. The effects of charging His18 at low 
pH can be recapitulated in the H18R mutant of amylin at neutral pH, and this substitution results 
in an amylin peptide that is not cytotoxic to -cells [95, 116].  Moreover, addition of a single 
charged lysine residue in the S20K mutation was reported to result in much slower fibrillization 
and to inhibit fibrillization of the WT-amylin peptide when the mutant peptide was added in trans 
[46]. Stimulated by these observations we designed three peptide analogs that substitute a string 
of 4-5 charged residues for neutral residues in the amylin sequence. The Arg-1 and Arg-2 analogs 
substitute four positively charged arginine residues for segments of the amylin that form the end 
of strand 1 and the beginning of strand 2, respectively, in the model of the amylin fibril structure 
derived from ssNMR [25] (Fig. 4.1B). The Arg-1 and Arg-2 analogs were designed as inhibitors 
of fibril elongation. The Mem-T peptide which was designed to interfere with the membrane 
insertion of mixed Mem-T:WT-amylin oligomers substitutes five negatively charged aspartate 
residues for the segment of the peptide that has the highest avidity for membranes[4, 86] and that 
is embedded in the hydrophobic environment of membrane-mimetic micelles in the solution NMR 
structure of amylin (Fig. 4.1C) [117]. In this work we characterized the ability of the peptides to 
form fibrils by themselves, the concentration dependence of their inhibition of WT-amylin 
fibrillization, and their inhibition of WT-amylin cytotoxicity towards the MIN6 mouse model of 
pancreatic -cells. 
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 In the cytotoxicity assays, Arg-1 was more potent than Arg-2 in protecting -cells from 
WT-amylin, while the Mem-T analog offered no protection (Fig. 4.11). Protection of cytotoxicity 
from WT-amylin was achieved at a stoichiometric ratio with the Arg-1 analog but required a two-
fold molar excess with the Arg-2 peptide (Fig. 4.11). The origins of these differences are unclear 
but Arg-1 also serves as a more potent inhibitor of fibril elongation rates than Arg-2, with an IC50 
of 0.60 ± 0.47 µM for Arg-1 compared to 8.6 ± 8.2 µM for Arg-2 (Fig. 4.6A). The greater potency 
of Arg-1 compared to Arg-2 could be a structural effect. In the ssNMR model of amylin protofibrils 
[25] the four substituted arginines would be positioned at the surface of the structure in Arg-1, 
whereas they would be placed in the interior between the two C2-symmetry related stacks of -
sheets in Arg-2 (Fig. 4.1B). Alternatively, the greater effectiveness of Arg-1 as an inhibitor may 
be related to its relatively better ability to form fibrils on its own, whereas Arg-2 did not form 
fibrils even at high concentrations of the peptide and salt. In other words, the capacity of Arg-1 to 
form fibrils although weakened compared to WT-amylin, may make it better able to associate with 
the latter, thereby allowing it to better exert its inhibitory effects on fibril elongation.  
 The lack of protection against WT-amylin cytotoxicity with Mem-T could indicate that the 
design strategy of interfering with oligomer insertion into membranes did not work. Another 
possibility, is that Mem-T could work at higher concentrations than the highest 2:1 Mem-T: WT-
amylin ratio tested in this work. Since we do not know the optimum Mem-T: WT-amylin 
stoichiometry ratio for the putative mixed oligomers on which the design strategy was based, it's 
conceivable that Mem-T could work at a larger molar excess to WT-amylin than used in this work. 
Like Arg-1 and Arg-2, Mem-T acts as an inhibitor of WT-amylin fibril elongation rates with an 
IC50 of 7.4 ± 6.6 µM. The reduction in elongation rates with Mem-T is only about half of that for 
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the arginine-peptides, and in contrast to the arginine peptides Mem-T decreases the lag times for 
WT-amylin fibrillization. The stimulation of the nucleation step for WT-amylin fibrillization, as 
manifested by the reduced lag times observed at high concentrations of Mem-T (Fig. 4.6B), may 
be why this analog is as ineffective as a cytotoxicity inhibitor.  The enhanced fibril nucleation of 
WT-amylin at high concentrations of Mem-T is most likely due to the insertion of negative charges 
in this analog which could complement the positive charges in the WT peptide.  An alternative 
way to design a peptide that could interfere with membrane insertion of mixed oligomers, would 
be to disrupt the -helix that interacts with the hydrophobic component of membranes (Fig. 4.1C) 
by inserting prolines rather than negatively charged residues.  This could have the desired effect 
of interfering with membrane insertion of mixed oligomers, while avoiding the stimulation of the 
nucleation of WT-amylin due to the negative charges in the Mem-T analog. 
 For the most effective analog Arg-1, we determined IC50 values of 1-10 µM from the 
inhibitor concentration-dependence of the kinetic parameters for WT-amylin fibrillization (Fig. 
4.6 and 4.8). These values are comparable to those of other fibrillization inhibitors reported in the 
literature, for example small molecules containing heterocyclic groups (IC50 = 1 µM) [126] and -
helix peptidomimetics (IC50 = 8 µM) [122, 123, 127]. We also looked at the Arg-1 concentration 
dependence of the inhibition of WT-amylin cytotoxicity and obtained an IC50 of 47 ± 17 µM. 
Although there is a dearth of similar studies for amylin inhibitors in the literature we were able to 
estimate a comparable IC50 of ~7 µM from the data reported (Fig. 4.3D) for the IS5 
oligopyridylamide -helix mimetic inhibitor of amylin cytotoxicity[122]. For the A peptide 
involved in Alzheimer's disease, a number of different types of inhibitors give IC50 values in the 
range between 10 and 100 µM in cell cytotoxicity assays [128-130]. A problem with the MIN6 
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cells used in this paper, is that a relatively high concentrations of WT-amylin is needed to give a 
significant cytotoxicity signal, as shown by the concentration series represented by the orange bars 
in Fig. 4.11. Under the conditions of this study (1% DMSO so as to not perturb cell membranes) 
10%, 25% and 50% cytotoxicity is achieved with WT-amylin concentrations of 40, 80, and 160 
µM WT-amylin, respectively. Because of the large amounts of WT-amylin needed to detect a 
sufficient cytotoxicity signal, large concentrations of inhibitor peptides were needed to protect 
from WT-amylin. One possibility is to use another -cell model, such as the INS-1 cell line but 
with this system as well concentrations in the range between 5 and 50 µM WT-amylin were needed 
to give 50% cytotoxicity [122, 123]. A more sensitive cytotoxicity assay would allow the use of 
lower WT-amylin concentrations and possibly lower inhibitor concentrations. 
 It is currently uncertain which states of amyloidogenic proteins are harmful to cells. In the 
case of amylin, amyloid fibrils could exert their cytotoxic effects by perforating -cell membranes 
or by disrupting the network of interactions with other cells in the islets (, , , PP) that are 
necessary for the -cells to function [4]. Many investigators have proposed that soluble oligomers 
rather than fibrils are responsible for the deleterious effects of amyloidogenic proteins. Annular 
oligomers could form membrane-spanning pores that would allow unregulated ion transport 
between the cell and its environment disrupting cellular homeostasis [4, 48, 131]. Because 
intermediates would be present at low concentrations and would be short-lived, oligomeric 
precursors to amyloids have proven difficult to isolate and their properties are ill-defined [4, 132]. 
Oligomers also pose the difficulty that because they are transiently formed, they could interconvert 
to fibrils during the cytotoxicity measurements, making a definite assignment of their role in 
pathology equivocal [4, 14]. In yet another proposed mechanism, it is not the oligomers or fibrils 
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themselves, but the process of fibril growth that could be responsible for cytotoxicity, by inducing 
membrane damage [133]. For the three analogs described in the paper we do see a positive 
correlation between inhibition of fibril elongation rates and protection against WT-amylin 
cytotoxicity to -cells (Fig. 4.6A and 4.11). Although Arg-1 and Arg-2 were designed as fibril 
elongation inhibitors, the two analogs together with Mem-T also have effects on the lag times for 
the reactions, and could conceivably protect against WT-amylin cytotoxicity through a different 
mechanism. To unequivocally prove that Arg-1 and Arg-2 act as fibril elongation inhibitors and 
that Mem-T can interfere with membrane disruption by WT-amylin will require additional studies.   
 The current results with the charge-based inhibitors are encouraging because they 
potentially represent a new electrostatic-based approach to inhibit amyloid fibrillization and 
toxicity. Clearly, the efficacy of these first-generation inhibitors could be improved. Possible 
strategies include substituting charged residues for the segments that form the earliest secondary 
structure during misfolding [134], using structural models of amylin fibrils to substitute charged 
residues for residues that face the surface or core of the fibril, substituting charged residues in both 
strands that form the amylin fibril -hairpin structure [25, 135], and combining charge-based 
substitutions with other approaches such as the introduction of H-bond blockers [136, 137]. 
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CHAPTER V: Future Directions 
 This thesis has explored the molecular structure of human amylin, real-time fluorescence 
imaging of amyloid fibrillization, and the development of possible amyloid cytotoxicity inhibitors. 
 Throughout different animal species, amylin sequences are strongly conserved with the 
most notable variation occurring in the residues 20-29 region (Fig 2.3D). The proline residue in 
amylin sequence of certain species such as rat, mouse and dog in the 20-29 residue amyloidogenic 
region inhibits aggregation and these animals are not susceptible to type 2 diabetes. This fact has 
been used in the development of the FDA-approved drug pramlintide (Symlin®) for diabetes. It 
has been shown that proline mutations outside the amyloidogenic region of amylin (proline 
substitutions at positions 17, 19, and 30) result in a large inhibition of amyloid propensity and the 
loss of amyloid fiber stability [133]. Conversely, the S20G mutation in human amylin had been 
shown to fibrillize faster than the WT amylin and cause an early onset of type 2 diabetes [17]. 
 Molecular dynamics simulation data is available for human amylin, S20G amylin, I26P 
amylin, and rat amylin [138]. These simulation studies show marked differences in secondary 
structures of mutated versus non mutated amylin. The simulation studies demonstrate varying 
helical populations as well as flexibility in the C-terminal region of mutated human amylin [138]. 
The intra helical angle for our SDS micelle-bound amylin structure is ~30°, whereas the intra 
helical angle for the mutated S20G amylin by molecular dynamics study samples two angles, one 
at 40° degree and the other at 90° [139]. The same study also reported that the simultaneous loss 
of both hydrogen bonds between Leu16 and Ser20 in S20G amylin coincides with the large 
fluctuations in backbone dihedral angles near His18 in one trajectory. An amidated version of 
human amylin aggregates significantly faster (~9 times) than the non-amidated variant [20], which 
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suggests an intrahelical angle of 85° found in micelle-bound NMR structure [92] of amidated form 
is significant in protein misfolding processes. These studies suggest that along with electrostatic 
interactions, intrahelical angle also plays a key role in aggregation, since, these L-shaped structures 
coincide with faster aggregation rate [139]. Generally, kinks in micelle-bound structure correspond 
with locations of turns adopted by the amyloidogenic proteins in fibril structure [77]. The 
conformational preorganization of the S20G mutant monomer into the overall fibril topology 
might reduce the cost of conformational search for aggregation.  A molecular dynamic simulations 
for amylin has also found evidence for a metastable beta hairpin structure which has been proposed 
to be responsible for the initial seeding of fibrils [102]. 
 In view of these structural variations, it is important to determine the NMR structures of 
S20G amylin variant, and what might be the driving force behind its higher fibrillization 
propensity. It would be informative to investigate the structural differences between our designed 
Arg-1 and Mem-T analogs by NMR to see how structural difference from the wild type correlate 
with their effectiveness as inhibitors and thereby rationally design improved inhibitors. Further 
fluorescence microscopy investigations could be done to determine how the inhibitors interact with 
and inhibit wild type amylin fibrillization. The specific techniques that could be applied towards 
these investigations include TIRFM. By using fluorescently tagged peptides [111] one could 
investigate the designed charged inhibitors Arg-1 and Mem-T to see the fibrillization inhibition in 
real time.  
 Studies have shown that human amylin dimerizes when in a highly α-alpha helical state 
[140] and this dimer is an on-pathway intermediate for fibril formation. AFM imaging of various 
amyloidogenic proteins have shown the possible oligomeric assembly in presence of lipid 
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membranes [141]. As of now molecular structure of the hypothesized pore forming oligomer is 
not available for any amyloidogenic protein. NMR studies from our lab and others have shown 
that human amylin monomers associate with the cell membrane [117, 142]. In addition, multiple 
factors such as protein concentration, cholesterol and lipids, glycosaminoglycans, temperature, and 
pH play a crucial role in the formation of amyloids [43, 143, 144]. It might be possible to stabilize 
oligomeric pore complexes for detailed structural studies, by controlling one or more of these 
variables while maintaining the peptide concentration high enough in the vicinity of the membrane 
to create microenvironments that favor stable oligomer formation. A helical wheel representation 
has been proposed for the pore complex, were the hydrophobic residues (shown in blue, Fig. 2.7) 
of human amylin are oriented toward the surrounding lipids to form a stable pentameric oligomer 
pore structure [145]. Such oligomeric structures could be characterized by CD, fluorescence 
resonance energy transfer (FRET), and electron microscopy techniques [146, 147]. Since, the 
fibrillization rates of our designed inhibitors are very low as compared to amylin (Fig. 4.3 A), a 
CD experiment could be a good starting point to determine the helical content within each of the 
designed inhibitor peptides for comparison. ThT fluorescence assays could be used to monitor the 
effect of lipids or micelle membranes on fibrillization kinetics, in conjunction with cytotoxicity 
assays in order to establish the correlation between a specific fibrillization stages and the maximal 
cytotoxicity effect. Amylin analog peptides with a fluorescent tag attached to a specific amino acid 
such as N-terminal lysine or by using unnatural amino acids such ring-substituted phenylalanine 
at residue F15 within α-helical region of human amylin could be used [111, 148]  to access the 
lateral binding of peptide in oligomeric form in lipid membrane environment.  
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Excerpted from: S. Jha, S.M. Patil, J. Gibson, C.E. Nelson, N.N. Alder, and A.T. Alexandrescu, Mechanism of 
amylin fibrillization enhancement by heparin, J. Biol. Chem. 286 (2011) 22894-22904. 
I performed NMR, Electron microscopy and TIRFM (Figures A1-1, A1-4, and A1-6) 
Dr. Suman Jha performed NMR and Fluorescence assays (Figure A1-1, A1-2, A1-3, and A1-5) 
Dr. Suman Jha and Dr. Jason Gibson performed Cytotoxicity assays (Figure A1-7) 
Appendix I: Mechanism of Amylin Fibrillization Enhancement by Heparin. 
Abstract  
  We characterized the interaction of amylin with heparin fragments of defined 
length, which model the glycosaminoglycan chains associated with amyloid deposits found in type 
2 diabetes. Binding of heparin fragments to the positively charged N-terminal half of monomeric 
amylin depends on the concentration of negatively charged saccharides but is independent of 
oligosaccharide length. By contrast, amylin fibrillogenesis has a sigmoidal dependence on heparin 
fragment length, with an enhancement observed for oligosaccharides longer than four monomers 
and a leveling off of effects beyond 12 monomers. The length dependence suggests that the 
negatively charged helical structure of heparin electrostatically complements the positively 
charged surface of the fibrillar amylin cross-structure. Fluorescence resonance energy transfer and 
total internal reflection fluorescence microscopy experiments indicate that heparin associates with 
amylin fibrils, rather than enhancing fibrillogenesis catalytically. Short heparin fragments 
containing two- or eight-saccharide monomers protect against amylin cytotoxicity toward a MIN6 
mouse cell model of pancreatic β-cells. 
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Introduction 
 Although there has been much progress in understanding the biophysical and structural 
basis of amyloid diseases from studies on purified amyloidogenic polypeptides [7], the amyloid 
deposits found in situ often interact or are associated with a variety of cofactors [42]. In the case 
of amylin, accessory molecules that could play a role in modulating pathology include insulin 
[149, 150], membrane lipids [9, 150], metals such as zinc [151], and glycosaminoglycans (GAGs) 
[152-155]. GAGs are a class of heterogeneous negatively charged oligosaccharides composed of 
seven different types of repeating disaccharide units [156]. GAGs and proteoglycans, particularly 
those composed of dermatan and heparan sulfate, are found ubiquitously in amyloid deposits 
formed in situ [157], and the heparan sulfate proteoglycan (HSPG) perlecan has been shown to co-
localize with pancreatic amylin deposits isolated from patients with type 2 diabetes [155]. GAGs 
and HSPGs enhance the rate of amylin fibrillization in vitro [153, 154, 158, 159] and stabilize 
fibrils once formed [42]. In addition to the mature form of the hormone considered herein, GAGs 
were also reported to accelerate the fibrillization of the incompletely processed amylin propeptide 
[152, 160]. 
 Here, we investigate the interactions of the GAG heparin with amylin fibrils. Although 
heparin is found primarily in the cytoplasmic granules of mast cells, its extensive characterization 
and similarity to heparan sulfate make it a suitable model for the GAG chains of HSPGs [152, 154, 
158, 160, 161]. The availability of fluorescein-tagged heparin made it possible to examine whether 
GAGs associate with amylin fibrils. The availability of a series of heparin fragments of defined 
length enabled us to look at how oligosaccharide size and charge content affect binding to amylin 
monomers, fibrillization kinetics, and amylin cytotoxicity. 
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Materials and Methods  
Materials-Synthetically prepared human amylin with an amidated C terminus and a Cys-2-Cys-7 
disulfide bond was from AnaSpec (Freemont, CA). Mature human amylin is naturally amidated at 
its C terminus, and amidation is required for hormone activity [8]. Except for NMR experiments 
to look at the interactions of amylin monomers with heparin fragments, all experiments were done 
with the C-terminally amidated peptide, which is the physiological form of the hormone [8]. For 
the NMR experiments, we used 15N-labeled recombinant amylin expressed in Escherichia coli, 
which was purchased from rPeptide (Bogart, GA). This peptide has a free-carboxyl group at the C 
terminus, but we can conclude that the lack of C-terminal amidation has no bearing on results 
because the NMR signals from the C-terminal half of the peptide are unaffected by the 
oligosaccharides. Heparin-dp2 was from V-LABS (Covington, LA), whereas the heparin 
fragments dp4 through dp20 were from Iduron (Manchester, UK). The low molecular weight 
fraction of heparin (LMWH) (catalog number A16198) was from Alfa Aesar (Ward Hill, MA), 
and the high molecular weight fraction of heparin (HMWH) (catalog number H3393) was from 
Sigma. Thioflavin T (ThT) was from Sigma or AnaSpec (ultrapure grade). Fluorescein-labeled 
heparin (FH) with an average molecular mass of 18 kDa and Alamar Blue were from Invitrogen. 
All other chemicals for solutions and buffers were from Fisher. 
NMR Spectroscopy-Lyophilized aliquots of 0.1 mg of 15Nlabeled amylin were suspended in 500 
l of 20 mM sodium phosphate buffer, pH 6.0, in 90% H2O, 10% D2O to give a 50 μM peptide 
concentration. A temperature of 10 °C was used for NMR experiments to avoid exchange of 
amylin amide protons with solvent. The binding of heparin fragments was monitored using two-
dimensional 1H-15N HSQC spectra collected with 1H X 15N spectral windows of 6000 X 1200 Hz 
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and matrix sizes of 2048 X 32 complex points. The experiments were done on a 600-MHz Varian 
Inova spectrometer equipped with a cryogenic probe. Assignments for amylin 1H-15N HSQC 
spectra were from the literature [162]. 
ThT Assays of Fibrillization Kinetics-Stock solutions of amylin were prepared in 100% DMSO, 
which disaggregates amylin [23], and stored at 80 °C when not in use. Starting from the 100% 
DMSO stock solutions, samples for fibrillization reactions were prepared to contain final 
concentrations of 5M amylin and 10 μM ThT in 20 mM sodium phosphate buffer, pH 7.4, with 
4% (v/v) DMSO. To reduce the dead time for the reactions, amylin was the final component added 
to the solutions. The reaction mixtures of 200 l were placed into 96-well white polystyrene clear-
bottom plates from Corning (Corning, NY) and sealed with clear polyester sealing tape from Fisher 
to prevent evaporation. The plate was incubated at 25 °C without agitation. Fluorescence intensity 
was recorded at 1-min intervals with excitation at 440 nm and emission at 490 nm on a Fluoroskan 
Ascent 2.5 fluorescence plate reader. 
 Fibrillization lag times were obtained from the x axis value at the intersection of the lag 
phase baseline slope and the slope of the steepest part of the growth phase [112]. Fibrillization 
rates were calculated by omitting the time points for the lag phase and fitting the initial part of the 
growth curve to the exponential function  y = A + B exp(-kx) [112] where k is the rate constant, B 
is the initial amplitude, and A is the plateau. ThT fluorescence plateau values were obtained from 
steady-state fluorescence intensities at 300 min. 
Fluorescence Spectroscopy-Proximity between amyloid-bound ThT and FH was analyzed by 
fluorescence resonance energy transfer (FRET) [163] using a Fluorolog 3-22 spectrophotometer. 
Samples containing 5 μM amylin, 10 μM ThT, and 0.28 μM FH were loaded into a 4 X 4-mm 
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quartz cuvette, and emission spectra (460-570 nm) were recorded at 6-min intervals for 3 h using 
excitation at 440 nm with a 4 nm band-pass filter. 
 To assess the amount of heparin incorporated into amylin fibrils (37), fibrils grown in the 
presence of 0.28 μM FH were run through an Amicon Ultra 100-kDa cut-off centrifugal filter at 
13,000 rpm for 15 min. The filtrand containing fibrils was washed with deionized water, and the 
suspension was filtered a second time. Fluorescence spectra of the filtrates and filtrands were used 
to determine the fraction of FH tightly associated with fibrils. 
Fluorescence Microscopy-Total internal reflection fluorescence microscopy (TIRFM) 
experiments were done on an Andor Revolution XD spinning disk confocal instrument with a 
Nikon TiE inverted microscope and an iXon EMCCD camera. ThT was excited with a 405 nm 
laser, and emission was filtered through a 483 nm band-pass filter. FH excitation was achieved 
with a 488 nm laser, and emission was filtered through a 523 nm band-pass filter. 
Transmission Electron Microscopy-Aliquots from the stationary phases of fibrillization 
reactions containing either amylin or amylin and heparin fragments were blotted for 1 min onto a 
carbon-coated 400-mesh Maxtaform copper/rhodium grid from Ted Pella Inc. (Redding, CA) 
followed by negative staining with 1% uranyl acetate. EM images were recorded on an FEI Tecnai 
G2 BioTWIN transmission electron microscope equipped with an AMT XR-40 camera. 
Cytotoxicity Assays-Cytotoxicity was measured using the mouse insuloma MIN6 cell line model 
of -pancreatic cells [164], which was a gift from Dr. Anil Rustgi (University of Pennsylvania). 
Cells were seeded to a density of 20,000/100μL/well in a black clear-bottom 96-well plate from 
BD Falcon containing DMEM medium from Invitrogen with 15% fetal bovine serum, 25 mM 
glucose, 2 mM L-glutamine, 500 mM sodium pyruvate, 55 μM β-mercaptoethanol, 1000 units/ml 
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penicillin, and 100 g/ml streptomycin. After 24 h of incubation at 37 °C, in a humidified incubator 
with 5% CO2, the culture medium was removed and replaced with fresh medium containing amylin 
or controls. The cells were incubated for another 24 h followed by the addition of 10% (v/v) 
Alamar Blue. Fluorescence, due to the reduction of the Alamar Blue dye by viable cells for 3 h, 
was measured using excitation and emission wavelengths of 544 and 590 nm, respectively [16]. 
Cell viability (in percentage) was calculated from the ratio of Alamar Blue fluorescence in treated 
cells to cells seeded in DMEM media alone. Uncertainties were calculated from the standard errors 
of measurements done in triplicate. 
 Amylin was prepared by dissolving lyophilized peptide in 100% DMSO to a 1.1 mM 
concentration for fresh amylin and 4 mM for experiments with mature amylin fibrils. The stock 
solutions were sonicated continuously for 5 min at 75 % amplitude before use. To look at the 
concentration dependence of cytotoxicity with fresh amylin, the amylin stock solution (1.1 mM) 
was diluted with reaction buffer and culture medium to final concentrations of 1, 5, 10, 40, and 80 
μM. For studies with mature amylin fibrils, fibrils were formed for 48 h at 25 °C using amylin 
monomer concentrations of 10, 50, 100, 400, and 800 μM. Aliquots of the fibril suspensions were 
then added to the culture medium to achieve final amylin concentrations equivalent to those used 
with the freshly prepared peptide (1, 5, 10, 40 and 80 μM). For these experiments, we assumed 
that the higher amylin concentrations used to prepare mature fibrils would affect fibrillization rates 
but not the cytotoxicity of the fibrils. 
 To look at the effects of heparin fragments on cytotoxicity with fresh amylin, cells were 
incubated in the presence of 40 μM amylin and 80 μM oligosaccharides (polymer concentration). 
For mature fibrils, aliquots of a fibril suspension grown from 400 μM amylin and 800 μM 
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oligosaccharides over 48 h were diluted 10-fold to obtain equivalent final concentrations expressed 
in amylin monomer equivalents [114]. 
Results 
 Heparin has previously been shown to enhance amylin fibril formation [154, 158]. To 
explore the interaction between the glycosaminoglycan and the polypeptide, we looked at a 
series of heparin fragments of defined length ranging from a 2-mer to a 20-mer. The fragments 
are products of the digestion of porcine high-grade heparin by bacterial heparinase and were 
purified by high-resolution gel filtration to a uniform fragment length or “degree of 
polymerization (dp)” [165] : dp2 (0.66 kDa), dp4 (1.33 kDa), dp8 (2.66 kDa), dp12 (4.00 kDa), 
dp16 (5.32 kDa), and dp20 (6.66 kDa). The main building block of the fragments (75%) is the 
IS disaccharide IdoUA, 2S-GlcNS, 6S, which has four negatively charged groups: three 
sulfates and one carboxylate. Because sulfation of heparin is done by sulfotransferase enzymes 
after the polymer is synthesized, there is some variation in the sulfate content of the 
disaccharide building blocks, with about 75% in the trisulfated form and 25% in the mono and 
disulfated forms [165]. For the molecular masses quoted above, we assumed full sulfation of 
the parent disaccharides, although in practice, the average sulfation of the heparin parent 
fragment is 2.5 [158], leading to a 40 dalton lower molecular mass per disaccharide as 
compared with the fully sulfated form. In addition to the fragments of defined length, we also 
did experiments on an LMWH with an average molecular mass of 5 kDa (4-6 kDa) and an 
HMWH that contains fragments from 6 to 30 kDa with most chains in the 17-19 kDa range. 
When considering the heparin fragments, it is important to note that both the molecular mass 
and the number of charges increase with increasing fragment length. Unless otherwise stated ,  
  
   102 
 
 
 
Figure A1.1. Effects of heparin fragments on 1H-15N HSQC spectra of 15N labeled amylin. The degree of 
polymerization of the heparin fragments is denoted by dp. A, control spectrum of amylin in the absence of heparin. B, 
amylin in the presence of a 1:1 molar ratio of the dp2 fragment (50 μM dp2). C, amylin in the presence of a 1:1 molar 
ratio of the dp16 fragment (50 μM dp16). D, amylin in the presence of a 1:8 molar ratio of the dp2 fragment (400 μM 
dp2). E, Data for equimolar ratios of 50 µM amylin to 50 µM dp2, dp16, and LMWH. F, Data for varying molar ratios 
of dp2 to 50 µM amylin. The crosspeak broadening data in E and F are presented as I/I(0) where, I is the crosspeak 
intensity in the presence of a given heparin fragment and I(0) is the control intensity in the absence of heparin. 
the concentrations of the heparin fragments quoted in this work are polymer concentrations (e.g. 
dp20 or dp16). For experiments in which we want to vary the chain length but keep the ionic 
strength constant, it is more useful to work with concentrations expressed in terms of saccharide 
monomers (e.g. (dp20)/20, (dp16)/16), and we explicitly note in those cases that we are reporting 
the saccharide monomer concentration. 
E 
F 
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Heparin Binds to the Positively Charged N-terminal Half of Amylin Monomers. Fig. A1.1A 
shows a two-dimensional 1H-15N HSQC spectrum of 50 μM amylin at pH 6 and a temperature of 
10 °C. Under these conditions, we see a single set of resonances corresponding to amylin 
monomers. Any fibrils formed during the 30 min time used to acquire the spectrum would be too 
large to be seen by NMR. We detected 1H-15N correlations for all 37 residues in the peptide except 
Lys-1-Asn-3, which are lost due to fast hydrogen exchange with solvent. In the presence of an 
equimolar concentration of the dp2 heparin fragment, the 1H-15N HSQC spectrum of amylin is 
unaffected (Fig. A1.1B). By contrast, in the presence of an equimolar concentration of the longer 
dp16 fragment (50 μM), resonances from residues 1-20 are broadened beyond detection, whereas 
resonances from residues 21-37 persist (Fig. A1.1C). The cross-peaks that remain in the presence 
of dp16 fragment show chemical shift changes that become progressively smaller, going from 
residue 21 to residue 37. The effects on the NMR spectrum of amylin could be due to the longer 
size of the dp16 fragment or to the presence of eight times as many negatively charged saccharide 
monomers as compared with dp2. 
 To distinguish between these possibilities, we looked at the NMR spectra of amylin in the 
presence of an excess of the dp2 fragment. At a 2:1 molar ratio of dp2: amylin, the NMR spectrum 
of amylin is largely unperturbed except for selective partial broadening of cross-peaks from 
residues 4–6, 10–12, and 18–21. These segments are close to the only four charged groups in the 
amylin sequence: the -amino group, Lys-1, Arg11, and His-18. Of these, the cross-peak for His-
18 shows the most pronounced decrease in intensity. At molar ratios of 8:1 dp2:amylin or above, 
the effects on the amylin NMR spectrum were similar to those obtained at 50 μM dp16, with 
residues 1-20 broadened beyond detection (Fig. A1.1D, E and F). Thus when the dp2 concentration 
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is increased 8-fold to give the same 400 μM charged saccharide monomer concentration as with 
an equimolar ratio of amylin:dp16, we see analogous effects on the NMR spectrum of the amylin 
monomer. This indicates that binding of heparin to amylin in its monomeric state depends on the 
amount of charged saccharide monomers rather than on the length or conformational properties of 
heparin. The NMR line broadening suggests intermediate exchange on the chemical shift 
timescale. The range of concentrations over which the effects are observed points to a Kd of 200 
μM for the binding of disaccharides to monomeric amylin. 
Fibrillization Enhancement Depends on Heparin Oligosaccharide Length. In contrast to the 
binding of heparin to amylin monomers, enhancement of amylin fibrillization depends on heparin 
fragment length. Amylin fibrillization kinetics were followed using the ThT assay; the marked 
changes in the fluorescence properties of this dye when it binds amyloid cross-sheet structures 
make it a specific probe for fibrils [23, 34, 98, 108, 166]. We first looked at the effects on amylin 
fibrillization of heparin fragments ranging from 2 to 20 saccharide monomers included in the 
reactions at a constant polymer concentration of 10 μM (Fig. A1.2A). With increasing length, 
heparin shortens the lag times for fibrillization, increases fibril growth rates, and increases the 
value of the steady-state ThT fluorescence plateau at the end of the reactions. In addition to the 
dp2-dp20 series, we also looked at the LMWH and HMWH fractions, using average molecular 
mass of 5 and 18 kDa to calculate a 10 μM concentration (Fig. A1.2A). Although the effects of the 
heparin fragments of defined length level off beyond dp12, the heterogeneous heparin fractions 
enhance amylin fibrillization more than any of the dp2–dp20 fragments. The effects of LMWH 
and HMWH are difficult to interpret because they contain a heterogeneous mixture of heparin 
fragments with a poorly defined length distribution. LMWH has fragments ranging in size from 
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dp12 to dp18 and possibly longer, whereas HMWH has fragments in a range between dp18 and 
dp90. The data for the series of defined-length fragments (dp2-dp20) shows that fibrillization is 
accelerated with increasing oligosaccharide size. In a mixture of short and large heparin fragments, 
the effects of the longest would be expected to predominate so that the enhancement of 
fibrillization would not scale with the average molecular weight. Consequently we did not include 
LMWH and HMWH in our analysis of amylin fibrillization kinetics. 
 The trend of increasing fibrillization rates with larger heparin fragments in Fig. A1.2A 
could reflect the increasing length of the oligosaccharide chains or could be due to an increase in 
the concentration of charged saccharide monomers as seen for the NMR experiments monitoring 
binding of heparin fragments to amylin monomers (Fig. A1.1). To distinguish between these 
possibilities, we carried out fibrillization reactions varying the concentration of the smallest dp2 
fragment between 50 and 500 μM (Fig. A1.2B). The fibrillization kinetics showed only small 
variations and no systematic trend with increasing concentration of dp2 (Fig. A1.2B). This 
indicates that the enhancement of amylin fibrillization depends primarily on oligosaccharide length 
rather than on the amount of charged saccharide monomers. 
 Finally, we carried out fibrillization reactions in the presence of heparin fragments of 
different lengths, varying the polymer concentration to maintain a fixed saccharide monomer 
concentration of 200 μM (Fig. A1.2C). With the charged saccharide monomer concentration fixed, 
we once again saw an increase in amylin fibrillization that depended only on the lengths of the 
heparin oligosaccharides. 
 Fig. A1.3 summarizes how the three parameters that characterize the kinetics of the amylin 
fibrillization depend on heparin fragment length. We focus our analysis on the reactions where the  
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Figure A1.2 Effects of heparin fragments on amylin fibrillization. A, fibrillization at a constant heparin polymer 
concentration of 10 μM. B, Fibrillization over a 10-fold range of dp2 concentrations from 50 to 500 μM. C, 
fibrillization over a range of fragment concentrations selected to keep the saccharide monomer concentration constant 
at 200 μM. The control sample in each series is amylin without heparin. The data are presented as averages of duplicate 
experiments. Representative standard errors are shown for the LMWH sample in panel A. 
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Figure A1.3 Kinetic parameters obtained from the data in Fig. A1.2C using a range of heparin fragment concentrations 
selected to keep the saccharide monomer concentration constant. A, lag times. B, fibrillization rates. C, ThT 
fluorescence plateaus. The data are averages of kinetic parameters obtained from duplicate runs, shown with their 
associated standard errors. The dp = 0 point corresponds to amylin in the absence of heparin. 
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heparin fragment length varies but the charged saccharide monomer concentration is fixed (Fig. 
A1.2C). With increasing oligosaccharide length, the lag time for fibrillization decreases (Fig. 
A1.3A), whereas the elongation rates (Fig. A1.3B) and steady-state fluorescence plateaus (Fig. 
A1.3C) increase. All three parameters show a sigmoidal dependence on oligosaccharide length, 
starting at dp4, reaching a mid-point near dp6, and leveling off beyond dp12. 
 To demonstrate that fibrils are formed in the presence of heparin fragments, we obtained 
electron microscopy (EM) data on aliquots taken from the stationary phases of the amylin 
fibrillization reactions of the control, dp2, dp8, and dp16 samples shown in Fig. A1.2A (Fig. A1.4). 
The images for amylin fibrils grown in the presence of heparin fragments are similar to those 
obtained for the control sample containing amylin alone. Although EM does not lend itself to 
quantifying the amounts of fibril formed, we saw a qualitative increase in the number of fibrils in 
the presence of the longer heparin fragments. The amylin fibrils grown in the presence of dp8 and 
dp16 fragments also appeared to be longer than those from the dp2 or control samples (Fig. A1.4). 
Co-localization of Heparin with Amylin Fibrils by FRET. Immunohistochemical studies have 
previously shown that the HSPG perlecan is associated with plaques of amylin isolated from 
patients with type 2 diabetes [155]. Given the complex composition of the amyloid plaques, which 
can include a variety of proteins and cofactors besides HSPGs [42, 157], we wanted to ascertain 
more directly whether GAGs are associated with amyloid fibrils using heparin as a model. To this 
end, we used FH with an average molecular mass of 17 kDa that has one fluorescein conjugated 
per heparin irrespective of the oligosaccharide size [167]. 
 Fig. A1.5A compares amylin fibrillization kinetics in the presence of ThT alone, FH alone, 
and both dyes. The data in the presence of ThT alone are typical of a fibrillization reaction. With  
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Figure A1.4. EM images of amylin taken from the plateau phases of the fibrillization reactions in Fig. A1.2A. 
 
FH alone, the fluorescence is nearly constant as amyloid starts to form. Fluorescein does not 
undergo the large changes in fluorescence properties that are a hallmark of the binding of ThT dye 
to amyloid fibrils [98]. Moreover, the spectral parameters were selected for the detection of 
amyloid-bound ThT (excitation 440 nm, emission 490 nm) rather than fluorescein (excitation 488 
nm, emission 518 nm). In the presence of both ThT and FH, we observed 50% reduction in the 
quantum yield of the amyloid-bound ThT donor due to FRET to the FH acceptor fluorophore (Fig. 
A1.5A). Additional control experiments were done to rule out that the hydrophobic fluorescein dye 
  
   110 
 
 
could be driving the interaction with amylin fibrils.  
 To further characterize FRET between FH and amyloid bound ThT, we collected emission 
spectra on a fluorescence spectrophotometer using excitation at 440 nm (Fig. A1.5B). As amylin 
fibrils started to form in the reaction, between 10 and 158 min, we saw an increase in fluorescence 
at 478 nm due to fibril-bound ThT [98] and at 508 nm due to FRET between the ThT donor and 
FH acceptor. The increases in fluorescence are accompanied by a blue shift in the FH emission 
maximum from 513 to 508 nm (Fig. A1.5B) as amylin fibrils start to grow. The increase in 
fluorescence at 508 nm was about half that at 478 nm (Fig. A1.5C), consistent with the previously 
observed 50% FRET from ThT to FH (Fig. A1.5A). The experiments indicate that the two 
fluorophores come within a 1–10-nm FRET distance [163] of each other in the presence of amylin 
fibrils. 
Co-localization of Heparin with Amylin Fibrils by TIRFM. We next examined the association 
of FH with amylin fibrils using TIRFM. The TIRFM technique has been previously used to image 
a variety of amyloid fibrils through the fluorescence of the non-covalently bound dye ThT [33, 34, 
166]. In the first experiment, we started with amylin fibrils grown in the presence of ThT, which 
were imaged using a 483-nm emission filter after excitation with a 405 nm laser. After imaging 
the fibrils using ThT fluorescence, the solution containing ThT was removed from the coverslip 
and replaced with a solution containing FH. The same area was used to image fibrils using FH 
fluorescence, detected using a 523 nm emission filter after excitation with a 488 nm laser. As 
compared with the ThT image, the FH image is more diffuse, but the same fibrils are observed 
(Fig. A1.6A). 
 ThT may remain associated to the fibrils after the addition of FH in the experiment shown  
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Figure A1.5. FRET between fibril-bound ThT and FH. A, fibrillization kinetics of amylin in the presence of ThT only, 
FH only, or ThT and FH. Fluorescence was measured with a plate reader using an excitation filter of 440 nm and an 
emission filter of 490 nm. Representative standard errors from duplicate experiments are shown for each reaction. B, 
representative emission spectra for amylin fibrillization in the presence of ThT and FH. The left arrow indicates the 
increase in quantum yield at 478 nm due to amyloid-bound ThT. The right arrow indicates the increase in quantum 
yield, as well as the blue shift in the emission maximum of FH from 513 to 508 nm as amylin fibrillization progresses 
with time. The experiments were done in a fluorescence spectrophotometer using an excitation wavelength of 440 nm. 
C, kinetics of amylin fibrillization monitored by the increase in fluorescence at 478 nm (ThT) and 508 nm (FRET 
from ThT to FH). The intensity data are from the spectra in panel B after subtracting the baseline spectrum of ThT 
and FH in the absence of amylin. 
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Table A1.1 Incorporation of FH into amylin fibrilsa.  
  
Sample  
  
Peak Fluorescence 
(cps)  
Fluorescence Retained 
(%)  
λmax  (nm)  
Initial fluorescenceb  7.416 x 106  ---  513  
Final fluorescencec  1.199 x 107  ---  508  
First filtrated  4.66 x 106  63f  512  
First filtrande  4.37 x 106  36g  508  
Second filtrated  4.14 x 105  6f (17% of first filtrand)   511  
Second filtrande  3.61 x 106  30 g (83% of first filtrand)   510  
aAmylin (5 µM) fibrillized in the presence of 0.28 mM FH was filtered through a 100 KDa MW cut-off filter to 
determine the fraction of FH associated with fibrils. 
bFluorescence at the start of the fibrillization reaction.  
cFluorescence at the end of the fibrillization reaction.  
dFluorescence of the FH fraction that passed through the 100 kDa cut-off filter.  
eFluorescence of the FH fraction retained in the 100 kDa cut-off filter.  
fFluorescence normalized to the initial value at the start of the reaction, assuming this represents free FH. 
gFluorescence normalized to the final value at the end of the reaction, assuming this represents fibrilbound FH. 
in Fig. A1.6A. The spectral parameters used to obtain the image after the addition of FH (488 nm 
excitation, 513 nm emission) should be selective for FH, although there is a chance we could still 
be detecting ThT fluorescence because the emission maxima of ThT and FH are separated by only 
25 nm. To rule out that the fibrils were detected through ThT fluorescence, we did a second 
experiment in which we grew fibrils in the presence of only FH (Fig. A1.6B). We once again 
obtained images of species with a fibrillar morphology detected using FH fluorescence. The 
solution containing FH was replaced by a ThT solution followed by imaging of the same section 
replaced with the ThT solution. A number of species with fibrillar morphology of the coverslip 
using ThT fluorescence filters. As compared with the image obtained using ThT fluorescence, the 
image obtained using FH fluorescence shows additional globular species, which are no longer seen 
when the FH solution is replaced with the ThT solution. Presumably these was (indicated by 
  
   113 
 
 
arrows) are seen in both images, however, demonstrating that FH and ThT bind to the same 
individual fibrils. In this regard, it is interesting to note that a very recent confocal microscopy 
study reported co-localization of FH with amyloid fibrils [168]. In a final experiment, we grew 
amylin fibrils in the absence of fluorophores and then added FH. Within 5 min of adding FH, we 
saw species with a fibrillar morphology (Fig. A1.6C). The experiment demonstrated that like ThT 
[34], FH can bind rapidly to fibrils after they are formed. 
Amylin Fibrils Contain Weakly and Tightly Bound Heparin. To determine whether heparin is 
incorporated into amylin fibrils, we carried out a fibrillization experiment using 5 μM amylin in 
the presence of 0.28 μM FH. After the fibrillization reaction was complete, the sample was run 
through a 100 kDa cutoff centrifugal filter. A 36% fraction of the fluorescence was retained in the 
filter, whereas 63% passed through the filter corresponding to unbound FH or FH bound to amylin 
species with a molecular mass smaller than 100 kDa. The fibrils and FH retained in the filter were 
washed with deionized water and run through the 100 kDa filter a second time. After the second 
filtration, 30% of the initial fluorescence was retained in the filter, corresponding to an FH that is 
tightly bound to the fibrils (Table A1.1). The results of the experiment with amylin are similar to 
those previously reported for -synuclein fibrils grown in the presence of FH [108], where 15% of 
FH was incorporated into the fibrils, 12% was weakly associated, and the remainder of the FH was 
not bound [108]. 
Effect of Heparin Fragments on Amylin Cytotoxicity. We next wanted to see whether heparin 
fragments had an impact on amylin cytotoxicity to a MIN6 mouse cell line model of pancreatic β 
cells [164]. There are conflicting reports regarding whether amylin is cytotoxic when added as a 
freshly dissolved peptide or in its fibrillar form [10-12, 169]. To address this, we first looked at 
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the dependence of cytotoxicity on amylin concentration using either freshly dissolved amylin or 
mature amylin fibrils formed over 2 days (48 h). With freshly dissolved amylin, we saw an 
apparent concentration mid-point at 25 μM amylin, with cell viability reaching 50% asymptotic 
minimum at amylin concentrations 40 μM (Fig. A1.7A, solid line). By contrast, with mature amylin 
fibrils, cytotoxicity appeared to be independent of peptide concentration within experimental error 
(Fig. A1.7A, dashed line), giving an average cell viability of 71 ± 4% over the five points sampled 
in the 1-80 μM amylin concentration range. The lowered cytotoxicity with mature fibrils as 
compared with freshly dissolved amylin is consistent with previous reports [10, 12, 169]. The lack 
of a concentration dependence for mature fibrils is puzzling and could signify an equilibrium 
between non-toxic fibrils and a toxic species. The latter toxic species could be formed 
simultaneously with the fibrils or could dissociate from them when they are transferred to cell 
cultures.   
 The lack of an apparent concentration dependence could be due to a limiting factor for the 
toxic species such as its solubility. Although with the mature fibrils the reaction has reached a 
steady state, with fresh amylin, the reaction is ongoing so that the toxic species could be 
replenished as the reaction proceeds in the presence of the cells. A possible precedent for such a 
mechanism has been recently reported for mouse prion, where the levels of a distinct toxic species 
are uncoupled from the titer of infective prion [170]. 
 Fig. A1.7B summarizes the effects of heparin on cytotoxicity obtained with either fresh 
amylin or amylin fibrils. The first column shows untreated cells. The Alamar Blue fluorescence of 
all other experiments was normalized to the untreated cells, which were assigned a cell viability 
of 100%. The next five experiments show controls. The 1% DMSO vehicle present in all experiments 
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Figure A1.6. TIRFM images of fibrils formed from a 100 μM amylin sample detected with ThT and FH fluorophores. 
A, fibrils grown for 210 min in the presence of 15 μM ThT followed by the addition of FH to a final concentration of 
0.3 μM. B, fibrils grown for 210 min in the presence of 0.3 μM FH followed by the addition of ThT to a final 
concentration of 15 μM. Arrows indicate examples of species with a fibrillar morphology that are observed in both 
images. C, fibrils grown for 240 min without dye followed by the addition of FH to a final concentration of 1 μM. The 
images on the right-hand side were obtained within 5 min of adding the respective fluorescence probes. 
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Figure A1.7. Amylin cytotoxicity toward mouse MIN6 cells (38). The data are presented as means S.E. from 
experiments done in triplicate. A, concentration dependence of cytotoxicity for freshly dissolved amylin and amylin 
fibrillized for 2 days. B, effects of heparin fragments on amylin cytotoxicity. The first five experiments (white bars) 
are controls: untreated MIN6 cells; 1% DMSO, which was present in all experiments except the first; dp2, dp8, and 
dp20 oligosaccharides at 80 μM concentrations in the absence of amylin; and a 5 μM bee venom melittin positive 
control. The next five experiments (striped bars) are for freshly dissolved amylin, alone or in the presence of 
oligosaccharides. The next five experiments (gray bars) are for amylin fibrils formed for 2 days in the absence or 
presence of the indicated oligosaccharides. 
except the untreated cells had no effect on cell viability. The dp2, dp8, and dp20 heparin fragments by 
themselves also had little effect on cell viability. The bee venom toxin melittin, used as a positive control, 
reduced cell viability to 45 % at a 5 μM concentration. The next series of five experiments (striped 
columns) looks at the effects of freshly dissolved amylin. Amylin alone at a 40 μM concentration reduced 
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cell viability to 61%. Amylin together with an 80 μM concentration of the longest dp20 heparin fragment 
had a similar cell viability of 68%. Inclusion of the short dp8 and dp2 oligosaccharides res cued cell 
viabilities to levels of 93 and 96%, respectively. We also looked at the effects of adding a mixture of 80 
μM dp2 and 80 μM dp20 to 40 μM amylin, which gave a cell viability of 90%. This value is greater than 
the average of the data for the individual dp2 and dp20 oligosaccharides (82%), indicating that the dp2 
disaccharide has a protective effect even in the presence of the longer dp20 heparin fragment. The last 
set of five experiments looks at amylin fibrils (Fig. A1.7B, gray columns). The trends are similar, 
although less clear, because the fibril samples had less of an effect than freshly dissolved amylin. Amylin 
fibrils grown in the presence of the dp20 and dp8 oligosaccharides showed reduced cell viabilities of 66 
and 73%, respectively. Fibrils grown in the presence of dp2 or of a mixture of the dp2 and dp20 fragments 
gave cell viabilities approaching those of the untreated cells. 
Discussion 
 HSPGs and GAGs are ubiquitous components of the extracellular matrix that are found in 
association with amyloid deposits formed by a variety of disease-linked proteins [42, 157] including 
amylin [155]. GAGs have been shown to enhance the fibrillization of amylin in vitro [153, 154, 158]. 
The interaction of heparin with proamylin has also been investigated because GAGs could play a role in 
amyloidosis of the incompletely processed hormone [152, 160]. Finally, heparin is given as an 
anticoagulant to diabetic patients receiving pancreas transplants and could contribute to graft dysfunction 
by stimulating amylin fibrillization [171]. To better understand how GAGs affect amylin dysfunction, 
we characterized the interaction of heparin with amylin and looked at the effects of heparin fragments on 
amylin cytotoxicity. 
 NMR experiments show that heparin binds to the positively charged N-terminal half of amylin 
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(Fig. A1.1). Binding does not depend on the length of heparin fragments but on the concentration of 
negatively charged saccharide monomers, in as much as the broadening effects on the amylin NMR 
spectrum with dp16 can be replicated with an 8-fold excess of the shorter dp2 fragment. Neutralization 
of the positive charges on amylin by the negative charges on heparin would render the peptide more 
hydrophobic, thus facilitating aggregation and fibrillization. In this regard, it is worth noting that the loss 
of a single charge on His-18 at high pH dramatically increases the rate of amylin fibrillization [23, 151]. 
 By contrast, the enhancement of amylin fibrillization by heparin depends on oligosaccharide 
length rather than the amount of charged monosaccharaides (Fig. A1.2). The oligosaccharide length 
dependence is sigmoidal (Fig. A1.3), with an enhancement of fibrillogenesis starting at four monomers 
(dp4) and leveling off beyond 12 monomers (dp12). Heparin adopts a left-handed helix structure with a 
21 symmetry axis and four sugar residues per turn, based on solution NMR studies [172, 173]. The length 
dependences of the kinetic parameters in Fig. A1.3 suggest that a minimum of one turn of heparin helix 
is needed to favor amylin fibrillization and that enhancement of fibrillization begins to level off beyond 
three turns of the heparin helix. Heparin is the most negatively charged naturally occurring biopolymer 
known, and its binding to proteins is mediated through electrostatic interactions with basic groups in 
proteins [174]. We have proposed that electrostatic repulsion between like charges, replicated by the 
symmetry of the cross- structure along the length of fibrils, could be one of the main forces opposing 
fibrillogenesis [175]. The heparin polyanion could aid fibrillogenesis by providing a suitable scaffold to 
complement the positive charges displayed on the surfaces of amylin fibrils. Indeed, it has been shown 
that the enhancement of amylin fibrillization drops by 86%, going from heparin to completely desulfated 
heparin, emphasizing the importance of charge-coupling in the interactions between the two polymers 
[158]. 
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 Heparin is composed of the disaccharide unit iduronic acid (IdoUA)-glucosamine (GlcN). In the 
heparin structure determined by NMR (PDB code: 1HPN), the 6S sulfate of residue GlcN (i-1), the 2S 
sulfate of residue IdoUA (i), the NS sulfate of residue GlcN (i1), and the carboxyl C of residue IdoUA 
(i2) form an array of negative charges on one side of the heparin helix. The distances between the charged 
groups vary between 6.1 Å for the 2S(IdoUA) to NS(GlcN) contact and 7.1 Å for the NS(GlcN) to 
C(IdoUA) contact. After a 7.3 Å contact between C(IdoUA) and 6S(GlcN), the pattern is repeated on the 
same side of the helix for the next four saccharide monomers. In the structure of amylin fibrils based on 
solid-state NMR [25], the average spacing between positively charged groups on alternate amylin 
monomers laying along the fibril axis is 5.8 Å for His-18 (Cγ toms) and 6.7 Å for Arg-11 (Cz atoms). 
Thus the spacing of negative charges in the heparin helix is complimentary to the spacing of positive 
charges from alternating amylin monomers running along the fibril axis. Because heparin has a flexible 
structure that can kink to achieve optimal binding to proteins [174, 176] and because side chains can 
adjust in both polymers, the match may be even better than suggested by considering individual 
structures. Our conclusions about the structural basis of interactions between amylin fibrils and heparin 
are supported by recent molecular dynamics modeling of the interactions of amyloid with GAGs [168]. 
 Although amylin fibrils are formed in the presence of heparin fragments of various lengths (Fig. 
A1.4), the effects of the oligosaccharides on fibrillization could be catalytic or could involve association 
with the fibrils. Our FRET (Fig. A1.5) and TIRFM (Fig. A1.6) data indicate that heparin associates with 
amylin fibrils during fibrillogenesis. TIRFM also indicates that heparin can bind to amylin fibrils after 
they are formed (Fig. A1.6C). Filtration experiments suggest that of the fluorescein-tagged heparin bound 
to amylin fibrils, a fraction of 83% is tightly associated, whereas another 17% is weakly associated. 
Because heparin affects fibrillization kinetics and associates with fibrils, we wanted to see whether there 
  
   120 
 
 
is an effect on the biological activity of amylin. GAGs could increase cytotoxicity simply by enhancing 
fibrillogenesis. Alternatively, fibrils could disrupt normal function by sequestering important 
components of the extracellular matrix [40]. In contrast to these hypotheses, a number of recent reports 
indicate that heparin [177-179] as well as other GAGs [180] reduce the cytotoxicity of the Alzheimer 
amyloid peptide and of the aortic amyloid peptide medin [181]. In the present work, we found that the 
cytotoxicity of amylin toward a mouse model of -pancreatic cells depends on heparin fragment length 
(Fig. A1.7). Amylin in the presence of the longest dp20 heparin fragment has a cytotoxicity comparable 
with amylin alone. By contrast, the shortest dp2 fragment protects against cytotoxicity with both freshly 
dissolved and fibrillar amylin samples. 
 The protective effects of the dp2 fragment are intriguing but will need further study to establish 
a mechanistic basis. Based on the current data, we can conclude that the effects of the heparin fragments 
on cytotoxicity are probably unrelated to their effects on fibrillization kinetics. The dp2 fragment has 
negligible effects on amylin fibrillization kinetics (Figs. A1.2B and A1.3) yet protects against cytotoxicity 
(Fig. A1.7B). By contrast, the dp20 fragment enhances amylin fibrillization (Figs. A1.2B and A1.3), yet 
amylin cytotoxicity is similar in the presence and absence of dp20 (Fig. A1.7B). One possibility is that 
the heparin fragments exert their effects on soluble amylin oligomers or some other species and that these 
rather than the fibrils are cytotoxic [10, 12, 169, 179]. The roles of putative intermediates in cytotoxicity 
remain poorly characterized and controversial not only for amylin but for other amyloidogenic proteins 
[14, 16]. An alternative possibility is that the structure or surface properties of the fibrils differ in the 
presence of heparin fragments of different lengths in a way that affects their interactions with β cells 
[180]. Finally, heparin fragments could affect cofactor molecules [178] that mediate the interactions of 
amylin with β cells. 
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Excerpted from: Croke, R. L., Patil, S. M., Quevreaux, J., Kendall, D. A. and Alexandrescu, A. T. (2011), 
NMR determination of pKa values in α-synuclein. Protein Science, 20: 256–269. 
I and Dr. Robyn Croke performed NMR experiment and data analysis (Figures A1-1 to A1-5) 
Dr. Jason Quevreaux performed protein synthesis 
Appendix II: NMR determination of pKa values in α-Synuclein 
Abstract 
  The intrinsically unfolded protein α-Synuclein, which is involved in Parkinson’s disease, has an 
N-terminal domain with seven imperfect repeats of the sequence KTKEGV and a C-terminal domain 
with a large proportion of acidic residues. To better understand the charge properties of α-Synuclein, 2D 
1H-15N HSQC and 3D C(CO)NH NMR experiments were used to determine pKa values for all 26 sites 
in the 140 amino acid protein that ionize below pH 7. In the absence of salt, pKa values of aspartate and 
glutamate residues from the first 100 residues are systematically lowered compared to random coil model 
compounds suggestive of weak ion pair interactions between acidic and basic residues in the KTKEGV 
repeats. By contrast, the pKa values of acidic residues from the last 40 residues are raised due to 
electrostatic repulsion between negatively charged residues in the C-terminal tail.  The effects are smaller 
but persist at a physiological salt concentration. Determination of pKa values for α-Synuclein in a 
membrane-like environment is hampered by the deterioration of NMR spectra of the protein bound to 
SDS micelles below pH 5, as the C-terminal tail becomes uncharged. Nevertheless, we could characterize 
the titration of His50, which has pKa raised by 1.5 pH units when α-Synuclein is bound to SDS micelles 
compared to the free monomer. pH titrations for His50 in the disease-linked mutants E46K and A53T 
show that this shift is primarily due to interactions between the histidine and SDS, with electrostatic 
interactions between His50 and Glu46 in the a-helical structure playing a much smaller role. Our results 
indicate that the pKa values of intrinsically unfolded α-Synuclein differ significantly from those of 
random coil model compounds and that electrostatic interactions may help nucleate protein misfolding. 
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Introduction 
 Alpha-Synuclein (αS) is a 14.5 kDa protein expressed predominantly at the pre-synaptic 
terminals of brain neurons [182, 183].  The physiological function of the protein remains unknown 
[182] although a role in synaptic vesicle recycling has been suggested [184, 185].  Misfolding of 
αS leads to the formation of fibrillar cytoplasmic aggregates [107, 186] called Lewy bodies which 
are a defining characteristic of Parkinson’s disease [187-190].  Because the number of Lewy bodies 
is often poorly correlated with the severity of Parkinson’s disease symptoms controversy surrounds 
the issue of whether fibrils or smaller soluble oligomers are responsible for the neurotoxicity of 
misfolded αS [48].  Regardless of the mechanism of neurotoxicity, genetic evidence establishes a 
link between the αS gene (SNCA) and Parkinson’s disease.  Although 90-95% cases of Parkinson’s 
disease cases are sporadic [191], the autosomal-dominant familial mutations A30P, E46K, A53T, 
as well as the triplication of the wild-type SNCA gene lead to early onset of the disease [182, 187, 
192, 193]. 
 The amino acid sequence of αS can be conceptually subdivided into three domains with an 
unusual distributions of charged residues (Fig. A2.1A).  The first 90 residues of  αS contain seven 
imperfect repeats of the amino acid sequence xKTKEGVxxxx [194], which have been shown to 
be important for the induction of α-helical structure in αS [195] and for the binding of the protein 
to the negatively charged lipids it prefers [195-197].  Residues 61-95 of αS correspond to the 
hydrophobic “non-amyloid-β component” (NAC), the most aggregation-prone part of the protein 
[198-203].  The name NAC, derives from the occurrence of this segment as a second protein 
component of the extracellular amyloid-β plaques found in patients with Alzheimer’s disease 
[204].  The mechanism by which the NAC fragment of the intracellular αS is cleaved and comes  
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Figure A2.1 Sequence of αS and structure of the protein bound to SDS micelles.  (A) The three domains of the αS 
amino acid sequence and the locations of the seven xKTKEGVxxxx repeats [194]. (B) Structure of αS bound to SDS 
micelles [197], showing the side-chains of residues that are positively (blue) or negatively charged (red) at neutral pH.  
(C) Expanded view of the micelle-bound αS structure showing the location of His50 compared to Glu46 and Ala53 
(the sites of the familial Parkinson’s mutations E46K and A53T). 
to be associated with extracellular amyloid-β plaques is unknown.  The last two of the KTKEGV 
repeats occur within the NAC segment [194], however, due to the imperfect nature of the repeats 
only two charged residues occur in the hydrophobic region 62-95: Lys 80 and Glu 83.  The last 40 
amino acids of αS contain a large proportion of acidic residues, giving the C-terminal tail of the 
protein a pronounced negatively charged character at physiological pH.      
Monomeric αS is intrinsically unfolded with a fractional population of at most 10-20% 
α-helix structure [201, 205].  The first ~90 residues of the protein fold into an α-helical 
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structure in the membrane-like environments provided by micelles, vesicles, or bilayers that 
contain a large fraction of negatively charged lipids [2, 76, 200, 206, 207].  By contrast, the 
negatively charged C-terminal tail remains disordered when αS binds to lipid assemblies [2, 
27, 76, 197].  The highest-resolution structure available for αS in a membrane environment, is 
for the protein bound to sodium dodecylsulfate (SDS) micelles [197].  Although the SDS 
detergent is not physiological, it forms relatively small micelles that are amenable to direct 
high-resolution NMR studies [27, 197].  When bound to SDS micelles, the amphipathic N-
terminal domain forms two long α-helices that lie on the surface of the micelle.  The hairpin 
structure is likely an artifact of the small size of SDS micelles.  With larger lipid assemblies 
that approach the sizes of synaptic vesicles, αS folds into a single uninterrupted α -helix [206, 
208].  The structure of αS bound to SDS micelles is shown in Fig. A2.1B.  The view of the 
structure is opposite to the face of the protein that interacts with SDS micelles [197]. Charged 
residues are shown in blue (positive) and red (negative).  In an α-helix, residues separated by 
three or four positions in the sequence have the potential to form ion-pairs [209].  
Consideration of the αS sequence and structure suggests that residues in the amphipathic 
domain of the protein are poised to form electrostatic interactions between acidic and basic 
amino acids, including the pairs Asp2-Lys6, Lys10-Glu13, Glu20-Lys23, Glu28-Lys32, 
Lys32-Glu35, Lys42-Glu46, Glu46-His50, Glu57-Lys60, Lys58-Glu61, and Lys80-Glu83.  By 
contrast, the negatively charged residues in the C-terminal tail could be subject to electrostatic 
repulsion due to a high density of like charges.  It is important to note that the structure of αS 
bound to SDS micelles was determined entirely with perdeuterated protein samples using NMR 
experiments that look at the protein backbone [197].  As such there is no information on the 
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conformations of side-chains in the αS structure; these are shown in random orientations in 
Fig. A.1B and A2.1C.  
To better understand the role of charges in αS structure we determined pKa values for 
the 26 sites in monomeric αS that ionize below pH 7.  In the absence of salt, we see pKa 
deviations up to 0.6 pH units compared to random coil model compounds.  Sites in the first 
100 residues have pKa values lowered compared to random coil values, while those in the last 
40 residues are raised.  The pH titrations were repeated in the presence of 150 mM NaCl.  
While the effects are smaller the same sequence pattern is observed.  We tried obtaining 
titration data for αS bound to SDS micelles but the NMR spectrum of the protein deteriorates 
below pH 5 as the acidic residues in the C-terminal tail become neutralized.  We thus focused 
on the pH titration of His50, a residue of particular interest.  His50 has been identified as the 
high-affinity binding-site for Cu2+, a metal which has been implicated in Parkinson’s disease 
and that markedly increases the fibrillization rates of αS [210].  Moreover, in the αS structure 
His50 is within one turn of α-helix of the sites of the two familial Parkinson’s disease mutations 
E46K and A53T (Fig. A2.1C). We wanted to obtain data on the ionization of His50 to test the 
hypothesis that the E46K and A53T mutations perturb the electrostatic properties of His50.   
  The pKa data reported in this work provides a foundation for understanding the roles of 
charges in the αS structure.  A number of studies have shown that pKa values of unfolded 
proteins deviate from random coil model compounds [211-215].  The unusual distribution of 
charged residues in αS provides a stringent test of the assumption that pKa values of residues 
in unfolded proteins are approximated by those in random coils.   The unfolded state is an 
important reference state for theoretical calculations of the roles of charges in protein structure 
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stabilization [212, 215-217].  Accurate pKa values for unfolded αS will help the analysis of the 
effects of protonation of residues on the structures of membrane-bound and fibrillar αS.   
Materials and Methods 
Materials - The peptides Ac-AADAA-NH2 and Ac-AAEAA-NH2 used to obtain random coil 
pKa values for Asp and Glu were prepared by solid-phase synthesis at > 95% purity by NEO-
Peptide (Cambridge, MA).  Deuterated SDS (d25-sodium dodecyl sulfate) was from Cambridge 
Isotopes (Andover, MA).  The chemical shift standard 2, 2-Dimethyl-2-silapentane-5-sulfonate 
(DSS) was from Sigma (St. Louis, MO). 
Site-Directed Mutagenesis of αS - The E46K and A53T mutants were prepared starting from 
the pT7-7/asyn-WT vector [218] which was a gift from the  Lansbury lab (Harvard Medical 
School).  Oligonucleotide primers were purchased from Integrated DNA Technologies 
(Coralville, IA).  For E46K, the forward primer was 5'-CC AAA ACC AAG AAG GGA GTG 
GTG-3' and the reverse primer 5'-CAC CAC TCC CTT CTT GGT TTT GG-3'.  For A53T, the 
forward primer was 5'-GTG CAT GGT GTG ACG ACA GTG GCT GAG-3' and the reverse 
primer 5'-CTC AGC CAC TGT CGT CAC ACC ATG CAC-3'. Site-directed mutagenesis was 
performed using the QuikChange protocol, utilizing PFU Turbo Polymerase from Stratagene 
(La Jolla, CA). The PCR product was purified using digestion with the restriction endonuclease 
DpnI from New England Biolabs (Ipswich, MA) at 37 oC, followed by transformation into 
Stratagene E. coli BL21 (DE3)-pLysS cells according to the manufacturer’s instructions.  
Sequences of the αS clones were verified using Beckman Coulter CEQ 2000 Dye Terminator 
Cycle Sequencing at the UConn Biotechnology facility.  
Expression and Purification of αS - Expression and purification of αS was carried out 
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according to published methods [205, 219].  Cells were grown in M9 minimal media 
supplemented with 1 g/L 15N ammonium chloride and/or 3 g/L 13C-glucose at a temperature of 
37°C and a shaker speed of 250 rpm.  To make unlabeled protein the M9 media was 
supplemented with the same amounts of ammonium chloride and glucose at natural isotopic 
abundance.  Ampicillin (100 µg/mL) was used to select for the ampicillin resistance marker in 
the pT7-7/asyn-WT vector, and 37 µg/mL chloramphenicol was used to maintain the pLysS 
copy number.  When the cells reached an OD600 of 0.6, αS expression was induced by addition 
of IPTG to a final concentration of 1 mM, and the cells were incubated for an additional 4 h at 
37°C.  Cells were collected by sedimentation at 4 oC for 30 min in a GSA rotor operating at 
4294 rpm.  The cell pellet was resuspended in lysis buffer (10mM Tris at pH 8.0, 1 mM EDTA, 
1 mM PMSF, 1mM DTT and a few crystals of RNase, DNase and lysozyme) and sonicated at 
70% (pulse 45 sec, delay 15 sec) for ten minutes on a Fisher Scientific Sonic Dismembrator  
Model 500.  After sonication, the cell lysate was boiled for 20 min and the cell debris was 
separated by sedimentation for 30 min at 12,800 rpm at a temperature of 4 C.  The supernatant 
was boiled again for 20 min, taking advantage of the heat stability of αS to achieve partial 
purification from other proteins in the lysate [220, 221], and the precipitate was removed by 
sedimentation for 30 min at 12,800 rpm and 4 oC.  The resulting supernatant was subject to 
ammonium sulfate precipitation (361g/L) for 1 hr at 4C, followed by collection of the pellet 
containing αS by sedimentation for 30 min at 12,800 rpm, 4C.  The ammonium sulfate 
precipitate containing αS was resuspended in 20 mM Na2HPO4, pH 7.4 and dialyzed overnight 
against the same buffer, followed by application on an Amersham Q-Sepharose Fast Flow 
anion exchange column. A linear 1M NaCl gradient was used to elute αS.  SDS -PAGE was 
  
   128 
 
 
used to identify column fractions containing αS, the fractions were pooled and dialyzed for 
24h against 20 mM Na2HPO4, pH 7.4.  The αS purified in this way was determined to be at 
least 90% homogeneous by 15% tricine gel electrophoresis and electrospray ionization (ESI) 
mass spectroscopy.  Final yields of purified αS were about 50 mg per liter of E. coli culture.  
Prior to use, purified αS samples were stored at –80°C in 20 mM Na2HPO4, pH 7.4 containing 
0.02% NaN3. 
pH Titrations - The pH titrations of free αS (Fig. A2.2 and A2.3), αS in the presence of SDS 
micelles (Fig. A2.4), and random coil model peptides were performed on samples dissolved in 
90% H2O /10% D2O.  All αS and peptide samples used in this study were initially in 20 mM 
sodium phosphate buffer at pH 7.4.  The sample pH was adjusted by adding aliquots of 1 M 
HCl and NaOH stock solutions.  For comparisons of the titration of His50 in WT αS, E46K-
αS and A53T-αS in the presence of d25-SDS micelles (Fig. A2.5) samples were dissolved in 
99.96% D2O and pH adjustments were made using 1 M stock solutions of DCl and NaOD.  
For pH measurements in aqueous solution we used a Mettler (Columbus, OH) Inlab 
Micro pH glass electrode.  For any solutions containing SDS we used a PH46-SS probe metal 
electrode from IQ Scientific (Loveland, CO) since trace amounts of KCl from glass electrodes 
precipitate SDS.  Three-point electrode calibrations (pH 4, 7, 10) were done before each pH 
titration. Solution pH values were measured before and after each experiment with typical 
differences between measurements of less than 0.05 to 0.1 pH units.  The average of the pH 
measurements before and after the NMR experiment was taken as the solution pH.  We found 
that the following protocol reduces fluctuations in pH measurements before and after NMR 
experiments.  The pH after the NMR experiment is measured by transferring the sample from 
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the NMR tube to an Eppendorf tube.  For the next pH value, HCl or NaOH are added to 
adjust the pH, the sample is stirred on a Vortex mixer, transferred to the NMR tube, and then 
back to the Eppendorf for the pH measurement before the NMR experiment.  This minimizes 
pH fluctuations from traces of the sample before the pH adjustment that remain in the NMR 
tube.  The same NMR tube, Eppendorf tube, and pipette for transferring samples were used 
throughout the entire pH titration.  For the pH titrations samples were contained in 5 mm 
(Wilmad 535-pp) NMR tubes, with a larger initial volume (0.75 to 1.0 ml) than the 
recommended 0.6 ml, to make up for sample losses due to pipetting and pH measurements 
during the titration. 
NMR Spectroscopy - NMR experiments were done on a Varian 600 MHz instrument 
equipped with a cryogenic probe.  The αS concentration for all experiments was 0.25 mM.  
DSS was used as an internal 1H chemical shift reference standard for all experiments. 13C 
and 15N chemical shifts were referenced indirectly as described in the literature [222].  The 
pH titration of 13C,15N-labeled αS in the absence of salt was characterized with twelve 3D 
C(CO)NH and 2D 1H-15N HSQC experiments recorded between pH 7.4 and pH 1.5.  Eleven 
experiments over the same pH range and were used to determine pKa values for αS in the 
presence of 150 mM NaCl.  An additional four 2D 1H-15N HSQC experiments were recorded 
up to pH 8.1 for each titration, to define the high pH chemical shift plateau of the His 50 
backbone 15N resonance.  Experiments on αS in the absence of micelles were done at 10 oC 
to prevent loss of amide proton signals due to fast exchange with solvent [205].  Experiments 
of αS in the presence of SDS micelles were done at 37 oC since lower temperatures reduce 
the quality of NMR spectra [2].   
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The peptides Ac-AADAA-NH2 and Ac-AAEAA-NH2, dissolved to 3 mM 
concentrations in 90% H2O /10 % D2O were used to determine random coil pKa values for 
Asp and Glu. The titration of the peptides in the absence of salt was followed using twelve 
1D 1H NMR spectra recorded between 6.7 and 1.7.  For experiments in the presence of 150 
mM NaCl ten spectra were obtained between pH 6.4 and 2.4.  All peptide experiments were 
done at a temperature of 10 oC for direct comparison with the αS data. 
The titration of 13C, 15N-labeled αS in the presence of SDS micelles was characterized 
with sixteen 2D 1H-15N HSQC and 1D 13C-filtered aromatic spectra (50 mM SDS) collected 
between pH 10.4 and 4.2.  Four representative pH points that show the deterioration of 1H-
15N HSQC spectra below ~pH 5.0 are shown in Fig. A2.4. The titration of His50 in WT, 
E46K and A53T αS was monitored by 1D 1H NMR using with protein samples at natural 
isotopic abundance in the presence of 50 mM d25-SDS dissolved in 99.96% D2O.  For each 
of the experiments at least twelve spectra were recorded between pH 9.7 and 5.6 (Fig. A2.5)  
The following spectral parameters were used for NMR experiments.  1D 1H NMR 
spectra were collected with spectral windows of 8000 Hz digitized into 2048 complex points.   
2D 1H-15N HSQC spectra were acquired with 1H x 15N spectral windows of 1024 x 128 Hz 
digitized into 6000 x 1380 complex points.  The total acquisition time for each spectrum was 
10 min.  3D C(CO)NH spectra were acquired with 1H x 13C x 15N spectral windows of 6000 
x 8800 x 1380 Hz digitized into 1024 x 64 x 32 complex points.  The total acquisition time 
for each spectrum was 12 hr. 
NMR Data Analysis - Identification of NMR signals over the pH range studied was 
facilitated by published 1H, 15N and 13C assignments for αS at pH 7 [223], pH 3 [201], as 
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well as data on the pH dependence of αS NMR spectra from our lab [205].  For 1D spectra, 
chemical shifts at the various pH values were obtained from the center of the peak envelope.  
For 2D and 3D spectra, 1D traces were extracted along the frequency of the nucleus of 
interest.  The traces were phased as necessary before measuring chemical shifts from the 
center of the peak envelope. 
The pH dependence of chemical shifts was analyzed using non-linear least squares 
fits of the data to the modified Henderson-Hasselbach equation [224, 225]: 
                                             δ = δ low −
δ low−δ high
1+10n(pKa−pH)
                                                  Eq. A2.1 
Where, the pKa is the ionization constant, low is the low pH chemical shift plateau, high is 
the high pH chemical shift plateau, and n is the apparent Hill coefficient.  The parameters 
obtained from the fits and their associated standard errors are given in Table A2.1. 
Results 
pKa Values for αS in the Absence of Salt. Ionization constants for aspartate and glutamate 
residues in αS were obtained from 3D C(CO)NH experiments recorded at different pH 
values.  The C(CO)NH experiment [226] correlates the amide of a given residue with all the 
aliphatic 13C resonances of the preceding residue.  The experiment circumvents the spectral 
overlap typically encountered for Asp and Glu side-chains, which is particularly severe for 
an unfolded protein like αS, by correlating these spin systems with the well dispersed 
nitrogens of the following residues in the amino acid sequence.  Fortuitously, the strongest 
crosspeaks were from the aliphatic carbons closest to the titrating carboxyl groups of the 
acidic residues.   
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Figure A2.2 Representative pH titration data.  (A) Superposed 2D strips from twelve 3D C(CO)NH experiments used 
to determine pKa values for Glu and Asp residues in the absence and presence of 150 mM NaCl.  Contours are shown 
for residues Glu28 and Glu114 on a red (neutral) to blue (acidic) color ramp using data collected between pH 7.4 
(black) and pH 1.5 (blue).  The individual pH values are shown in panels B and C.  The width of the strips in the HN 
dimension is 0.1 ppm.  The contours centered at ~38 ppm in the strips for Glu114 are from another spin system that 
appears in the same HN and N frequency range at low pH.  (B) pH titration data for Glu28 and Glu114 in the absence 
of salt.  (C) pH titration data for Glu28 and Glu114 in the presence of 150 mM NaCl.  The curves are non-linear least 
squares fits of the data to Eq. A2.1, used to obtain the titration parameters in Table A2.1. 
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Representative data for Glu28 and Glu114 showing superimpositions of 2D slices from the 3D 
C(CO)NH experiments obtained at pH values between 7.4 and 1.5 are shown in Fig. A2.2A. The 
pH dependence of the Cγ chemical shifts of Glu28 and Glu114 in the absence  of salt is shown 
in Fig. A2.2B. The glutamate Cγ carbons shift from ~37 ppm at neutral pH, to ~33 ppm at acidic 
pH.  For the aspartate Cβ carbons the corresponding shift is between ~42 and ~38 ppm.  The Cα 
resonances are also sensitive to the titration of the carboxyl groups but the pH dependence of 
these shifts is much smaller, typically from ~57.0 to ~56.0 ppm for glutamate and ~54.5 to ~53.0 
ppm for aspartate between neutral and acidic pH. 
The 3D C(CO)NH experiment enabled us to obtain data for 21 of the 26 sites that ionize 
between neutral and acidic pH in αS.  The sites that could not be characterized with the C(CO)NH 
experiment were His50, Glu61, Asp119, Glu137, and the α-carboxyl group at the C-terminus.  
Two of these sites are in the residue pairs D119-P120 and E137-P138 since prolines lack an 
amide proton we could not use the 3D C(CO)NH experiment to follow the pH titration of the 
preceding residues. Similarly, the α-carboxyl group is at the end of the sequence (Ala140) and 
the titration of His50 involves the ionization of an aromatic side-chain that cannot be detected 
in the C(CO)NH experiment.  For these sites pKa values were obtained by monitoring the pH 
dependence of 1H-15N correlations in 2D 1H-15N HSQC spectra.  In the case of Glu61, the 
E61(Cγ)-Q62(HN) spin system occurs as a partially overlapped shoulder on the E114(Cγ)-
D115(HN) spin system throughout most of the pH transition.  While we could obtain accurate 
data for the Cγ resonance of Glu114 from the C(CO)NH experiments the titration of Glu61 was 
more accurately determined from the 15N resonance in 2D 1H-15N HSQC experiments.  
Consistent with previous results on unfolded proteins [227] we found that the 15N shifts of 
  
   134 
 
 
ionizable residues in αS are dominated by the protonation of the residue’s own side-chain. 
Protonation of residues more than one position removed in the amino acid sequence have 
negligible effects on backbone 15N chemical shifts.   
The KTKEGV repeats in the amphipathic region of αS give seven instances of Glu-Gly 
pairs (Fig. A2.1A). In the 3D C(CO)NH experiments the E83(Cγ)-G84(HN) and E131(Cγ)-
G132(HN) spin systems are well resolved so that unambiguous pKa values were obtained for 
Glu83 and Glu131. The two correlations E35(Cγ)-G36(HN) and E110(Cγ)-G111(HN) overlap 
between pH 7.4 and 4.0 but separate at lower pH.  We based our assignments on a slightly 
more downfield 15N chemical shift of 110.9 for Gly111 compared to 110.5 for Gly36 [201].  
The assignment is tentative, however, as indicated in Table A2.1.  The three correlations 
E13(Cγ)-G14(HN), E46(Cγ)-G47(HN) and E105(Cγ)-G106(HN) are unresolved throughout 
the entire pH range in the absence of salt.  We assigned the parameters obtained from the 
unresolved pH titration of the group to all three residues Glu13, Glu46, and Glu105.  We 
estimate the pKa values of the three individual residues differ by at most 0.1 pH unit from the 
unresolved pKa of 4.21. pH titration parameters for αS are summarized in Table A2.1.  In the 
absence of salt, the pKa values of the 18 Glu residues in αS are spread over 0.8 pH units while 
those of the 6 Asp residues are spread over 1.0 pH units.  The ranges are large for an unfolded 
protein and comparable to those of ionizable residues on the surfaces of folded proteins [212, 
214, 216]. The pKa values of the intrinsically unfolded αS show a pronounced dependence on 
residue position in the amino acid sequence (Table A2.1). Acidic residues within the first 100 
amino acids of αS have lowered pKa values indicating a lower affinity for protons (hydronium 
ions) such that they resist losing their negative charge.   
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Table A2.1.  pKa Values of S in the absence and presence of salt.a      
                               No salt                          150 mM NaCl  
Site    pKa       n low high     pKa
      n low high Resonance
 
Asp2 3.61±0.05 1.30±0.21 38.64±0.09 41.99±0.06 3.63±0.04 1.00±0.08 122.81±0.05 124.92±0.03 Cd 
Glu13c 4.21±0.06 0.90±0.08 33.11±0.08 36.79±0.08 4.32±0.09 1.42±0.35 32.85±0.14 36.24±0.16 C 
Glu20 4.07±0.04 0.93±0.06 33.10±0.05 36.74±0.04 4.24±0.04 0.90±0.08 32.77±0.19 36.49±0.18 C 
Glu28 4.20±0.06 0.96±0.09 33.16±0.08 36.92±0.08 4.27±0.04 0.85±0.06 32.77±0.06 36.50±0.06 C 
Glu35b 4.17±0.06 0.93±0.08 33.11±0.07 36.69±0.07 4.08±0.13 0.88±0.20 30.42±0.41 36.39±0.29 C 
Glu46 c 4.21±0.06 0.90±0.08 33.11±0.08 36.79±0.08 4.31±0.10 0.86±0.15 32.99±0.18 36.39±0.13 C 
His50 6.78±0.04 1.08±0.08 123.11±0.02 125.05±0.06 6.52±0.07 1.52±0.37 123.45±0.02 125.05±0.05 N 
Glu57 4.20±0.05 0.94±0.08 33.10±0.07 36.87±0.07 4.33±0.09 0.76±0.11 32.89±0.13 36.49±0.13 C 
Glu61 4.04±0.27 0.86±0.35 121.05±0.07 121.70±0.08 3.97±0.06 1.12±0.22 121.35±0.04 122.07±0.02 N 
Glu83 4.35±0.05 1.07±0.10 33.14±0.06 36.71±0.07 4.33±0.03 0.91±0.05 32.70±0.05 36.32±0.05 C 
Asp98 3.68±0.06 0.87±0.11 38.23±0.10 41.56±0.07 4.00±0.03 1.44±0.16 38.60±0.05 41.01±0.04 C 
Glu104 4.39±0.13 1.12±0.26 33.13±0.15 36.74±0.17 4.51±0.11 1.01±0.17 33.02±0.12 36.36±0.14 C 
Glu105c 4.21±0.06 0.90±0.08 33.10±0.08 36.79±0.08 4.49±0.17 1.04±0.35 33.85±0.18 36.33±0.20 C 
Glu110 b 4.50±0.09 0.98±0.19 34.34±0.06 36.71±0.08 4.31±0.07 0.85±0.09 32.65±0.12 36.36±0.10 C 
Glu114 4.70±0.05 0.86±0.08 33.09±0.06 36.97±0.09 4.49±0.09 0.64±0.08 32.59±0.13 36.58±0.14 C 
Asp115 4.15±0.05 0.76±0.06 38.18±0.06 41.69±0.05 4.18±0.09 0.94±0.16 38.10±0.12 41.11±0.11 C 
Asp119 4.02±0.07 0.69±0.06 122.85±0.08 125.87±0.06 3.99±0.02 0.77±0.03 123.27±0.03 126.20±0.02 N 
Asp121 4.62±0.06 0.97±0.08 39.11±0.03 41.43±0.06 4.39±0.03 0.78±0.04 117.42±0.03 119.36±0.03 Cd 
Glu123 4.87±0.05 0.77±0.06 33.16±0.05 36.95±0.08 4.69±0.10 0.78±0.12 32.69±0.13 36.46±0.16 C 
Glu126 4.89±0.06 0.97±0.18 32.53±0.08 36.72±0.14 4.55±0.10 0.91±0.16 32.03±0.16 36.12±0.19 C 
Glu130 4.53±0.06 0.85±0.09 33.09±0.09 36.82±0.09 4.40±0.09 1.09±0.22 33.05±0.14 36.38±0.15 C 
Glu131 4.58±0.05 0.93±0.09 33.26±0.06 36.84±0.07 4.71±0.15 0.61±0.12 32.80±0.22 37.09±0.27 C 
Asp135 4.16±0.07 0.70±0.06 38.18±0.08 41.74±0.08 4.05±0.06 0.77±0.07 37.88±0.09 41.16±0.07 C 
Glu137 4.82±0.16 0.56±0.11 123.36±0.11 125.77±0.17 4.42±0.03 0.92±0.05 123.88±0.02 125.56±0.02 N 
Glu139 4.69±0.04 0.97±0.10 33.14±0.06 36.99±0.08 4.54±0.06 0.84±0.09 32.72±0.09 36.62±0.11 C 
-CO2- 3.65±0.03 1.10±0.07 8.537±0.006 8.081±0.003 3.67±0.03 1.01±0.06 8.541±0.007 8.087±0.005 HN(A140) 
aAll values are for a temperature of 10 oC.  
bThe assignments for Glu35 and Glu110 are tentative due to spectral overlap and may be reversed. 
c Glu13, Glu46 and Glu105 titrate as a single unresolved group and the three residues are assigned the same parameters 
in the absence of salt.  The pH titration of the three residues can be resolved in the presence of 150 mM NaCl. 
dThe pKa values of Asp2 and Asp121 were determined from Cβ chemical shifts in the absence of salt and 15N chemical 
shifts in the presence of 150 mM salt. 
  Sites within the last 40 residues have raised pKa values indicating a higher affinity for 
protons, which would facilitate the neutralization of acidic residues in the C-terminal tail compared 
to the N-terminal amphipathic domain.  
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pKa Values for αS in the Presence of Salt. Deviations of pKa values from random coil model 
compounds have been reported for other unfolded proteins [211, 212, 214, 215] and the differences 
were found to decrease with increasing salt concentration [213].  To obtain pKa data at a 
physiological salt concentration we characterized the pH titration of αS in the presence of 150 mM 
NaCl (Fig. A2.2A, C).  The analysis of the data was similar to that for αS in the absence of salt.  
We determined pKa values for 20 of 26 sites from 3D C(CO)NH experiments.  The pH titrations 
of His50, Asp119, Glu137 and the C-terminal α-carboxyl group are not amenable to C(CO)NH 
spectroscopy and were determined using 2D 1H-15N HSQC spectra (Table A2.1).  The pKa values 
for two additional residues (Asp2, Asp121) were determined from 15N shifts in 1H-15N HSQC 
spectra because of overlap in the C(CO)NH experiments.  For αS in the presence of 150 mM NaCl 
we were able to resolve the pH titrations of all seven Glu(Cγ)-Gly(HN) spin systems although the 
assignments of E35 and E110 remain tentative and could be reversed (Table A2.1). The spread of 
pKa values in the presence of 150 mM NaCl is smaller than in the absence of salt, as exemplified 
by the representative titrations of residues E28 and E114 (compare Fig. A2.2B,C).  The distribution 
of smaller pKa values in the N-terminal domain and larger pKa values in the C-terminal domain is 
less pronounced but persists when αS is studied in the presence of 150 mM NaCl (Table A2.1). 
Differences from Random Coil pKa Values - To analyze the pKa data for αS we needed to obtain 
reference values for residues in random coil conformations.  Random coil pKa values are available 
in the literature [228-230] but to obtain accurate values for Glu and Asp residues which account 
for 24 of the 26 ionizable sites in this study, we carried out 1H NMR pH titrations on the model 
peptides Ac-AADAA-NH2 and Ac-AAEAA-NH2 under the exact same conditions used for 
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the pH titrations for αS.  The two Hα protons of the aspartate in the Ac-AADAA-NH2 peptide, 
which gave the same pKa within experimental uncertainty, were used to obtain an ionization 
constant for aspartate.  The Hγ protons of the glutamate in the Ac-AAEAA-NH2, which have 
degenerate chemical shifts throughout the entire pH range studied, were used to obtain an 
ionization constant for glutamate.  The random coil pKa values we obtained for aspartate were 4.00 
± 0.02 in the absence of salt and 3.94 ± 0.02 in the presence of salt.  For glutamate the pKa values 
were 4.42 ± 0.02 in the absence of salt and 4.38 ± 0.02 in the presence of 150 mM NaCl.  Our 
values are somewhat higher than those recently determined by the Pace group (3.67 for Asp, 4.25 
for Glu) using potentiometry of the same peptides at a temperature of 25 oC and in the presence of 
100 mM NaCl [230].  The values we obtained are in very good agreement with those reported for 
model peptides at 25 oC by potentiometry [228] (4.0 for Asp, 4.4 Glu) and NMR [229] (3.84 for 
Asp, 4.32 for Glu) respectively.  For histidine which occurs only once at position 50 in αS, we 
used a published random coil pKa of 6.54 ± 0.04 [228-230].  For the α-carboxyl group at the C-
terminus we used a random coil pKa of 3.67 ± 0.03 [230].   
 Differences between random coil and αS pKa values are shown in Fig. A2.3A for the 
protein without salt and Fig. A2.3B for the protein in the presence of 150 mM NaCl.  Uncertainty 
bars were calculated from the propagation of standard errors obtained from the least squares fits 
of the αS and the model peptide pH titration data.  Alternatively, if we consider that the primary 
source of errors in the pH titrations is the accuracy of the pH measurements which in our study is 
on the order of 0.05 to 0.1 pH units, the uncertainties in the pKa differences are between 0.07 to 0.14 
pH units.  Acidic residues from the N-terminal amphipathic domain of αS show uniformly negative 
differences (Fig. A2.3A) with pKa values lowered on average by 0.24 pH units from random coil 
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Figure A2.3 Differences between αS and random coil pKa values (pKa, αS – pKa, r.c.).  (A) αS In the absence of salt,  (B) 
αS in the presence of 150 mM NaCl.  The pKa values for αS are given in Table A2.1.  Random coil values were 
obtained from NMR titrations of the model peptides Ac-AAEAA-NH2 and Ac-AADAA-NH2 as described in the text.  
Random coil values for a histidine side-chain and the C-terminal α-carboxyl group were taken from published values 
[230].  For His50 the difference was multiplied by -1 since this group gains a positive charge, in contrast to the acidic 
groups which lose a negative charge at low pH.  Uncertainty bars were calculated using propagation of the standard 
errors obtained from fits of the αS pH titration data (Table A2.1) and the model peptide pH titration data.  All data 
were obtained at a temperature of 10 oC. 
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values.  In the C-terminal tail the differences are positive, with pKa values of acidic residues raised 
on average by 0.24 pH units compared to the corresponding random coil values.  The switch-point 
from positive to negative differences occurs between residues Glu105 and Glu110, just outside the 
amphipathic and NAC domains, at the start of the acidic C-terminal tail.  In the presence of 150 
mM NaCl (Fig. A2.3B) the differences between αS and random coil pKa values are lowered but 
maintain the same pattern, with residues from the N-terminal domain showing negative differences 
(average = 0.10) and those from the C-terminus showing positive differences (average = 0.15). 
The switch-point in the sequence occurs roughly nearby the demarcation of the amphipathic and 
acidic domains between residues D98 and E114. 
Figure A2.4 Representative data from a pH titration of αS bound to SDS micelles.  (A) 1H-15N HSQC spectra showing 
the deterioration of backbone 1H-15N below pH ~5.4.  (B) 13C-filtered aromatic spectra of αS in the presence of SDS 
showing the titration of the His50 Hε1 proton, which shifts from 7.6 to 8.6 ppm as the pH is lowered.  Samples 
contained 0.2 mM αS and 40 mM SDS in 90% H2O/10% D2O, and were recorded at a temperature of 37 oC. 
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The N- and C-terminal domains also show small differences in the parameter n, the Hill 
coefficient for the pH titration. The Hill coefficient (Eq. A2.1) describes the cooperativity of pH 
titrations [231].  Values of n less than 1 are associated with negative cooperativity, while n greater 
than 1 corresponds to positive cooperativity [231, 232].  The Hill coefficients for most sites in αS 
are very close to unity (Table A2.1).  Nevertheless, the average values for residues 1-105 are 
significantly larger than for residues 110-140: 0.98 versus 0.86 (statistical significance, P < 0.03) 
in the absence of salt; 1.06 versus 0.84 (P < 0.01) in the presence of salt.  The ionization of sites 
at the N-terminus thus appears to be more cooperative than at the C-terminus. 
pH Titration of αS Bound to SDS Micelles. We next tried to obtain information on ionization 
constants in the membrane-like environment provided by SDS micelles, where αS adopts the α-
helical hairpin structure shown in Fig. A2.1 [197].  As shown in Fig. A2.4A, 1H-15N HSQC spectra 
of αS in the presence of 50 mM SDS markedly deteriorate below ~pH 5.4 resulting in loss of cross-
peaks due to line-broadening accompanying the protonation of Asp and Glu residues in the protein.  
The mid-point of the transition occurs near pH 5.2, about 0.8 and 1.2 pH units above the random 
coil pKa values of Glu and Asp, respectively.  As we have described for amyloid-beta(1-40), the 
pKa values of acidic residues are uniformly raised in proteins bound to SDS micelles, due to 
electrostatic repulsion between the negatively charged side-chains and negatively charged sulfate 
groups on the SDS micelles [41]. At the present time we do not know the cause of the line-
broadening of NMR signals from micelle-bound αS at low pH.   One possibility is that the affinity 
of αS for SDS micelles decreases at low pH, which would result in loss of resonances due to fast 
solvent exchange from the αS monomers dissociated from the micelles at the 37 oC.  This seems 
unlikely, however, since the loss of negative charges at low pH should favor the binding of αS to 
  
   141 
 
 
negatively charged SDS micelles.  A more likely explanation is that neutralization of the negative 
charges in the C-terminal domain perturbs the structure of the αS-micelle complex, possibly by 
favoring aggregation of the protein through the C-terminal tail which at physiological pH is kept 
unfolded and away from the micelle by the high density of negatively charged residues in its 
sequence.  The poor quality of the spectra below pH 5.4 precluded the analysis of the protonation 
of Asp and Glu residues. 
 By contrast to the backbone 1H and 15N resonances, the aromatic Cε1 proton of His50 can 
still be seen at low pH presumably because of the high flexibility of this side-chain in the complex 
(Fig. A2.4B). In the WT αS bound to SDS micelles His50 titrates with a pKa of 8.06, with the 
titration reaching a low-pH chemical shift plateau by pH 6 (Fig. A2.5). Note that the titration of 
His50 is complete (Fig. A2.5) before broadening of crosspeaks is observed in 1H-15N HSQC 
spectra below pH 5.4 (Fig. A2.4A). The changes in the spectrum associated with the protonation 
of the C-terminal tail do not affect the pKa value obtained for His 50.   Under the same conditions 
(37 oC, 99.96% D2O) free αS has a pKa of 6.3 [41].  The pKa of His50 is thus raised by ~1.8 pH 
units when WT αS binds to SDS micelles compared to the unbound state.  The raised pKa of His50 
indicates that protonation is facilitated in the micelle bound state, either because the charged form 
of the histidine ion-pairs with Glu46 in the α-helical structure adopted by the micelle-bound protein 
(Fig. A2.1) or because the positively charged histidine interacts with the negatively charged sulfate 
groups of SDS.  To distinguish between these possibilities we collected titration data for His 50 in 
the Parkinson’s disease-linked mutants E46K and A53T (Fig. A2.5). Glu46 is the only negatively 
charged residue positioned to form an ion pair with the charged form of His50 in the α-helical 
structure of micelle-bound αS.  The E46K mutant, which replaces the glutamate with a positively 
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Figure A2.5 pH titrations for the His50 Hε1 proton of αS bound to SDS micelles.   The samples contained 99.96% 
D2O solutions of 0.2 mM protein and 50 mM SDS (0.8 mM SDS micelles).  All data were collected at 37 oC.   The 
parameters obtained from least-squares fits of the titration data were: WT - pKa = 8.06 ± 0.01, n = 0.90 ± 0.02; E46K 
- pKa = 7.86 ± 0.03, n = 0.89 ± 0.06; A53T - pKa = 7.97 ± 0.02, n = 0.85 ± 0.02.  For WT αS under the same conditions 
in the absence of SDS micelles [41], we obtained pKa = 6.33 ± 0.02, n = 0.99 ± 0.04. 
charged lysine gives a pKa of 7.86 for His50 in micelle-bound αS (Fig. A2.5). The pKa shift of -
0.2 pH units from the WT is comparable to the shifts for residues positioned to form ion pairs in 
the N-terminal domain of uncomplexed αS (Table A2.1, Fig. A2.3). For A53T the pKa shift of -
0.1 pH units is intermediate and close to the experimental uncertainty.  With both mutants the pKa 
perturbations are much smaller than the difference of ~1.8 pH units between free and micelle-
bound αS.  We can thus safely conclude that the pKa perturbation of His50 in micelle bound αS is 
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dominated by the interaction of the histidine cation with the negatively charged sulfate groups on 
the surface of the micelle.  
We looked for alternative membrane mimetics amenable to NMR studies of αS including 
micelles composed of the negatively charged lipid LPPG (1-palmitoyl-2-hydroxy-sn-glycero-3-
phospho-RAC-(1-glycerol)), the neutral lipid LMPC (1-myristoyl-2-hydroxy-sn-glycero-3-
phosphocholine) and the neutral detergent DPC (dodecyl phosphocholine).  Besides SDS, only 
LPPG gave a complete set of 1H-15N HSQC resonances for αS but the NMR spectra were of poorer 
quality than with SDS micelles (A.T.A and Andrew Mehta, unpublished results).  High-quality 
NMR spectra have been recently demonstrated [223] for αS complexed to micelles of the 
surfactant SLAS (sodium lauroyl sarcosinate) but like SDS and LPPG, the detergent is negatively 
charged and would be expected to perturb the pKa values of αS.  With neutral DPC micelles, we 
confirmed that αS binds only weakly [198], such that most of the 1H-15N HSQC correlations from 
the N-terminal domain of αS are lost due to fast hydrogen exchange through the free form of the 
protein, which is in dynamic equilibrium with the micelle bound form.  Since αS requires 
negatively charged lipids to bind to membranes we explored the amenability of mixed DPC/SDS 
micelles for NMR studies.  Starting from micelles composed of the neutral DPC detergent we 
gradually added negatively charged SDS detergent.  Below DPC: SDS molar ratios of 70:30 the 
1H-15N HSQC spectra of αS were poor with most 1H-15N resonances lost due to fast solvent 
exchange.  At a DPC:SDS molar ratio of 70:30 the 1H-15N HSQC spectrum was comparable to 
that of αS with pure SDS micelles [197] but resonances were still too broad for the more 
demanding C(CO)NH experiments used to determine pKa values.  Thus the characterization of pKa 
values for αS in a membrane-like environment is limited by the requirement of a small micelle size 
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amenable to direct NMR studies coupled with the requirement of micelles containing a high 
proportion of negatively charged lipids or surfactants that interfere with the characterization of 
ionization constants of titratable groups from the protein.  While charge coupling between Glu46 
and His50 is small when αS is bound to SDS micelles, this need not be the case when the protein 
is bound to physiological lipid bilayers with a lower proportion of negatively charged lipids.  
Discussion 
The pKa values obtained for αS in this work show surprisingly large differences from 
random coil values considering that the protein is intrinsically unfolded (Fig. A2.3).  The results 
are consistent with previous findings that ionizable sites in unfolded proteins can have electrostatic 
environments that are poorly approximated by random coil models of proteins [211, 212, 214, 215, 
233].  Site-specific pKa values are important for modeling the contributions of charges to protein 
structure [212, 216, 217, 233] and we anticipate that our data for the unfolded reference state will 
help analyze the contributions of charges to the fibrillar and membrane bound structures of αS. 
The sequence of αS is organized into an amphipathic domain (residues 1-100) consisting 
of seven imperfect KTKEGV repeats that have the potential to form ion pairs between acidic and 
basic residues and a C-terminal domain (residues 101-140) that has a high density of negatively 
charged residues at neutral pH.  The uniformly raised pKa values of acidic groups from the C-
terminal domain suggest that these sites experience electrostatic repulsion between like charges, 
which should have the effect of keeping this segment in extended disordered conformations.  
Functionally, the C-terminal tail may help αS recognize binding partners on the surfaces of lipid 
membranes [2].  Neutralization of the charges in the C-terminal tail by polycations [234] or low 
pH [201-203] enhances the aggregation and fibrillization of αS.  Similarly deletion of the C-
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terminal tail enhances the rate of fibrillization [84].  The loss of charges from the C-terminal tail 
of αS at low pH also appears to increase the aggregation of the protein in the membrane-like 
environment provided by SDS micelles (Fig. A2.4A). For the free protein it has been recently 
shown that removal of charges from the C-terminal tail causes a conformational transition that 
leads to transient interactions between the C-terminal and the non-polar NAC domain.  This state 
of αS aggregates with faster rates than the state populated at neutral pH [201-203].  The 
conformational transition leads to small changes in backbone chemical shifts of ~0.3 ppm for the 
Cα carbons of residues from the C-terminus [201, 202] but is unlikely to affect the pKa 
measurements in the present study.  First, the pH titrations of most residues in αS were followed 
by side-chain carbons which undergo much larger changes in chemical shifts with pH, on the order 
of 3 to 4 ppm (Table A2.1, Fig. A2. 2).  The chemical shifts of side-chain carbons from acidic 
residues are affected by the protonation of carboxyl groups but are much less sensitive to any 
residual secondary structure in the protein.  Second, the differences in pKa values correspond to 
differences in the mid-points of the pH transitions.  The limiting low- and high-pH chemical shift 
plateau values of side-chain 13C resonances in αS are similar and show no dependence on residue 
position in the sequence (Table A2.1). 
In contrast to the C-terminal tail, residues from the N-terminal domain show pKa values 
that are uniformly lowered compared to random coil values (Fig. A2.3).  This behavior indicates 
that acidic residues from the N-terminal domain resist losing their negative charges, becoming 
neutralized at larger hydronium ion concentrations (lower pH) than the corresponding amino acids 
from the C-terminal tail of αS, or random coil peptides.  The lowered pKa values suggest that the 
negatively charged acidic sites in the N-terminal domain form nascent ion-pair interactions with 
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positively charged basic amino acids in the KTKEGV repeats.  Although 150 mM NaCl screens 
the nascent electrostatic interactions they persist at a physiological salt concentration (Fig. 
A2.3B). The observed average pKa shifts of -0.10 (with salt) to -0.25 (no salt) pH units for 
acidic residues in the N-terminal domain of αS, correspond to stabilizing ∆∆G titr contributions 
of only -0.1 to -0.3 kcal/mol at 10 oC.  As such the effects of individual ion pairs on the stability 
of α-helix structure in αS are negligible being less than 1 kT (0.56 kcal/mol at 10 oC).  In 
analogy to other proteins, rather than stabilizing structure, nascent ion pair interactions may 
be more important in nucleating the folding of α-helix structure [235, 236].  Once an ion pair 
is formed it would allow localized folding which could then propagate α-helical structure 
through the rest of the N-terminal amphipathic domain.  The slightly raised n values for the 
acidic residues in the N-terminal domain are consistent with cooperativity amongst the 
ionization reactions of these residues. Nucleation of αS folding could occur in the cytosol, with 
α-helical structures selected for membrane binding.  Alternatively, the folding of α-helix 
structure may occur after the protein binds to the surfaces of lipid bilayers.  In addition to 
facilitating folding of αS into an α-helix structure, nascent ion-pairs in the N-terminal domain 
may decrease the rates of misfolding of the protein into alternative toxic conformations.  That 
is, the sequence of the N-terminal domain could offer protection from αS misfolding additional 
to that provided by the highly negatively charged sequence of the C-terminal tail.  In this 
regard, it is interesting to note that reducing the number of KTKEGV repeats in αS increases 
the rate of fibrillization, while increasing the number of repeats has the opposite effect [194]. 
αS is primarily distributed in the cytosol [237].  The membrane-bound protein which 
accounts for only ~15% of Synuclein in the brain, however, is probably the functional form, and 
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membranes may play role in αS aggregation [187, 237].  It would clearly be desirable to have 
information on the electrostatic properties of αS in membrane-like environments.  The highest-
resolution structural data for αS in a membrane-like environment has come from NMR but the 
technique is limited by the sizes and types of complexes that can be studied.  Although indirect 
NMR studies have recently provided information on the interactions of αS with lipid assemblies 
as large as vesicles [200], direct NMR studies which afford the highest resolution, typically require 
that the protein is tightly bound to lipid assemblies and that the sizes of the complexes are below 
~50 kDa [197].  While not physiological, micelles composed of the detergent SDS meet the 
requirements of tight association and small complex size for detailed NMR studies [76, 197, 238].  
For the purposes of investigating pKa values, SDS micelles pose the complication of presenting a 
high density of negative charges from the sulfate groups on the surface of the micelle.  Studies 
with the Aβ (1-40) peptide show that SDS micelles strongly perturb the electrostatic properties of 
ionizable residues with both acidic and basic residues experiencing increases in pKa values of 1 to 
2 pH units. These effects are specific to proteins and peptides since the pKa of single amino acids 
are unperturbed in the presence of SDS micelles [239].  The pKa shifts observed for proteins bound 
to SDS micelles, however, do not appear to depend on the context of the ionizable site within the 
protein structure or on the degree of interaction with the micelle [41].   
When αS is bound to SDS micelles the pKa values of His50 is raised by 1.8 pH units 
compared to the free protein.  This residue is of particular interest since it is flanked within a turn 
of α-helix by the sites of the early-onset Parkinson’s disease mutations E46K and A53T.  The 
E46K mutant breaks the pattern of acidic residues alternating with basic residues  with an i, i+3 or 
i, i+4 spacing in the N-terminal domain of αS (Fig. A2.1A).  To see if the raised pKa value of His50 
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in αS complexed to SDS micelles is due to an electrostatic interaction within the protein or between 
the histidine and the micelle, we obtained titration data for His50 in the micelle-bound form of the 
E46K mutant.  In the E46K mutant the pKa value of His 50 is lowered by 0.2 pH units from 8.06 
to 7.86 but is still 1.6 pH units higher than that of the histidine in natively unfolded WT αS.  Based 
on these observations we conclude that there is only a weak charge-charge interaction between 
Glu46 and His50.  The large pKa shift of His50 when αS binds to SDS micelles is due to ion pairing 
between the histidine cation and the anionic sulfate groups on the surface of the micelle.  In more 
physiological membrane where the density of negatively charged lipids is lower the interaction 
between Glu46 and His50 may be stronger.  Considering the sequence of αS (Fig. A2.1A) the 
possibility also exists that Glu46 could interact with Lys43 in addition or in lieu of His50.  Lys43 
occurs in the break between the two α-helices in the structure of αS  bound to SDS micelles so that 
it is not positioned to interact with Glu46 (Fig. A2.1B, C).  In lipid vesicles, however, αS folds 
into a single uninterrupted α-helix [206, 208] so it is possible that the two residues ion-pair when 
αS folds into an uninterrupted α-helix on the surfaces of physiological lipid bilayers. 
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